SONOCO PRODUCTS CO, 10-K filed on 2/28/2025
Annual Report
v3.25.0.1
Cover - USD ($)
12 Months Ended
Dec. 31, 2024
Feb. 14, 2025
Jun. 30, 2024
Cover [Abstract]      
Document Type 10-K    
Document Annual Report true    
Document Period End Date Dec. 31, 2024    
Current Fiscal Year End Date --12-31    
Document Transition Report false    
Entity File Number 001-11261    
Entity Registrant Name SONOCO PRODUCTS COMPANY    
Entity Incorporation, State or Country Code SC    
Entity Tax Identification Number 57-0248420    
Entity Address, Address Line One 1 N. Second St.    
Entity Address, City or Town Hartsville    
Entity Address, State or Province SC    
Entity Address, Postal Zip Code 29550    
City Area Code 843    
Local Phone Number 383-7000    
Title of 12(b) Security No par value common stock    
Trading Symbol SON    
Security Exchange Name NYSE    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
ICFR Auditor Attestation Flag true    
Document Financial Statement Error Correction false    
Entity Shell Company false    
Entity Public Float     $ 4,956,942,593
Entity Common Stock, Shares Outstanding   98,313,581  
Documents Incorporated by Reference
Portions of the Proxy Statement for the annual meeting of shareholders to be held on April 16, 2025, which statement shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates, are incorporated by reference in Part III.
   
Entity Central Index Key 0000091767    
Document Fiscal Year Focus 2024    
Document Fiscal Period Focus FY    
Amendment Flag false    
v3.25.0.1
Audit Information
12 Months Ended
Dec. 31, 2024
Audit Information [Abstract]  
Auditor Firm ID 238
Auditor Name PricewaterhouseCoopers LLP
Auditor Location Charlotte, North Carolina
v3.25.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 431,010 $ 138,895
Trade accounts receivable, net of allowances of $10,989 in 2024 and $18,868 in 2023 907,526 686,278
Other receivables 175,877 57,967
Inventories    
Finished and in process 494,090 238,395
Materials and supplies 522,049 365,253
Prepaid expenses 197,134 103,959
Current assets of discontinued operations 450,874 459,618
Total Current Assets 3,178,560 2,050,365
Property, Plant and Equipment, Net 2,718,747 1,662,767
Goodwill 2,525,657 1,298,011
Other Intangible Assets, Net 2,586,698 726,557
Long-term Deferred Income Taxes 17,371 30,623
Right of Use Asset-Operating Leases 307,688 233,461
Other Assets 208,759 206,064
Non-current assets of discontinued operations 964,310 984,109
Total Assets 12,507,790 7,191,957
Current Liabilities    
Payable to suppliers 1,130,500 537,877
Accrued expenses and other 463,543 265,432
Accrued wages and other compensation 140,912 63,767
Notes payable and current portion of long-term debt 2,054,525 38,934
Accrued taxes 6,755 10,863
Current liabilities of discontinued operations 242,056 248,404
Total Current Liabilities 4,038,291 1,165,277
Long-term Debt 4,985,496 2,998,002
Noncurrent Operating Lease Liabilities 258,735 192,703
Pension and Other Postretirement Benefits 180,827 142,784
Deferred Income Taxes 583,470 93,854
Other Liabilities 60,847 49,362
Non-current liabilities of discontinued operations 113,911 118,140
Total Liabilities 10,221,577 4,760,122
Commitments and Contingencies (Note 18)
Sonoco Shareholders’ Equity    
Serial preferred stock, no par value Authorized 30,000,000 shares 0 shares issued and outstanding as of December 31, 2024 and 2023
Common shares, no par value Authorized 300,000 shares 98,258 and 97,957 shares issued and outstanding as of December 31, 2024 and 2023, respectively 7,175 7,175
Capital in excess of stated value 183,250 159,047
Accumulated other comprehensive loss (502,734) (366,262)
Retained earnings 2,583,923 2,624,380
Total Sonoco Shareholders’ Equity 2,271,614 2,424,340
Noncontrolling Interests 14,599 7,495
Total Equity 2,286,213 2,431,835
Total Liabilities and Equity $ 12,507,790 $ 7,191,957
v3.25.0.1
CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Statement of Financial Position [Abstract]    
Allowances for trade accounts receivable $ 10,989 $ 18,868
Preferred stock, authorized (in shares) 30,000,000 30,000,000
Preferred stock, issued (in shares) 0 0
Preferred stock, outstanding (in shares) 0 0
Common stock, authorized (in shares) 300,000,000 300,000,000
Common stock, issued (in shares) 98,260,000 97,957,000
Common stock, outstanding (in shares) 98,260,000 97,957,000
v3.25.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 5,305,365 $ 5,441,426 $ 5,859,327
Cost of sales 4,166,132 4,238,857 4,634,009
Gross profit 1,139,233 1,202,569 1,225,318
Selling, general and administrative expenses 723,833 644,540 609,578
Restructuring/Asset impairment charges 65,370 47,909 52,385
(Loss)/Gain on divestiture of business and other assets (23,452) 78,929 0
Operating profit 326,578 589,049 563,355
Other (expenses)/income, net (104,200) 39,657 0
Non-operating pension costs 13,842 14,312 7,073
Interest expense 172,620 135,393 100,875
Interest income 27,570 10,026 4,527
Income from continuing operations before income taxes 63,486 489,027 459,934
Provision for income taxes 5,509 119,730 95,731
Income before equity in earnings of affiliates 57,977 369,297 364,203
Equity in earnings of affiliates, net of tax 9,588 10,347 14,207
Net income from continuing operations 67,565 379,644 378,410
Net income from discontinued operations 96,375 96,257 88,570
Net income 163,940 475,901 466,980
Net loss/(income) from continuing operations attributable to noncontrolling interests 180 (768) (284)
Net income from discontinued operations attributable to noncontrolling interests (171) (174) (259)
Net income attributable to Sonoco $ 163,949 $ 474,959 $ 466,437
Weighted average common shares outstanding:      
Basic (in shares) 98,637 98,294 97,991
Assuming exercise of awards (in shares) 653 596 741
Diluted (in shares) 99,290 98,890 98,732
Basic earnings per common share:      
Continuing operations (usd per share) $ 0.69 $ 3.85 $ 3.86
Discontinued operations (usd per share) 0.97 0.98 0.90
Basic earnings per share attributable to Sonoco (usd per share) 1.66 4.83 4.76
Diluted earnings per common share:      
Continuing operations (usd per share) 0.68 3.83 3.83
Diluted - attributable to Sonoco discontinued operations (usd per share) 0.97 0.97 0.89
Diluted earnings per share attributable to Sonoco (usd per share) $ 1.65 $ 4.80 $ 4.72
v3.25.0.1
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Statement of Comprehensive Income [Abstract]      
Net income $ 163,940 $ 475,901 $ 466,980
Other comprehensive (loss)/income      
Foreign currency translation adjustments (143,730) 70,308 (68,780)
Changes in defined benefit plans, net of tax [1] 9,014 (8,654) 424
Change in derivative financial instruments, net of tax [1] (2,133) 1,737 (1,842)
Other comprehensive (loss)/income (136,849) 63,391 (70,198)
Comprehensive income 27,091 539,292 396,782
Net loss/(income) from continuing operations attributable to noncontrolling interests 180 (768) (284)
Net income from discontinued operations attributable to noncontrolling interests (171) (174) (259)
Other comprehensive loss/(income) attributable to noncontrolling interests 377 430 (460)
Comprehensive income attributable to Sonoco $ 27,477 $ 538,780 $ 395,779
[1] net of tax
v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Non- controlling Interests
Beginning balance at Dec. 31, 2021 $ 1,849,541 $ 7,175 $ 119,690 $ (359,425) $ 2,070,005 $ 12,096
Beginning Balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 466,980       466,437 543
Other comprehensive (loss)/income            
Translation (loss)/income (68,780)     (69,240)   460
Defined benefit plan adjustment [1] 424     424    
Derivative financial instruments [1] (1,842)     (1,842)    
Other comprehensive (loss)/income (70,198)     (70,658)   460
Purchase of noncontrolling interest (13,196)   (7,080)     (6,116)
Dividends (188,259)       (188,259)  
Issuance of stock awards 1,167   1,167      
Issuance of stock awards (in shares)   354        
Shares repurchased (4,547)   (4,547)      
Shares repurchased (in shares)   (79)        
Share-based compensation 31,309   31,309      
Ending balance at Dec. 31, 2022 2,072,797 $ 7,175 140,539 (430,083) 2,348,183 6,983
Ending Balance (in shares) at Dec. 31, 2022   97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) 475,901       474,959 942
Other comprehensive (loss)/income            
Translation (loss)/income 70,308     70,738   (430)
Defined benefit plan adjustment [1] (8,654)     (8,654)    
Derivative financial instruments [1] 1,737     1,737    
Other comprehensive (loss)/income 63,391     63,821   (430)
Dividends (198,762)       (198,762)  
Issuance of stock awards 1,345   1,345      
Issuance of stock awards (in shares)   488        
Shares repurchased (10,617)   (10,617)      
Shares repurchased (in shares)   (176)        
Share-based compensation 27,780   27,780      
Ending balance at Dec. 31, 2023 $ 2,431,835 $ 7,175 159,047 (366,262) 2,624,380 7,495
Ending Balance (in shares) at Dec. 31, 2023 97,957 97,957        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income/(loss) $ 163,940       163,949 (9)
Other comprehensive (loss)/income            
Translation (loss)/income (143,730)     (143,353)   (377)
Defined benefit plan adjustment [1] 9,014     9,014    
Derivative financial instruments [1] (2,133)     (2,133)    
Other comprehensive (loss)/income (136,849)     (136,472)   (377)
Divestiture of non-controlling interest 2,043         2,043
Non-controlling interest from acquisition 9,533         9,533
Dividends (204,406)       (204,406)  
Issuance of stock awards 915   915      
Issuance of stock awards (in shares)   467        
Shares repurchased (9,246)   (9,246)      
Shares repurchased (in shares)   (164)        
Share-based compensation 29,659   29,659      
Other 2,875   2,875      
Ending balance at Dec. 31, 2024 $ 2,286,213 $ 7,175 $ 183,250 $ (502,734) $ 2,583,923 $ 14,599
Ending Balance (in shares) at Dec. 31, 2024 98,260 98,260        
[1] net of tax
v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities      
Net income $ 163,940 $ 475,901 $ 466,980
Adjustments to reconcile net income to net cash provided by operating activities:      
Asset impairment loss 17,027 26,445 21,444
Depreciation, depletion and amortization 374,859 340,988 308,824
Share-based compensation expense 29,659 27,780 31,309
Net loss on foreign currency remeasurement 113,697 0 0
Equity in earnings of affiliates, net of tax (9,588) (10,347) (14,207)
Cash dividends from affiliated companies 11,926 9,389 8,902
Net gain on disposition of assets (55) (65,947) (5,979)
Net loss/(gain) on divestiture of business 23,452 (57,104) 0
Gain on remeasurement of investment in affiliated companies (6,012) 0 0
Pension and postretirement plan expense 17,477 17,460 10,697
Pension and postretirement plan contributions (19,633) (14,662) (37,409)
Net decrease in deferred taxes (55,715) (12,209) (9,876)
Change in assets and liabilities, net of effects from acquisitions, divestitures and foreign currency adjustments      
Trade accounts receivable 17,763 24,935 (2,466)
Inventories (13,269) 342,713 (353,478)
Payable to suppliers 123,615 (148,841) 27,225
Prepaid expenses (19,144) 1,394 33,702
Income taxes payable and other income tax items (11,269) (28,286) 5,504
Accrued expenses and other assets and liabilities 75,115 (46,691) 17,877
Net cash provided by operating activities 833,845 882,918 509,049
Cash Flows from Investing Activities      
Purchase of property, plant and equipment (393,235) (363,077) (328,769)
Cost of acquisitions, net of cash acquired (3,793,569) (372,616) (1,427,020)
Proceeds from the sale of business, net 80,996 33,237 0
Proceeds from the sale of assets 15,649 80,339 9,621
Proceeds from settlement of net investment hedge 9,068 0 0
Cash settlement of forward contract (34,414) 0 0
Investments in affiliated companies and other net investing proceeds 9,978 2,781 4,732
Net cash used by investing activities (4,105,527) (619,336) (1,741,436)
Cash Flows from Financing Activities      
Proceeds from issuance of debt 4,061,319 962,557 2,153,355
Principal repayment of debt (151,534) (1,112,917) (285,511)
Net decrease in commercial paper borrowings 0 0 (349,000)
Net (decrease)/increase in book cash overdrafts (8,676) 6,408 (18,529)
Payment of loan financing costs (19,000) 0 0
Payment of contingent consideration (948) 0 0
Cash dividends – common (203,492) (197,416) (187,093)
Purchase of noncontrolling interest 0 0 (14,474)
Payments for share repurchases (9,246) (10,617) (4,547)
Net cash provided/(used) by financing activities 3,668,423 (351,985) 1,294,201
Effects of Exchange Rate Changes on Cash (105,618) 12,902 (5,354)
Increase/(Decrease) in Cash and Cash Equivalents 291,123 (75,501) 56,460
Cash and cash equivalents at beginning of year 151,937 227,438 170,978
Cash and cash equivalents at end of year 443,060 151,937 227,438
Supplemental Schedule of Non-Cash Investing Activities:      
Non-cash additions to property, plant and equipment 29,561 23,168 20,250
Supplemental Disclosures:      
Interest paid, net of amounts capitalized 151,182 135,910 88,208
Income taxes paid, net of refunds $ 92,427 $ 189,773 $ 122,881
v3.25.0.1
Summary of significant accounting policies
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Summary of significant accounting policies Summary of significant accounting policies
Basis of presentation
The Consolidated Financial Statements include the accounts of Sonoco Products Company and its majority-owned subsidiaries (the “Company” or “Sonoco”) after elimination of intercompany accounts and transactions.
On December 18, 2024, the Company announced that it had entered into an agreement to sell its Thermoformed and Flexibles Packaging business and its global Trident business (collectively, “TFP”) to TOPPAN Holdings Inc. (“Toppan”) for approximately $1,800,000 on a cash-free and debt-free basis and subject to customary adjustments (the “Transaction”). The Transaction, which reflects the completion of the Company’s previously announced strategic review of its Thermoformed and Flexibles Packaging business, is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first half of 2025. In accordance with applicable accounting guidance, the results of TFP, previously part of the Company’s Consumer Packaging segment, are presented as discontinued operations in the Consolidated Statements of Income and, as such, have been excluded from both continuing operations and segment results for all periods presented in this Annual Report on Form 10-K. Further, the Company reclassified the assets and liabilities of TFP as assets and liabilities of discontinued operations in the Consolidated Balance Sheets as of December 31, 2024 and 2023. The Consolidated Statements of Comprehensive Income, Changes in Total Equity, and Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented in this Annual Report on Form 10-K reflect only the continuing operations of Sonoco unless otherwise noted. See Note 2 for additional information.
Investments in affiliated companies in which the Company does not control the investee or in which the Company is not the primary beneficiary but has the ability to exercise significant influence over the investee’s financial and operating decisions, are accounted for by the equity method of accounting. Income applicable to these equity investments is reported in “Equity in earnings of affiliates, net of tax” in the Consolidated Statements of Income.
Affiliated companies over which the Company exercised a significant influence at December 31, 2024, included:
Entity
Ownership Interest
Percentage at
December 31, 2024
Cascades Conversion, Inc.50.0 %
Cascades Sonoco, Inc.50.0 %
ISI Robotics, LLC26.4 %
Showa Products Company Ltd.22.2 %
Papertech Energía, S.L.25.0 %
Weidenhammer New Packaging, LLC40.0 %
The Company has certain other equity investments in which it is not able to exercise significant influence that are accounted for under the measurement alternative (i.e., cost less impairment, adjusted for any qualifying observable price changes). These include a 19.5% ownership in a small tubes and cores business in Chile and an investment in a small South Carolina-based designer and manufacturer of sustainable protective packaging solutions in which the Company increased its ownership interest from 20.5% to 39.9% during the second quarter of 2024, which contributed to an investment increase of $18,512. See Note 4 for additional information.
The Company’s 2.7% equity interest in Northstar Recycling Company, LLC (“Northstar”), previously accounted for under the measurement alternative, was sold on December 23, 2024. This investment was acquired on January 26, 2023, as part of the sale of its Sonoco Sustainability Solutions (“S3”) business to Northstar. See Note 4 for additional information.
The aggregate carrying value of equity investments is reported in “Other Assets” in the Company’s Consolidated Balance Sheets and totaled $67,801 and $56,399 at December 31, 2024 and 2023, respectively.
Estimates and assumptions
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue recognition
The Company records revenue generally at a point in time when control transfers to the customer either upon shipment or delivery, depending on the terms of sale. Additionally, in certain cases, control transfers over time in conjunction with production where the Company is entitled to payment with margin for products produced that are customer specific and without alternative use. For products that meet these two criteria, the Company recognizes over time revenue under the input method as goods are produced. The Company commonly enters into Master Supply Arrangements with customers to provide goods and/or services over specific time periods. Customers submit purchase orders with quantities and prices to create a contract for accounting purposes. Shipping and handling expenses are considered a fulfillment cost, and are included in “Cost of Sales,” and freight charged to customers is included in “Net Sales” in the Company’s Consolidated Statements of Income.
The Company has rebate agreements with certain customers. These rebates are recorded as reductions of sales and are accrued using sales data and rebate percentages specific to each customer agreement. Accrued customer rebates are included in “Accrued expenses and other” in the Company’s Consolidated Balance Sheets.
Payment terms under the Company’s arrangements are typically short term in nature. The Company provides prompt payment discounts to certain customers if invoices are paid within a predetermined period. Prompt payment discounts are determinable within a short period after the originating sale and like sales returns, are treated as a reduction of revenue.
Accounts receivable and allowance for doubtful accounts
The Company’s trade accounts receivable are non-interest bearing and are recorded at the invoiced amounts. The allowance for doubtful accounts represents the Company’s best estimate of the amount of probable credit losses in existing accounts receivable. The Company performs an evaluation of lifetime expected credit losses inherent in its accounts receivable at each balance sheet date. Such an evaluation includes consideration of historical loss experience, trends in customer payment frequency, present economic conditions, and judgment about the future financial health of its customers and industry sector. The allowance for doubtful accounts is monitored on a regular basis and adjustments are made as needed to ensure that the account properly reflects the Company’s best estimate of uncollectible trade accounts receivable. Account balances are charged off against the allowance for doubtful accounts when the Company determines that the receivable will not be recovered.
No single customer comprised 10% or more of the Company’s consolidated net sales in 2024, 2023 or 2022, nor did the receivables balance from any single customer comprise 10% or more of the Company’s total trade accounts receivable at December 31, 2024 or December 31, 2023.
The Company engages with third-party financial institutions to sell certain trade accounts receivables from customers in order to accelerate its cash collection cycle. In addition, the Company also participates in supply chain finance arrangements promoted by certain of its customers. Receivables transferred under both these arrangements generally meet the requirements to be accounted for as a true sale in accordance with guidance under Accounting Standards Codification (“ASC”) 860, “Transfers and Servicing,” resulting in derecognition of such receivables from the Company’s consolidated balance sheets. The sales under these arrangements are made without recourse and the Company’s only continuing involvement with the sold receivables is providing collection services related to the transferred assets. The servicing fees for these arrangements are immaterial to the financial statements given the short-term nature of our arrangements. In total, approximately 12% and 15% of the Company’s consolidated net sales were subject to settlement under these arrangements in 2024 and 2023, respectively.
The acquisition of Eviosys on December 4, 2024, included arrangements under which certain trade receivables sold to third-party financial institutions are made with recourse and therefore do not meet the requirements under ASC 860 to be accounted for as a true sale with derecognition of such receivables from the Company’s consolidated balance sheets. Accordingly, receivables sold under such arrangements totaling $73,487 were included in “Notes payable and current portion of long-term debt” in the Company’s Consolidated Balance Sheets at December 31, 2024.
Accounts payable and supply chain financing
The Company facilitates voluntary supply chain financing programs (the “SCF Programs”) to provide certain of its suppliers with the opportunity to sell receivables due from the Company to the participating financial institutions in the programs. Such sales are conducted at the sole discretion of both the suppliers and the financial institutions on a nonrecourse basis at a rate that leverages the Company’s credit rating and thus might be more beneficial to the supplier. No guarantees are provided by the Company or any of our subsidiaries under the SCF Programs. The Company’s responsibility under the agreements is limited to making payment to the financial institutions for confirmed invoices based on the terms originally negotiated with its suppliers. Both the Company and the financial institutions have the right to terminate the SCF Programs by providing 30 days prior written notice to the other party. The Company does not enter into any agreements with suppliers regarding their participation in the SCF Programs.
Research and development
Research and development costs are charged to expense as incurred and include salaries and other directly related expenses. Research and development costs totaling approximately $23,000 in 2024, $23,900 in 2023 and $23,100 in 2022 are included in “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income.
Restructuring and asset impairment
Costs associated with exit or disposal activities are recognized when the liability is incurred. Identifying and calculating the cost to exit operations requires certain assumptions to be made about anticipated future liabilities, including severance costs, contractual obligations, and disposition of property, plant and equipment and leased assets. If assets become impaired as a result of a restructuring action, they are written down to fair value, less estimated costs to sell, if applicable. A number of significant estimates and assumptions are involved in the determination of fair value. The Company considers historical experience and all available information at the time the estimates are made; however, the amounts that are ultimately realized upon the sale of divested assets may differ from the estimated fair values reflected in the Company’s Consolidated Financial Statements. For facility closures, the Company also generally expects to record costs for equipment relocation and facility carrying costs as incurred and to accrue costs to terminate a lease or other contracts before the end of their term.
Cash and cash equivalents
Cash equivalents are composed of highly liquid investments with an original maturity to the Company of three months or less when purchased. Cash equivalents are recorded at cost, which approximates fair market value. The Company’s cash and cash equivalents are primarily placed with large sophisticated creditworthy financial institutions thereby limiting the Company’s credit exposure.
Inventories
The majority of the Company’s inventories are accounted for using the first-in, first-out (FIFO) method and are stated at the lower of cost or net realizable value.
The last in, first out (“LIFO”) method is used for the valuation of certain of the Company’s domestic inventories, primarily metal, internally manufactured paper and paper purchased from third parties, and approximated 9% and 17% of total inventories at December 31, 2024 and 2023, respectively. Inventories accounted for using the LIFO method are stated at the lower of cost or market. If the FIFO method of accounting had been used for all inventories, total inventory would have been higher by $33,265 and $39,528 at December 31, 2024 and 2023, respectively.
Property, plant and equipment
Property, plant and equipment assets represent the original cost of land, buildings and equipment, less depreciation, computed under the straight-line method over the estimated useful lives of the assets, and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Equipment lives generally range from 3 to 11 years, and buildings range from 15 to 40 years.
Expenditures for repairs and maintenance are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and related allowance accounts, respectively. Gains or losses upon disposal are credited or charged to income as incurred.
The Company sold its timberland properties in March 2023. Prior to the sale, these timber resources were stated at cost and depletion expense was recognized based on the estimated number of units of timber cut during the period.
Leases
At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. When the Company determines a lease exists, a leased asset and corresponding lease liability are recorded on its consolidated balance sheet. Lease contracts with a term of 12 months or less are not recorded in the consolidated balance sheet in conjunction with the Company’s practical expedient election under ASC 842, “Leases.” Leased assets represent the Company’s right to use an underlying asset during the lease term and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Lease liabilities represent the Company’s obligation arising from the lease. The Company’s leased assets and liabilities may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. The Company has lease agreements with non-lease components that relate to lease components (e.g., common area maintenance such as cleaning or landscaping, etc.). The Company accounts for each lease and any non-lease components associated with that lease as a single lease component for all underlying asset classes in accordance with the scope of the lease accounting standard.
Leased assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When the implicit rate in the Company’s leases is not readily determinable, the Company calculates its lease liabilities using discount rates based upon the Company’s incremental secured borrowing rate, which contemplates and reflects a particular geographical region’s interest rate for the leases active within that region of the Company’s global operations. The Company further utilizes a portfolio approach by assigning a “short” rate to contracts with lease terms of 10 years or less and a “long” rate for contracts greater than 10 years. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the expense is paid during the lease term.
The Company recognizes fixed lease expense for operating leases on a straight-line basis over the lease term. For finance leases, the Company recognizes interest expense on the lease liability using the effective interest method over the lease term and the finance lease asset balance is amortized on a straight-line basis.
Goodwill
Goodwill is not amortized. The Company assesses its goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. In performing the impairment test, the Company compares the fair value of the reporting unit with its carrying amount, and if the carrying value of the reporting unit exceeds the fair value of that reporting unit, an impairment charge is recognized for the excess.
In determining the fair value of the reporting units, management considers both the income approach and the market approach. Fair value is estimated using a discounted cash flow model (income valuation approach) based on projections of future years’ operating results and associated cash flows combined with comparable trading and transaction multiples based on guideline public companies. The calculated estimated fair value of the reporting unit reflects a number of significant management assumptions and estimates including the forecast of sales growth, gross profit margins, and discount rates. Changes in these assumptions could materially impact the estimated fair value.
The Company’s projections incorporate management's best estimates of the expected future results, which include expectations related to new and retained business and future operating margins. Projected future cash flows are then discounted to present value using a discount rate management believes is commensurate with the risks inherent in the cash flows.
Impairment of long-lived, intangible and other assets
Other intangible assets are amortized using the straight-line method when management has determined that the straight-line method approximates the pattern of consumption of the respective intangible assets, or in relation to the specific pattern of consumption of the assets if the straight-line method does not provide a fair approximation of the consumption of benefits. The useful lives of the Company’s intangible assets generally range from 3 to 40 years. The Company has no intangibles with indefinite lives. The Company evaluates its intangible assets for impairment whenever indicators of impairment exist.
Assumptions and estimates used in the evaluation of potential impairment can result in adjustments affecting the carrying values of long-lived, intangible and other assets and the recognition of impairment expense in the Company’s Consolidated Financial Statements. The Company evaluates its long-lived assets (property, plant and equipment), definite-lived intangible assets and other assets (including right of use lease assets, notes receivable and equity and other investments) for impairment whenever indicators of impairment exist, or when it commits to sell the asset. If the sum of the undiscounted expected future cash flows from a long-lived asset, definite-lived intangible, or other asset group is less than the carrying value of that asset group, an asset impairment charge is recognized. Key assumptions and estimates used in the projection of expected future cash flows generally include price levels, sales growth, profit margins and asset life. The amount of an impairment charge, if any, is calculated as the excess of the asset’s carrying value over its fair value, generally represented by the discounted future cash flows from that asset or, in the case of assets the Company evaluates for sale, estimated sale proceeds less costs to sell. The Company takes into consideration historical data and experience together with all other relevant information available when estimating the fair values of its assets. However, fair values that could be realized in actual transactions may differ from the estimates used to evaluate impairment. In addition, changes in the assumptions and estimates may result in a different conclusion regarding impairment.
Income taxes
The Company provides for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting requirements and tax laws. Assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
The Company recognizes liabilities for uncertain income tax positions based on its estimate of whether it is more likely than not that additional taxes will be required and the Company reports related interest and penalties within the provision for income taxes line item in the Consolidated Statements of Income.
Derivatives
The Company uses derivatives to mitigate the effect of fluctuations in some of its raw material and energy costs, foreign currencies, and, from time to time, interest rates. The Company purchases commodities such as metal and energy, generally at market or at fixed prices that are established with the vendor as part of the purchase process for quantities expected to be consumed in the ordinary course of business. The Company may enter into commodity futures or swaps to manage the effect of price fluctuations. The Company may use foreign currency forward contracts and other risk management instruments to manage exposure to changes in foreign currency cash flows and the translation of monetary assets and liabilities on the Company’s consolidated financial statements. The Company is exposed to interest-rate fluctuations as a result of using debt as a source of financing for its operations. The Company may from time to time use traditional, unleveraged interest rate swaps to manage its exposure to interest rate movements. Additionally, the Company elected the normal purchase, normal sale scope exception for physical commodity contracts that meet the definition of a derivative. Derivative instruments, to the extent in an asset position, expose the Company to credit loss in the event of nonperformance by the counterparties to the derivative agreements. The Company manages its exposure to counterparty credit risk through minimum credit standards, diversification of counterparties and procedures to monitor concentrations of credit risk. The Company may enter into financial derivative contracts that may contain credit-risk-related contingent features, which could result in a counterparty requesting immediate payment or demanding immediate and ongoing full overnight collateralization on derivative instruments in net liability positions.
The Company records its derivatives as assets or liabilities on the balance sheet at fair value using published market prices or estimated values based on current price and/or rate quotes and discounted estimated cash flows. Changes in the fair value of derivatives designated as accounting hedges are recognized in net income, and otherwise are recognized in other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. It is the Company’s policy not to speculate in derivative instruments.
Share-Based Compensation Plans
The Company utilizes share-based compensation in the form of restricted stock units (“RSUs”), performance contingent restricted stock units (“PCSUs”), and other share-based awards. The fair value of the Company’s RSUs is equal to the closing price of the Company’s stock on the date of grant discounted for any projected dividends that are not eligible to be received during the vesting period. The amount of share-based compensation expense associated with PCSUs is based on estimates of future performance using measures defined in the stock plan descriptions for each award granted. As of December 31, 2024, these performance measures include the following:
Adjusted earnings per share — three-year sum of forecasted future and historical annual adjusted earnings per share for the three-year measurement period associated with each award; and
Return on invested capital — three-year simple average of annual returns calculated by dividing 1) adjusted operating profit after tax (derived from historical or projected earnings) by 2) the average of total historical or projected debt plus equity for the respective annual periods.
For the awards granted in 2024 and 2023, the performance payout will be subject to adjustment by a total stock return modifier as determined by the Company’s relative performance within its targeted peer group for each grant. Changes in estimates regarding the future achievement of these performance measures may result in significant fluctuations from period to period in the amount of share-based compensation expense recognized in the Company’s Consolidated Financial Statements.
Pension and Postretirement Benefit Plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, Greece, France, and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements. The actuarial valuations used to evaluate the plans employ key assumptions that can have a significant effect on the calculated amounts.
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected rate of return assumption is derived by taking into consideration the targeted plan asset allocation, projected future returns by asset class and active investment management. A third-party asset return model is used to develop an expected range of returns on plan investments over a 12- to 15-year period, with the expected rate of return selected from a best estimate range within the total range of projected results. The Company periodically re-balances its plan asset portfolio in order to maintain the targeted allocation levels. The rate of compensation increase assumption is generally based on salary and incentive compensation increases.
Other assumptions and estimates impacting the projected liabilities of these plans include inflation, participant withdrawal and mortality rates, medical cost trends, and retirement ages. The Company evaluates the assumptions used in projecting the pension and postretirement liabilities and associated expenses annually. These judgments, assumptions and estimates may affect the carrying value of pension and postretirement plan net assets and liabilities and pension and postretirement plan expenses in the Company’s Consolidated Financial Statements.
Business combinations
The Company’s acquisitions of businesses are accounted for in accordance with ASC 805, “Business Combinations.” The Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in an acquired business at their fair values as of the date of acquisition. Goodwill is measured as the excess of consideration transferred, also measured at fair value, over the net of the acquisition date fair values of the identifiable assets acquired and liabilities assumed. The acquisition method of accounting requires the Company to make significant estimates and assumptions regarding the fair values of the elements of a business combination as of the date of acquisition, including the fair values of identifiable intangible assets; property, plant and equipment; deferred tax asset valuation allowances; liabilities including those related to debt, pensions and other postretirement plans; uncertain tax positions; contingent consideration and contingencies. This method also requires the Company to refine these estimates over a measurement period not to exceed one year to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. If the Company is required to adjust provisional amounts that were recorded for the fair values of assets and liabilities in connection with acquisitions, these adjustments could have a material impact on its financial condition and results of operations.
Significant estimates and assumptions in estimating the fair value of acquired patents, customer lists, trademarks, proprietary technology, and other identifiable intangible assets include future cash flows that the Company expects to generate from the acquired assets, discount rate,
customer attrition rate, and long-term revenue growth projections. Projecting discounted future cash flows requires the Company to make significant estimates regarding projected revenues, projected earnings before interest, taxes, depreciation, and amortization margins, discount rates and customer attrition rates. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, the Company could record impairment charges. In addition, the Company has estimated the economic lives of certain acquired assets, and these lives are used to calculate depreciation on property, plant and equipment and amortization expense on definite-lived intangible assets. If the estimates of the economic lives change, depreciation or amortization expenses could be increased or decreased, or the acquired assets could be impaired.
For leases acquired in a business combination, the Company measures the lease liability at the present value of the remaining lease payments, as if the acquired lease were a new lease of the Company at the acquisition date. The Company measures the right-of-use asset at the same amount as the lease liability as adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms.
Reportable segments
The Company identifies its reportable segments by evaluating the level of detail reviewed by the chief operating decision maker and the similarities among operating segments related to gross profit margins, nature of products sold, nature of the production processes, type and class of customer, methods used to distribute products, and nature of the regulatory environment. Of these factors, the Company believes that the most significant in determining the aggregation of operating segments are the nature of the products and the type of customers served. The Company’s operating and reporting structure consists of two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other.
Contingencies
Pursuant to GAAP for accounting for contingencies, accruals for estimated losses are recorded at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. Amounts so accrued are not discounted. Changes in estimates and assumptions could impact the carrying value of the accruals from one period to another as additional information becomes known.
Foreign currency translation
The Company’s foreign operations are exposed to political, geopolitical, and cultural risks, but the risks are mitigated by diversification and the relative stability of the countries in which the Company has significant operations. Because the economies in Turkey and Venezuela are considered highly inflationary under GAAP, the Company considers the U.S. dollar to be the functional currency for these operations and uses the official exchange rate when remeasuring the financial assets and liabilities of these operations. The remeasurement adjustments are recorded against earnings within the Company’s consolidated income statement.
v3.25.0.1
Discontinued operations
12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Discontinued operations Discontinued operations
As disclosed in Note 1, on December 18, 2024, the Company entered into an agreement to sell TFP. As a result of the planned sale, and in accordance with applicable accounting guidance, the financial results of TFP are presented as discontinued operations in the Consolidated Statements of Income and, as such, have been excluded from both continuing operations and segment results for all periods presented. Further, the Company reclassified the assets and liabilities of TFP as assets and liabilities of discontinued operations in the Consolidated Balance Sheets as of December 31, 2024 and 2023. The Consolidated Statements of Comprehensive Income, Consolidated Statements of Changes in Total Equity, and Consolidated Statements of Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented reflect only the continuing operations of Sonoco unless otherwise noted.
The following table presents the assets and liabilities that are classified as discontinued operations in the Consolidated Balance Sheets as of
December 31, 2024 and 2023:
  
20242023
Cash and cash equivalents$12,050 $13,042 
Trade accounts receivable, net of allowances of $2,582 in 2024 and $2,793 in 2023
209,379 218,620 
Other receivables46,001 48,677 
Inventories
     Finished and in process80,573 86,515 
     Materials and supplies94,083 83,338 
Prepaid expenses8,788 9,426 
Current assets of discontinued operations $450,874 $459,618 
Property, plant and equipment, net of accumulated depreciation of $465,923 in 2024 and $480,416 in 2023
262,662 243,370 
Goodwill502,621 512,643 
Other intangible assets, net of accumulated amortization of $206,437 in 2024 and $189,471 in 2023
103,593 127,113 
Long-term deferred income taxes262 706 
Right of use asset-operating leases75,855 81,483 
Other assets19,317 18,794 
Non-current assets of discontinued operations$964,310 $984,109 
Payable to suppliers172,720 169,613 
Accrued expenses and other62,562 70,593 
Notes payable and current portion of long-term debt6,774 8,198 
Current liabilities of discontinued operations$242,056 $248,404 
Long-term debt29,850 37,866 
Noncurrent operating lease liabilities67,789 72,751 
Pension and other postretirement benefits— 116 
Deferred income taxes15,928 6,934 
Other liabilities344 473 
Non-current liabilities of discontinued operations$113,911 $118,140 
The following table presents key components of “Income from discontinued operations, net of taxes” for the years ended December 31, 2024, 2023, and 2022:
 Year Ended December 31,
  
202420232022
Net sales$1,291,461 $1,339,866 $1,391,225 
Cost of sales1,037,196 1,106,970 1,176,894 
Gross profit254,265 232,896 214,331 
Selling, general and administrative expenses122,488 97,131 97,762 
Restructuring/Asset impairment charges3,740 9,024 4,525 
Operating profit128,037 126,741 112,044 
Interest expense1
13,396 1,293 790 
Interest income1,668 357 94 
Income from discontinued operations before income taxes116,309 125,805 111,348 
Provision for income taxes19,934 29,548 22,778 
Net income from discontinued operations96,375 96,257 88,570 
Net income from discontinued operations attributable to noncontrolling interests(171)(174)(259)
Net income attributable to discontinued operations$96,204 $96,083 $88,311 
Weighted average common shares outstanding:
Basic98,637 98,294 97,991 
Diluted99,290 98,890 98,732 
Per common share
Net income attributable to discontinued operations:
Basic$0.97 $0.98 $0.90 
Diluted$0.97 $0.97 $0.89 
1 Includes $9,528 of interest expense in 2024 relating to certain debt contractually required to be repaid by the Company upon completion of the TFP divestiture. No such interest expense is reflected in 2023 or 2022.
The following table presents significant cash flow items from discontinued operations for the years ended December 31, 2024, 2023, and 2022:
 Year Ended December 31,
  
202420232022
Depreciation, depletion and amortization$58,798 $58,959 $58,291 
Capital expenditures
$(65,321)$(55,624)$(48,049)
v3.25.0.1
New accounting pronouncements
12 Months Ended
Dec. 31, 2024
Accounting Changes and Error Corrections [Abstract]  
New accounting pronouncements New accounting pronouncements
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which modifies the rules on income tax disclosures to require disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The purpose of the amendment is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this standard effective with its reporting for the year ended December 31, 2024 and has provided the enhanced reportable segment financial disclosures in this Annual Report on Form 10-K.
In September 2022, the FASB issued ASU 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” The amendments require that a buyer in a supplier finance program disclose qualitative and quantitative information about its supplier finance programs in each annual reporting period, including a description of key payment terms, amounts outstanding, and a rollforward of the outstanding obligation. In each interim reporting period, the amount outstanding requires disclosure. The amendments were effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which was effective for fiscal years beginning after December 15, 2023. The Company adopted this standard in the first quarter of 2023, with the exception of the amendment on rollforward information, which was adopted effective with its reporting for the year ended December 31, 2024 and is included in this Annual Report on Form 10-K.
Other than the pronouncements discussed above, there have been no other newly issued nor newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s financial statements.
v3.25.0.1
Acquisitions and divestitures
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Acquisitions and divestitures Acquisitions and divestitures
Eviosys Acquisition
On December 4, 2024, the Company completed the acquisition of all issued and outstanding equity interests in Eviosys from an affiliate of KPS Capital Partners, LP for net cash consideration of $3,789,826. Eviosys, a global supplier of metal packaging that produces food cans and ends, aerosol cans, metal closures and promotional packaging with a large metal food can manufacturing footprint in the Europe, Middle East, and Africa region, has approximately 6,500 employees in 44 manufacturing facilities across 17 countries. The Company funded the Eviosys acquisition, including related fees and expenses, with the net proceeds from the registered public offering of senior unsecured notes, borrowings from two term loan facilities, and cash on hand. See Note 11 for more information. The financial results of Eviosys are included in the Company’s Consumer Packaging segment.
In order to fund the Eviosys acquisition in euros, the Company entered into foreign currency forward contracts during the month of October 2024 with varying settlement dates to sell USD and buy euro. Upon settlement of these trades, the Company, a USD functional currency entity, held euro denominated cash balances between the date of settlement and the December 4, 2024 closing date of the acquisition. Such euro cash balances, being monetary assets, were subject to remeasurement in the intervening period between settlement and December 4, 2024, resulting in the recognition of a $113,697 remeasurement loss. This loss is reflected in “Other (expenses)/income, net” in the Company’s Consolidated Statement of Income for the year ended December 31, 2024. The majority of the remeasurement loss was non-cash in nature; however, included in the remeasurement loss are cash payments to counterparties totaling $34,414 reflecting the settlement of a tranche of the foreign currency forward contracts. The Company no longer holds significant euro-denominated cash on its USD functional currency entity that would be subject to future remeasurement gain/loss.
The Company’s preliminary fair values of the assets acquired and liabilities assumed in the acquisition of Eviosys, are as follows:
Preliminary Allocation
Trade accounts receivable$300,385 
Other receivables114,634 
Inventories445,945 
Prepaid expenses47,509 
Property, plant and equipment1,057,779 
Right of use asset - operating leases43,566 
Other intangible assets1,967,678 
Goodwill1,285,518 
Long-term deferred income taxes39,023 
Other assets3,330 
Payable to suppliers(518,766)
Accrued expenses and other(168,529)
Accrued wages and other compensation(41,749)
Notes payable and current portion of long-term debt(76,438)
Noncurrent operating lease liabilities(32,022)
Pension and other postretirement benefits(51,849)
Deferred income taxes(599,941)
Other long-term liabilities(16,714)
Noncontrolling Interests
(9,533)
Net assets acquired$3,789,826 
The preliminary allocation of the purchase price of Eviosys to the tangible and intangible assets acquired and liabilities assumed, as reflected in the table above, is based on the Company’s preliminary allocations of their respective fair values, based on information currently available. Management is continuing to finalize its valuation of certain assets and liabilities including, but not limited to: inventory; property, plant and equipment; goodwill; other intangible assets; operating leases; and deferred income taxes, and expects to complete its valuations within one year of the date of acquisition.
Factors comprising goodwill for Eviosys, none of which is expected to be deductible for income tax purposes, include increased access to certain markets and the value of the assembled workforce.
The following table presents the financial results for Eviosys from December 4, 2024, the date of acquisition, through December 31, 2024:
Supplemental Information
December 4 to
Eviosys
December 31, 2024
Net sales$115,031 
Net loss
$15,086 
The following table presents the Company’s pro forma consolidated results for the years ended December 31, 2024 and December 31, 2023, assuming the acquisition of Eviosys had occurred on January 1, 2023. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2023, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Years Ended
Consolidated
December 31, 2024
December 31, 2023
Net sales$7,546,920 $8,032,135 
Net income from continuing operations
$159,926 $112,963 
Net income attributable to Sonoco1
$255,800 $208,436 
1 Includes results of discontinued operations
The pro forma information above does not project the Company’s expected results for any future period and gives no effect to any future synergistic benefits that may result from the combination or the costs of integrating the acquired operations with those of the Company. Pro forma information for the years ended December 31, 2024 and December 31, 2023 includes adjustments to depreciation, amortization, and income taxes based upon the preliminary fair value allocation of the purchase price to Eviosys’ tangible and intangible assets acquired and liabilities assumed as though the acquisition had occurred on January 1, 2023. Interest expense on the additional debt issued by the Company to fund the acquisition and retention bonuses incurred related to the acquisition are also included in the pro forma information as if the acquisition had occurred on January 1, 2023. Acquisition-related costs of $272,303 include the $113,697 remeasurement loss discussed above and charges related to fair value adjustments to acquisition-date inventory. These costs are excluded from 2024 pro forma net income and are instead reflected in 2023 pro forma net income as though the acquisition had occurred on January 1, 2023.
Other Acquisitions
On June 1, 2024, the Company completed the purchase of a small tube and paper cone manufacturer in Brazil for $2,660. The financial results of this business are included in the Company’s Industrial Paper Packaging segment.
The Company completed two acquisitions during 2023 at a net cash cost of $372,616. On December 1, 2023, the Company completed the acquisition of Inapel Embalagens Ltda. (“Inapel”), a manufacturer of single-layer and multilayer materials for flexible packaging in Brazil, for net consideration of $64,390, including $59,228 of cash paid at closing. During the second quarter of 2024, the Company paid additional consideration in the amount of $2,340 and a final net working capital settlement in the amount of $489. The Company finalized its valuations of the assets acquired and the liabilities assumed in the acquisition of Inapel during 2024. As Inapel is one of the operations included in the pending sale of TFP, the acquired assets and liabilities are reflected as assets and liabilities of discontinued operations on the Company’s Consolidated Balance Sheets as of December 31, 2024 and December 31, 2023. Additional obligations to the seller totaling $2,333 are expected to be paid during 2025 and are recorded in “Current liabilities of discontinued operations” in the Company’s Consolidated Balance Sheet as of December 31, 2024.
On September 8, 2023, the Company completed the acquisitions of the remaining 65% ownership interest in RTS Packaging, LLC (“RTS Packaging”) from joint venture partner WestRock Company (“WestRock”) and a paper mill in Chattanooga, Tennessee (the “Chattanooga Mill”) from WestRock for net cash consideration of $313,388. In December 2023, the Company agreed to a final working capital settlement of $452, which was paid to WestRock in January 2024. Prior to completing the acquisitions, the Company held a 35% ownership interest in the RTS Packaging joint venture, which was formed in 1997, and combined the former protective packaging operations of WestRock and Sonoco to market recycled paperboard to glass container manufacturers and producers of wine, liquor, food, and pharmaceuticals. Prior to the acquisitions, the Company reported its 35% interest in the RTS Packaging joint venture using the equity method of accounting. Subsequent to the acquisitions, the financial results of RTS Packaging and the Chattanooga Mill are accounted for under the acquisition method and their results of operations are included in the Company’s Industrial Paper Packaging segment.
On September 8, 2023, the fair value of the Company’s 35% ownership interest in RTS Packaging was determined to be $59,472 based on the cash consideration exchanged for acquiring the remaining 65% ownership interest in RTS Packaging adjusted for the deemed payment of a control premium, and the carrying value of the 35% ownership interest in RTS Packaging was $8,654. The Company recognized a net gain of $44,029 resulting from this remeasurement to fair value and the reclassification of certain amounts related to the Company’s 35% ownership interest in RTS Packaging out of “Accumulated other comprehensive loss,” including foreign currency translation losses of $2,033 and losses related to defined benefit pension plans of $4,756. The net gain from such remeasurement and reclassification was recorded in “Other income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023.
The Company also recognized a loss of $7,086 on the settlement of a contract associated with the Chattanooga Mill. The contract was determined to have unfavorable terms given market conditions at the time of the acquisition. This loss is reflected in “Other income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023. This loss, along with the settlement of a note receivable
from RTS Packaging held by the Company on the acquisition date, are reflected as components of purchase consideration transferred in connection with these acquisitions.
The following table provides a summary of the purchase consideration (as defined under ASC 805) transferred for the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill:
Purchase Consideration
Cash consideration, net of cash acquired $313,388 
Fair value of previously held interest in RTS Packaging59,472 
Final working capital settlement
452 
Settlement of preexisting relationships1,235 
Purchase consideration transferred$374,547 
During 2024, the Company finalized its valuations of the assets acquired and liabilities assumed in the acquisitions of the remaining ownership interest in RTS Packaging and the Chattanooga Mill. As a result, final fair values reflecting adjustments made during the measurement period are as follows:
Initial AllocationMeasurement Period AdjustmentsFinal Allocation
Trade accounts receivable$17,488 $— $17,488 
Inventories20,209 (947)19,262 
Prepaid expenses2,720 (589)2,131 
Property, plant and equipment73,483 753 74,236 
Right of use asset - operating leases34,604 290 34,894 
Other intangible assets199,560 (8,995)190,565 
Goodwill92,657 14,909 107,566 
Other assets2,465 (412)2,053 
Payable to suppliers(7,320)— (7,320)
Accrued expenses and other(12,436)(25)(12,461)
Accrued wages and other compensation(2,731)— (2,731)
Notes payable and current portion of long-term debt(24)— (24)
Noncurrent operating lease liabilities(29,905)— (29,905)
Pension and other postretirement benefits(10,761)(768)(11,529)
Long-term debt(1,942)— (1,942)
Deferred income taxes(3,419)(2,502)(5,921)
Other long-term liabilities(3,293)1,478 (1,815)
Net assets acquired$371,355 $3,192 $374,547 
Goodwill for RTS Packaging and the Chattanooga Mill, of which $83,000 is expected to be deductible for income tax purposes, consists of increased manufacturing capacity, access to certain markets, and the capability to support marquee customers in growing markets.
The Company completed three acquisitions during 2022 at a net cash cost of $1,444,618. On November 15, 2022, the Company completed the acquisition of S.P. Holding, Skjern A/S (“Skjern”), a privately owned manufacturer of paper based in Skjern, Denmark for $89,610, net of cash acquired. Tangible assets totaled $40,489, intangible assets totaled $39,330, liabilities totaled $22,403, and Goodwill totaled $32,194. Skjern produces high-grade paperboard from recycled paper for rigid paper containers, tubes and cores, and other applications.
On August 31, 2022, the Company completed the acquisition of Nordeste Tubetes and NE Tubetes (collectively, “Nordeste”), two small tube and core operations in Brazil. Total consideration for the two businesses was $6,419. Tangible assets totaled $1,374, intangible assets totaled $3,031, and Goodwill totaled $2,014. The Company paid $3,933 at closing and recorded a deferred payment obligation totaling $2,486 in “Other liabilities” in the Company’s Consolidated Balance Sheets. The deferred payment obligation is expected to be paid by the end of 2028.
On January 26, 2022, the Company completed the acquisition of Ball Metalpack Holding, LLC (“Ball Metalpack”), renamed Sonoco Metal Packaging (“Metal Packaging”), a leading supplier of sustainable metal packaging for food and household products and the largest aerosol can producer in North America, for $1,348,589, net of cash acquired. Prior to the Company’s acquisition, Ball Metalpack was a joint venture formed in 2018 and owned by Platinum Equity (51%) and Ball Corporation (49%). Metal Packaging consists of eight manufacturing plants in the United States and a headquarters facility in Broomfield, Colorado.
Financial results for Metal Packaging are included in the Company’s Consumer Packaging Segment, and financial results for Nordeste and Skjern are included in the Industrial Paper Packaging segment. Except for the Eviosys and Metal Packaging acquisitions, the Company does not believe that the results of the businesses acquired in 2024, 2023, and 2022 were material to the years presented, individually or in the aggregate, and are therefore not subject to the requirements to provide supplemental pro-forma information.
The following table presents the financial results for Metal Packaging from the date of acquisition through December 31, 2022:
Supplemental InformationJanuary 26 to
Metal PackagingDecember 31, 2022
Net sales$1,035,020 
Net income$62,777 
The following table presents the Company’s pro forma consolidated results for the year ended December 31, 2022, assuming the acquisition of Metal Packaging had occurred on January 1, 2021. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2021, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Year Ended
ConsolidatedDecember 31, 2022
Net sales$5,908,915 
Net income from continuing operations
$440,791 
Net income attributable to Sonoco1
$528,818 
1 Includes results of discontinued operations
The pro forma information above does not project the Company’s expected results for any future period and gives no effect to any future synergistic benefits that may result from the combination or the costs of integrating the acquired operations with those of the Company. Pro forma information for the year ended December 31, 2022 includes adjustments to depreciation, amortization, and income taxes based upon the final fair value allocation of the purchase price to Metal Packaging’s tangible and intangible assets acquired and liabilities assumed as though the acquisition had occurred on January 1, 2021. Interest expense on the additional debt issued by the Company to fund the acquisition and retention bonuses incurred related to the acquisition are also included in the pro forma information as if the acquisition had occurred on January 1, 2021. Acquisition-related costs of $28,171 and charges related to fair value adjustments to acquisition-date inventory of $33,155 were recognized during 2022. These costs are excluded from 2022 pro forma net income and are instead reflected in the previously disclosed 2021 pro forma net income as though the acquisition had occurred on January 1, 2021.
The Company has accounted for these acquisitions as business combinations under the acquisition method and has included the results of operations of the acquired businesses in the Company’s Consolidated Statements of Income from their respective dates of acquisition.
Divestiture of Businesses
On December 18, 2024, the Company announced that it had entered into an agreement to sell TFP to Toppan for approximately $1,800,000 on a cash-free and debt-free basis and subject to customary adjustments. The sale is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first half of 2025. See Notes 1 and 2 for additional information.
In November 2024, the Company completed the sale of two production facilities in China, both of which were part of the Company’s Industrial Paper Packaging segment, for $302. As a result of the sale, the Company reclassified $590 of cumulative translation losses from Accumulated Other Comprehensive Loss and recognized a loss of $25,607, which is included in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On April 1, 2024, the Company completed the sale of its Protective Solutions business (“Protexic”), part of the All Other group of businesses, to Black Diamond Capital Management, LLC (“Black Diamond”) for cash proceeds of $80,267 at closing. Upon final settlement of working capital in the third quarter of 2024, the Company paid Black Diamond $1,805. This business provided foam components and integrated material solutions for various industrial end markets. This sale was the result of the Company’s continuing evaluation of its business portfolio and is consistent with the Company’s strategic and investment priorities. In connection with the Protexic divestiture, the Company wrote off net assets totaling $74,644, including $16,559 of allocated goodwill and reclassified $2,913 of cumulative translation adjustment losses from Accumulated Other Comprehensive Loss, resulting in a net pretax gain of $905, which is included in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income. The Company used the majority of the cash proceeds from the sale to pay down debt.
On July 1, 2023, the Company completed the sale of its U.S. BulkSak business, which consisted of the manufacturing and distribution of flexible intermediate bulk containers, plastic and fiber pallets, and custom fit liners and was a part of the Company’s Industrial Paper Packaging segment, to U.S. BulkSak Holdings, LLC. The cash selling price, as adjusted for the final working capital settlement, was $20,271 with cash proceeds totaling $18,271 received in 2023, and the remaining $2,000 held in escrow to be released to the Company within eighteen months from the date of the sale, pursuant to the settlement of any indemnity claims. The escrow balance of $2,000 is reflected in “Other receivables” in the Company’s Consolidated Balance Sheet as of December 31, 2024. As a result of the U.S. BulkSak divestiture, the Company wrote off net assets totaling $13,437, including $3,333 of allocated goodwill, and recognized a total pretax gain of $6,834 upon completion of the sale. The gain, of which $7,371 was recognized in the second quarter of 2023, as reflected in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income, was reduced by $537 in the third quarter of 2023 upon the final working capital settlement.
Also on July 1, 2023, the Company agreed to the sale of its Mexico BulkSak business. The sale closed in December 2023 for a cash selling price, as adjusted for working capital, of $1,096. As a result of the Mexico BulkSak sale, the Company recognized a pretax gain of $85 which is included in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
On January 26, 2023, the Company completed the sale of its S3 business, a provider of customized waste and recycling management programs and part of the Company’s Industrial Paper Packaging segment, to Northstar. The Company received cash proceeds of $13,839 at closing. An additional $1,500 of cash proceeds were released to the Company from escrow in September 2024. The Company wrote off net assets totaling $4,274 as part of the divestiture of the business, including $3,042 of allocated goodwill, and recognized a pretax gain of $11,065 during the first quarter of 2023. In the second quarter of 2024, upon resolution of certain contingencies, the Company received cash proceeds and recognized an additional pretax gain of $1,250 on the sale. These gains are included in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income for their respective periods.
On January 26, 2023, in connection with the sale of the S3 business, the Company acquired a 2.7% equity interest in Northstar valued at $5,000. This Company sold its equity interest in Northstar on December 23, 2024 for cash proceeds of $8,630. The resulting pretax gain of $3,630 is included in “Other (expenses)/income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024.
The divestitures of the two production facilities in China, Protexic, S3, and BulkSak businesses did not represent a strategic shift for the Company or have a major effect on its operations or financial results. Consequently, these sales did not meet the criteria for reporting as discontinued operations. The cash proceeds from the sales were used for general corporate purposes.
The Company continually assesses its operational footprint as well as its overall portfolio of businesses and may consider the divestiture of plants and/or business units it considers to be suboptimal or nonstrategic.
Sale of Assets
With the completion of Project Horizon, the Company’s project to convert the corrugated medium machine in Hartsville, South Carolina, to produce uncoated recycled paperboard was realized. The Company now produces paper exclusively from recycled fibers and no longer requires natural tree fiber for production. Accordingly, on March 29, 2023, the Company sold its timberland properties, consisting of approximately 55,000 acres, to Manulife Investment Management for net cash proceeds of $70,802. The Company disposed of assets with a net book value of $9,857 as part of the sale and recognized a pretax gain from the sale of these assets of $60,945 during the year ended December 31, 2023, which is included in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income.
Additional Ownership Investment
During the second quarter of 2024, the Company increased its ownership investment in a small South Carolina-based designer and manufacturer of sustainable protective packaging solutions from 20.5% to 39.9%. The Company acquired its initial ownership interest in June 2022. The preferred stock investment increased by $18,512 during the second quarter of 2024, which included a $10,000 cash payment, a $5,400 remeasurement of the fair value of the existing investment, and a $2,500 conversion of the carrying value of the outstanding convertible notes into a preferred series stock investment, which yielded a $467 fair value increase and a $145 increase for interest income earned. The outstanding investment of $21,212 as of December 31, 2024 is included within “Other assets” in the Company’s Consolidated Balance Sheet. The remeasurement of the carrying value of the existing investment to fair value during the second quarter of 2024 resulted in a gain of $5,867 and interest income of $145, which are included in “Other (expenses)/income, net” and “Interest income,” respectively, in the Company’s Consolidated Statements of Income.
Acquisition, Integration, and Divestiture-Related Costs
Acquisition, integration, and divestiture-related costs from continuing operations of $125,169, $24,624, and $70,210 were incurred in 2024, 2023 and 2022, respectively. The majority of costs incurred in 2024 related to the acquisition of Eviosys. These costs include legal and professional fees, investment banking fees, representation and warranty insurance premiums, as well as employee-related and other integration activity costs, that are included in “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income. The costs incurred in 2024, 2023, and 2022 also include fair value adjustments to acquisition-date inventory totaling $5,806, $5,227, and $33,155, respectively, that are included in “Cost of sales” in the Company’s Consolidated Statements of Income. The costs incurred in 2024 also include losses on treasury lock derivative instruments and amortization of financing fees related to debt instruments associated with the financing of the Eviosys acquisition totaling $33,569 that are included in “Interest expense” in the Company’s Consolidated Statements of Income.
v3.25.0.1
Restructuring and asset impairment
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Restructuring and asset impairment Restructuring and asset impairment
Due to its geographic footprint and the cost-competitive nature of its businesses, the Company is continually seeking more cost-effective means and structures to serve its customers and to respond to fundamental changes in its markets. As such, plant closures in connection with footprint rationalization and headcount reductions are an important component of the Company’s cost control initiatives. The amount of these costs can vary significantly from quarter to quarter and from year to year depending upon the scope, nature, and location of the restructuring activities.
Following are the total restructuring and asset impairment charges, net of adjustments, recognized during the periods presented:
 Year Ended December 31,
  
202420232022
Restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
Other asset impairments— — 10,095 
Restructuring/Asset impairment charges$65,370 $47,909 $52,385 
The table below sets forth restructuring and restructuring-related asset impairment charges by type incurred:
 Year Ended December 31,
202420232022
Severance and Termination Benefits$37,307 $15,543 $13,808 
Asset Impairment/Disposal of Assets15,719 24,415 9,182 
Other Costs12,344 7,951 19,300 
Total restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
The table below sets forth restructuring and restructuring-related asset impairment charges by reportable segment:
 Year Ended December 31,
202420232022
Consumer Packaging$19,259 $4,111 $8,207 
Industrial Paper Packaging33,923 38,754 15,598 
All Other1,434 2,547 (44)
Corporate10,754 2,497 18,529 
Total restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
“Restructuring and restructuring-related asset impairment charges” and “Other asset impairments” are included in “Restructuring/Asset impairment charges” in the Consolidated Statements of Income.
The following table sets forth the activity in the restructuring accrual included in “Accrued expenses and other” in the Company’s Consolidated Balance Sheets:

Accrual Activity
Severance
and
Termination
Benefits
Asset
Impairment/
Disposal
of Assets
Other
Costs
Total
Liability, December 31, 2022$12,780 $— $1,286 $14,066 
2023 charges15,543 24,415 7,951 47,909 
Cash (payments)/receipts(19,437)— (8,995)(28,432)
Asset write downs/disposals— (24,415)— (24,415)
Foreign currency translation(22)— 30 
Liability, December 31, 2023
$8,864 $— $272 $9,136 
2024 charges37,307 15,719 12,344 65,370 
Cash (payments)/receipts(21,653)9,680 (11,610)(23,583)
Asset write downs/disposals— (25,399)— (25,399)
Foreign currency translation(484)— (97)(581)
Liability, December 31, 2024
$24,034 $— $909 $24,943 

“Severance and Termination Benefits” in 2024 includes the cost of severance for approximately 300 employees whose positions were eliminated in conjunction with the Company’s ongoing organizational effectiveness efforts, including the relocation of certain facilities in Greece and Germany, and severance related to the closures of paper mills in Sumner, Washington (the “Sumner Mill”) and Kilkis, Greece (the “Kilkis Mill”), the closures of two small industrial converted products facilities in China, and the closure of an industrial converted products facility in Mississauga, Canada, all part of the Industrial Paper Packaging segment.
“Severance and Termination Benefits” in 2023 include the cost of severance for approximately 200 employees whose positions were eliminated in conjunction with the Company’s ongoing organizational effectiveness efforts and severance related to the following plant closures: paper mills in Hutchinson, Kansas and Indonesia, part of the Industrial Paper Packaging segment; a metal packaging facility in the United States, part of the Consumer Packaging segment; and severance related to the closures of several smaller operations.
“Asset Impairment/Disposal of Assets” in 2024 consist primarily of asset impairment charges related to the closures of the Sumner Mill and the Kilkis Mill, both part of the Industrial Paper Packaging segment, and the exit of a small metal canning lid business within Metal Packaging, part of the Consumer Packaging segment. These charges were partially offset by gains from the sales of previously closed facilities that were part of the Industrial Paper Packaging and Consumer Packaging segments.
“Asset Impairment/Disposal of Assets” in 2023 consist primarily of asset impairment charges related to the closure of a paper mill in Hutchinson, Kansas, part of the Industrial Paper Packaging segment, and a metal packaging facility in the United States, part of the Consumer Packaging segment. These charges were partially offset by gains from the sale of previously impaired assets.
“Other Costs” in 2024 consist primarily of equipment removal, utilities, plant security, property taxes, insurance and environmental remediation costs related to the closure of the Sumner Mill, and ongoing facility carrying costs of previously announced plant closures. “Other Costs” in 2023 consist primarily of costs related to plant closures including equipment removal, utilities, plant security, property taxes and insurance.
The Company expects to pay the majority of the remaining restructuring reserves by the end of 2025 using cash generated from operations. The Company also expects to recognize future additional charges totaling approximately $3,000 in connection with previously announced restructuring actions and believes that the majority of these charges will be incurred and paid by the end of 2025. The Company continually evaluates its cost structure, including its manufacturing capacity, and additional restructuring actions are likely to be undertaken.
Other Asset Impairments
The Company recognized other asset impairment charges totaling $10,095 for the year ended December 31, 2022, as a result of exiting our operations in Russia, consisting of two small tube and core plants in the Industrial Paper Packaging segment. These charges include $3,747 of cumulative translation losses that were reclassified from accumulated other comprehensive income upon completion of the Company's exit from Russia on July 1, 2022.
These impairment charges are included in “Restructuring/Asset impairment charges” in the Company’s Consolidated Statements of Income.
v3.25.0.1
Book cash overdrafts and cash pooling
12 Months Ended
Dec. 31, 2024
Cash and Cash Equivalents [Abstract]  
Book cash overdrafts and cash pooling Book cash overdrafts and cash pooling
As part of its cash management system, the Company uses “zero balance” accounts to fund disbursements. Under this system, the bank balance is zero at the end of each day, while the book balance is usually a negative amount due to reconciling items such as outstanding checks. At December 31, 2024 and 2023, outstanding checks totaling $15,799 and $24,638, respectively, were included in “Payable to suppliers” in the Company’s Consolidated Balance Sheets. In addition, outstanding payroll checks of $162 and $0 as of December 31, 2024 and 2023, respectively, were included in “Accrued wages and other compensation” in the Company’s Consolidated Balance Sheets. Changes in these book cash overdrafts are reported as cash flows from financing activities.
The Company uses a notional pooling arrangement with an international bank to help manage global liquidity requirements. Under this pooling arrangement, the Company and its participating subsidiaries may maintain either cash deposit or borrowing positions through local currency accounts with the bank, so long as the aggregate position of the global pool is a notionally calculated net cash deposit. Because it maintains a security interest in the cash deposits, and has the right to offset the cash deposits against the borrowings, the bank provides the Company and its participating subsidiaries favorable interest terms on both. The Company’s Consolidated Balance Sheets reflect a net cash deposit under this pooling arrangement of $12,915 and $1,308 as of December 31, 2024 and 2023, respectively.
v3.25.0.1
Property, plant and equipment
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Property, plant and equipment Property, plant and equipment
Details of the Company’s property, plant and equipment at December 31 are as follows:
20242023
Land$314,278 $123,438 
Buildings967,237 660,001 
Machinery and equipment3,726,377 3,236,966 
Construction in progress337,796 225,660 
5,345,688 4,246,065 
Accumulated depreciation and depletion(2,626,941)(2,583,298)
Property, plant and equipment, net$2,718,747 $1,662,767 
Depreciation and depletion expense amounted to $224,595 in 2024, $202,917 in 2023 and $179,746 in 2022.
v3.25.0.1
Leases
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Leases Leases
The Company routinely enters into leasing arrangements for real estate (including manufacturing facilities, office space, and warehouses), transportation equipment (automobiles, forklifts, and trailers), and office equipment (copiers and postage machines). The assessment of the certainty associated with the exercise of various lease renewal, termination, and purchase options included in the Company’s lease contracts is performed after contemplating all the relevant facts and circumstances in accordance with guidance under ASC 842, “Leases.” Most real estate leases, in particular, include one or more options to renew, with renewal terms that typically extend the lease term in increments from one to five years. The Company’s leases do not have any significant residual value guarantees or restrictive covenants.
The Company completed the Eviosys acquisition on December 4, 2024. The acquisition included operating lease liabilities of $42,468 with a weighted-average remaining lease maturity term and discount rate of 8.1 years and 4.5%, respectively. The Company completed the acquisitions of the Chattanooga Mill and the remaining interest in RTS Packaging on September 8, 2023, which included operating lease liabilities of $34,604 with a weighted-average remaining lease maturity term and discount rate of 11.5 years and 6.4%, respectively. See Note 4 for additional information about these acquisitions.
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2024 and December 31, 2023:
ClassificationBalance Sheet LocationDecember 31, 2024December 31, 2023
Lease Assets
Operating lease assetsRight of Use Asset - Operating Leases$307,688 $233,461 
Finance lease assetsOther Assets76,831 78,949 
Total lease assets$384,519 $312,410 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other$52,648 $44,279 
Current finance lease liabilitiesNotes payable and current portion of long-term debt22,284 17,268 
Total current lease liabilities74,932 61,547 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities258,735 192,703 
Noncurrent finance lease liabilitiesLong-term Debt, net of current portion45,344 55,341 
Total noncurrent lease liabilities304,079 248,044 
Total lease liabilities$379,011 $309,591 
Certain of the Company’s leases include variable costs. Variable costs include lease payments that were volume or usage-driven in accordance with the use of the underlying asset, and also non-lease components that were incurred based upon actual terms rather than contractually fixed amounts. In addition, variable costs are incurred for lease payments that are indexed to a change in rate or index. Because the right of use asset recorded on the balance sheet was determined based upon factors considered at the commencement date, subsequent changes in the rate or index that were not contemplated in the right of use asset balances recorded on the balance sheet result in variable expenses being incurred when paid during the lease term.
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2024, 2023, and 2022:
Lease Cost202420232022
Operating lease cost(a)$49,327 $43,524 $40,485 
Finance lease cost:
     Amortization of lease asset(a) (b)12,871 11,789 10,524 
     Interest on lease liabilities(c)3,711 3,912 4,023 
Variable lease cost(a) (d)31,404 32,016 20,317 
Impairment charges(e)— — 61 
Total lease cost$97,313 $91,241 $75,410 
(a) Production-related and administrative amounts are included in cost of sales and selling, general and administrative expenses, respectively.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short-term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/asset impairment charges” in the Company’s Consolidated Statements of Income. See Note 5 for more information.

The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2024:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2025$55,277 $22,814 $78,091 
202646,883 18,488 65,371 
202740,440 6,038 46,478 
202835,633 5,000 40,633 
202933,545 3,716 37,261 
Beyond 2029183,690 20,795 204,485 
Total lease payments395,468 76,851 472,319 
     Less: Interest84,085 9,223 93,308 
Lease Liabilities$311,383 $67,628 $379,011 
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2024, 2023, and 2022, along with other lease-related information for the years ended December 31, 2024, 2023, and 2022:
Lease Term and Discount Rate202420232022
Weighted-average remaining lease term (years):
     Operating leases10.110.010.4
     Finance leases6.77.17.7
Weighted-average discount rate:
     Operating leases4.97%5.07%4.22%
     Finance leases5.16%5.27%5.29%
Other Information202420232022
Cash paid for amounts included in the measurement of lease liabilities:
     Operating cash flows used by operating leases $48,380 $43,638 $40,595 
     Operating cash flows used by finance leases$3,711 $3,912 $4,023 
     Financing cash flows used by finance leases$15,433 $14,617 $11,090 
Leased assets obtained in exchange for new operating lease liabilities$66,585 $18,225 $32,860 
Leased assets obtained in exchange for new finance lease liabilities$11,925 $7,755 $9,349 
Modification to leased assets for increase in operating lease liabilities$37,731 $4,431 $1,215 
Modification to leased assets for increase/(decrease) in finance lease liabilities$53 $18 $(841)
Termination reclasses to decrease operating lease assets$5,765 $5,702 $(3,695)
Termination reclasses to decrease operating lease liabilities$5,768 $6,063 $(4,015)
Termination reclasses to decrease finance lease assets$270 $1,429 $(44)
Termination reclasses to decrease finance lease liabilities$271 $482 $(44)
Leases Leases
The Company routinely enters into leasing arrangements for real estate (including manufacturing facilities, office space, and warehouses), transportation equipment (automobiles, forklifts, and trailers), and office equipment (copiers and postage machines). The assessment of the certainty associated with the exercise of various lease renewal, termination, and purchase options included in the Company’s lease contracts is performed after contemplating all the relevant facts and circumstances in accordance with guidance under ASC 842, “Leases.” Most real estate leases, in particular, include one or more options to renew, with renewal terms that typically extend the lease term in increments from one to five years. The Company’s leases do not have any significant residual value guarantees or restrictive covenants.
The Company completed the Eviosys acquisition on December 4, 2024. The acquisition included operating lease liabilities of $42,468 with a weighted-average remaining lease maturity term and discount rate of 8.1 years and 4.5%, respectively. The Company completed the acquisitions of the Chattanooga Mill and the remaining interest in RTS Packaging on September 8, 2023, which included operating lease liabilities of $34,604 with a weighted-average remaining lease maturity term and discount rate of 11.5 years and 6.4%, respectively. See Note 4 for additional information about these acquisitions.
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2024 and December 31, 2023:
ClassificationBalance Sheet LocationDecember 31, 2024December 31, 2023
Lease Assets
Operating lease assetsRight of Use Asset - Operating Leases$307,688 $233,461 
Finance lease assetsOther Assets76,831 78,949 
Total lease assets$384,519 $312,410 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other$52,648 $44,279 
Current finance lease liabilitiesNotes payable and current portion of long-term debt22,284 17,268 
Total current lease liabilities74,932 61,547 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities258,735 192,703 
Noncurrent finance lease liabilitiesLong-term Debt, net of current portion45,344 55,341 
Total noncurrent lease liabilities304,079 248,044 
Total lease liabilities$379,011 $309,591 
Certain of the Company’s leases include variable costs. Variable costs include lease payments that were volume or usage-driven in accordance with the use of the underlying asset, and also non-lease components that were incurred based upon actual terms rather than contractually fixed amounts. In addition, variable costs are incurred for lease payments that are indexed to a change in rate or index. Because the right of use asset recorded on the balance sheet was determined based upon factors considered at the commencement date, subsequent changes in the rate or index that were not contemplated in the right of use asset balances recorded on the balance sheet result in variable expenses being incurred when paid during the lease term.
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2024, 2023, and 2022:
Lease Cost202420232022
Operating lease cost(a)$49,327 $43,524 $40,485 
Finance lease cost:
     Amortization of lease asset(a) (b)12,871 11,789 10,524 
     Interest on lease liabilities(c)3,711 3,912 4,023 
Variable lease cost(a) (d)31,404 32,016 20,317 
Impairment charges(e)— — 61 
Total lease cost$97,313 $91,241 $75,410 
(a) Production-related and administrative amounts are included in cost of sales and selling, general and administrative expenses, respectively.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short-term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/asset impairment charges” in the Company’s Consolidated Statements of Income. See Note 5 for more information.

The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2024:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2025$55,277 $22,814 $78,091 
202646,883 18,488 65,371 
202740,440 6,038 46,478 
202835,633 5,000 40,633 
202933,545 3,716 37,261 
Beyond 2029183,690 20,795 204,485 
Total lease payments395,468 76,851 472,319 
     Less: Interest84,085 9,223 93,308 
Lease Liabilities$311,383 $67,628 $379,011 
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2024, 2023, and 2022, along with other lease-related information for the years ended December 31, 2024, 2023, and 2022:
Lease Term and Discount Rate202420232022
Weighted-average remaining lease term (years):
     Operating leases10.110.010.4
     Finance leases6.77.17.7
Weighted-average discount rate:
     Operating leases4.97%5.07%4.22%
     Finance leases5.16%5.27%5.29%
Other Information202420232022
Cash paid for amounts included in the measurement of lease liabilities:
     Operating cash flows used by operating leases $48,380 $43,638 $40,595 
     Operating cash flows used by finance leases$3,711 $3,912 $4,023 
     Financing cash flows used by finance leases$15,433 $14,617 $11,090 
Leased assets obtained in exchange for new operating lease liabilities$66,585 $18,225 $32,860 
Leased assets obtained in exchange for new finance lease liabilities$11,925 $7,755 $9,349 
Modification to leased assets for increase in operating lease liabilities$37,731 $4,431 $1,215 
Modification to leased assets for increase/(decrease) in finance lease liabilities$53 $18 $(841)
Termination reclasses to decrease operating lease assets$5,765 $5,702 $(3,695)
Termination reclasses to decrease operating lease liabilities$5,768 $6,063 $(4,015)
Termination reclasses to decrease finance lease assets$270 $1,429 $(44)
Termination reclasses to decrease finance lease liabilities$271 $482 $(44)
v3.25.0.1
Goodwill and other intangible assets
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and other intangible assets Goodwill and other intangible assets
Goodwill
Changes in the carrying amount of goodwill by segment for the year ended December 31, 2024, are as follows:
Consumer
Packaging
Industrial Paper
Packaging
All Other
Total
Balance as of January 1, 2024
$543,598 $506,406 $248,007 $1,298,011 
Acquisitions
1,285,518 — — 1,285,518 
    Divestitures— — (16,559)(16,559)
    Foreign currency translation(21,145)(19,770)(398)(41,313)
Balance as of December 31, 2024
$1,807,971 $486,636 $231,050 $2,525,657 

Goodwill activity reflected under the caption “Acquisitions” relates to the December 2024 acquisition of Eviosys, and goodwill activity reflected under the caption “Divestitures” relates to the April 2024 divestiture of Protexic. See Note 4 for additional information.
The Company assesses goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. The Company completed its most recent annual goodwill impairment testing during the third quarter of 2024 and analyzed certain qualitative and quantitative factors in determining whether a goodwill impairment existed. The Company’s assessments reflected a number of significant management assumptions and estimates including the Company’s forecast of sales growth, gross profit margins, and discount rates. Changes in these assumptions could materially impact the Company’s conclusions. Based on its assessments, the Company concluded that there was no impairment of goodwill for any of its reporting units.
Although no reporting units failed the annual impairment test, in management’s opinion, the goodwill balances of the Plastics-Medical, Plastics-Food, and Metal Packaging reporting units are individually at risk of impairment in the near term if each reporting unit’s operation does not perform in line with management’s expectations, or if there is a negative change in the long-term financial outlook for each reporting unit or in other factors such as the particular discount rates used. Both the Plastics-Medical and Plastics-Food reporting units are part of the Company’s Thermoformed and Flexibles Packaging business and are included in the pending sale of TFP to Toppan. See Notes 1 and 2 for additional information. In the case of Metal Packaging, the lower differential between the fair value and carrying value of the reporting unit is due to the acquisition of Ball Metalpack Holding, LLC in 2022, at which time the majority of assets and liabilities acquired were recorded at fair value. The total goodwill associated with the Plastics-Medical and Plastics-Food reporting units at December 31, 2024 was $63,575 and $198,807, respectively, and are reflected in “Non-current assets of discontinued operations” in the Company’s Consolidated Balance Sheets. The total goodwill associated with the Metal Packaging reporting unit at December 31, 2024 was $384,315 and is reflected in “Goodwill” in the Company’s Consolidated Balance Sheets.
In the annual goodwill impairment analysis completed during the third quarter of 2024, projected future cash flows for the Plastics-Medical, Plastics-Food, and Metal Packaging reporting units were discounted at 11.5%, 10.5%, and 11.0%, respectively, and their estimated fair values were determined to exceed their individual carrying values by approximately 18.7%, 18.9%, and 12.6%, respectively. Based on the discounted cash flow model and holding other valuation assumptions constant, the discount rates for the Plastics-Medical, Plastics-Food and Metal Packaging reporting units would have to increase to 13.8%, 12.4%, and 12.1%, respectively, in order for the estimated fair values of the reporting units to fall below their carrying values.
During the time subsequent to the annual evaluation, and at December 31, 2024, the Company considered whether any events and/or changes in circumstances had resulted in the likelihood that the goodwill of any of its reporting units may have been impaired. It is management’s opinion that no such events and/or changes in circumstances have occurred.
Other intangible assets
Details at December 31 are as follows:
20242023
Other Intangible Assets, Gross:
Patents$28,941 $23,970 
Customer lists2,679,372 995,077 
Trade names38,623 27,108 
Proprietary technology226,936 48,657 
Other2,339 6,206 
Total Other Intangible Assets, Gross$2,976,211 $1,101,018 
Accumulated Amortization:
Patents$(15,955)$(14,215)
Customer lists(332,680)(328,895)
Trade names(13,239)(8,327)
Proprietary technology(26,203)(20,813)
Other(1,436)(2,211)
Total Accumulated Amortization$(389,513)$(374,461)
Other Intangible Assets, Net$2,586,698 $726,557 

The acquisition of Eviosys in December 2024 resulted in the addition of $1,967,678 of intangible assets, primarily related to customer lists. These intangibles will be amortized over an average useful life of 18.9 years. The fair values of intangible assets associated with this acquisition were determined using an income valuation approach. “Total Other Intangibles Assets, gross” and “Total Accumulated Amortization” were both reduced by $54,860 during the year ended December 31, 2024 as a result of the divestiture of Protexic in April 2024. These fully amortized intangible assets consisted primarily of customer lists. See Note 4 for additional information.
Other intangible assets are amortized using the straight-line method over their respective useful lives when management determines that the straight-line method approximates the pattern of consumption of the respective intangible assets or in relation to the asset’s specific pattern of consumption if management determines that the straight-line method does not provide a fair approximation of the consumption of benefits. These lives generally range from three to forty years. The Company has no intangible assets with indefinite lives.
Aggregate amortization expense on intangible assets was $78,595, $67,323, and $60,263 for the years ended December 31, 2024, 2023, and 2022, respectively. Amortization expense on other intangible assets is expected to approximate $173,400 in 2025, $171,600 in 2026, $170,300 in 2027, $169,700 in 2028 and $167,200 in 2029 based on intangible assets as of December 31, 2024.
v3.25.0.1
Supply chain financing
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Supply chain financing Supply chain financing
The following table sets forth the balance sheet location and rollforward of the Company’s outstanding obligations confirmed under its SCF Programs for the year ended December 31, 2024:
Balance Sheet LocationDecember 31, 2024
Confirmed obligations outstanding at the beginning of the yearPayable to suppliers$24,779 
Invoices confirmed during the year (a) (b)
96,785 
Confirmed invoices paid during the year (b)
(93,068)
Confirmed obligations outstanding at the end of the yearPayable to suppliers$28,496 

(a) Includes $7,547 of obligations under SCF programs acquired in the acquisition of Eviosys on December 4, 2024.
(b) The net payment of these obligations, exclusive of the $7,547 of obligations acquired in the acquisition of Eviosys, is included in “Net cash provided by operating activities” in the Company’s Consolidated Statements of Cash Flows.
v3.25.0.1
Debt
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Debt Debt
Details of the Company’s debt at December 31 were as follows:
20242023
364-Day term loan due December 2025$1,493,568 $— 
Term loan due December 2026698,167 — 
Syndicated term loan due August 2028497,674 572,025 
1.80% notes due February 2025
399,933 399,149 
4.450% notes due September 2026
496,869 — 
2.25% notes due February 2027
298,930 298,421 
4.600% notes due September 2029
594,519 — 
3.125% notes due May 2030
596,958 596,480 
2.85% notes due February 2032
496,302 495,785 
5.000% notes due September 2034
689,802 — 
5.75% notes due November 2040
536,282 536,246 
Other foreign denominated debt, average rate of 6.0% in 2024 and 8.8% in 2023
155,048 49,418 
Finance lease obligations67,628 72,609 
Other debt18,341 16,803 
Total debt$7,040,021 $3,036,936 
Less: Notes payable and current portion of long-term debt(2,054,525)(38,934)
Long-term debt$4,985,496 $2,998,002 

On July 12, 2024, the Company entered into a credit agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent which provides the Company with the ability to borrow up to $700,000 on an unsecured basis (the “Term Loan Facility”) to finance a portion of the cash consideration for the Company’s acquisition of Eviosys. The Company drew down the entire Term Loan Facility on December 2, 2024 in connection with the consummation of the Eviosys acquisition on December 4, 2024. Borrowings under the Term Loan Facility, net of any prepayments, will become payable in full on December 2, 2026 and will bear interest at a fluctuating rate per annum equal to, at the Company’s option, (i) the forward-looking Secured Overnight Financing Rate term rate (such borrowings, “Term SOFR Loans”), (ii) a base rate, or (iii) a combination thereof, plus, in each case, an applicable margin calculated based on the Company’s credit ratings and, in the case of Term SOFR Loans, an adjustment of 10 basis points.
On September 16, 2024, the Company entered into a credit agreement with the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent which provides the Company with the ability to borrow up to $1,500,000 on an unsecured basis (the “364-Day Term Loan Facility”) to finance a portion of the cash consideration for the Company’s acquisition of Eviosys. The Company drew down the entire 364-Day Term Loan Facility on December 2, 2024 in connection with the consummation of the Eviosys acquisition on December 4, 2024. Borrowings under the 364-Day Term Loan Facility, net of any prepayments, will become payable in full on December 1, 2025 and will bear interest under the same terms as the Term Loan Facility.
On September 19, 2024, the Company completed a registered public offering of senior unsecured notes (the “Notes”) in a combined aggregate principal amount of $1,800,000. The Notes consisted of the following:
Principal AmountIssuance Costs and DiscountsNet ProceedsInterest RateMaturity
2026 Notes$500,000 (3,697)$496,303 4.450 %September 1, 2026
2029 Notes600,000 (5,851)594,149 4.600 %September 1, 2029
2034 Notes700,000 (10,542)689,458 5.000 %September 1, 2034
Total$1,800,000 $(20,090)$1,779,910 
The Company used the net proceeds from the Notes, together with the borrowings under the Term Loan Facility and 364-Day Term Loan Facility and cash on hand to fund the cash consideration payable by the Company in connection with the Eviosys acquisition and to pay related fees and expenses. See Note 4 for more information.
Included in “Other foreign denominated debt” at December 31, 2024 is $73,487 of transfers of certain trade receivables of Eviosys to third-party financial institutions for which the requirements to be accounted for as true sale in accordance with the guidance under ASC 860 were not met.
In conjunction with the announcement of the acquisition of Eviosys, the Company entered into a commitment letter with certain financial institutions that provided for a 364-day senior unsecured bridge term loan facility (the “Bridge Loan Facility”) on June 22, 2024 in an aggregate amount of up to $4,000,000 to secure funding of the acquisition. As a result of obtaining financing for the Eviosys acquisition through the Term Loan Facility, the 364-Day Term Loan Facility, and the Notes, the Company terminated the commitments under the Bridge Loan Facility and the related commitment letter effective September 19, 2024. Fees related to the Bridge Loan Facility of $19,000 were amortized to interest expense during the year ended December 31, 2024.
On August 7, 2023, the Company entered into a credit agreement with a consortium of Farm Credit System institutions and CoBank, ACB, as Administrative Agent (the “Syndicated Term Loan Agreement”). The Syndicated Term Loan Agreement provides the Company with the ability to borrow up to $900,000 on an unsecured basis (the “Syndicated Term Loan Facility”). A total of $600,000 was drawn from the Syndicated Term Loan Facility on August 7, 2023 and used to repay the syndicated term loans that were due in December 2023 and January 2025, and to make certain capital expenditures and reimburse the Company for certain capital expenditures it had made in its operation of waste disposal facilities in rural areas. An additional $270,000 was drawn from the Syndicated Term Loan Facility on September 8, 2023 and used to partially fund the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill (see Note 4 for more information). Borrowings under the Syndicated Term Loan Facility, net of any prepayments, will become payable in full on August 7, 2028. During the years ended December 31, 2024 and December 31, 2023, the Company repaid $75,000 and $295,000, respectively, of the amounts drawn under the Syndicated Term Loan Facility. Borrowings under the Syndicated Term Loan Facility bear interest at a fluctuating rate per annum equal to, at the Company’s option, (i) the forward-looking SOFR term rate (“Term SOFR” and such borrowings, “Syndicated Term SOFR Loans”), (ii) a base rate set forth in the Syndicated Term Loan Agreement, or (iii) a combination thereof, plus, in each case, an applicable margin calculated based on the Company’s credit ratings and, in the of case of Syndicated Term SOFR Loans, a SOFR Adjustment (as defined in the Syndicated Term Loan Agreement) of 0.1%. The Company has designated its borrowings under the Syndicated Term Loan Facility as Syndicated Term SOFR Loans. The margin currently applicable to Syndicated Term SOFR Loans based on the Company’s credit ratings, together with the SOFR Adjustment, is 1.90%. If Term SOFR ceases to be available, the benchmark rate shall switch to Daily Simple SOFR (as defined in the Syndicated Term Loan Agreement). There is no required amortization under the Syndicated Term Loan Facility, and voluntary prepayments are permissible without penalty, subject to certain conditions pertaining to minimum notice and minimum prepayment and reduction amounts as described in the Syndicated Term Loan Agreement.
The Syndicated Term Loan Agreement contains various customary representations and warranties and affirmative and negative covenants, as more fully described in the Syndicated Term Loan Agreement. The Syndicated Term Loan Agreement also contains various customary events of default (subject to grace periods, as applicable) including, among others: nonpayment of principal, interest or fees; breach of covenant; payment default on, or acceleration under, certain other material indebtedness; inaccuracy of the representations or warranties in any material respect; bankruptcy or insolvency; inability to pay debts; certain unsatisfied judgments; certain ERISA-related events; the invalidity or unenforceability of the Syndicated Term Loan Agreement or certain other documents executed in connection therewith; and the occurrence of a change of control.
On May 3, 2024, the Company entered into an Amended and Restated Credit Agreement (the “Agreement”) to extend the maturity and make certain other changes to the terms under the Company’s existing five-year credit agreement dated June 21, 2021. The Agreement increases the commitments under the Company’s revolving credit facility by $350,000 to $1,250,000 and extends the maturity date to May 3, 2029. The Company also increased its $500,000 commercial paper program by $750,000 to $1,250,000. The revolving credit facility continues to support the commercial paper program. At December 31, 2024, the Company had no commercial paper balances outstanding; accordingly, the committed capacity available for drawdown under its revolving credit facility at December 31, 2024 was $1,250,000. Based on the pricing grid, the credit agreement for the revolving credit facility and Sonoco’s current credit ratings, any drawings are subject to the Term SOFR plus the 137.5 basis points margin.
The principal requirements of debt maturing in the next five years are:
  
20252026202720282029
Debt maturities by year$2,054,525 $1,218,544 $310,533 $508,115 $598,367 
As of December 31, 2024, the Company has scheduled debt maturities through the next twelve months of $2,054,525. At December 31, 2024, the Company had $443,060 in cash and cash equivalents on hand, including discontinued operations, and $1,250,000 in committed capacity available for drawdown under its revolving credit facility. The Company believes that these amounts, combined with expected net cash flows from operating activities, provide ample liquidity to cover these debt maturities and other cash flow needs of the Company over the course of the next year. On February 3, 2025, the Company repaid the 1.80% notes due February 2025 using proceeds from the issuance of commercial paper.
In addition, the Company had approximately $179,660 available under unused short-term lines of credit at December 31, 2024. These short-term lines of credit are available for general corporate purposes of our subsidiaries, including working capital and hedging requirements.
Certain of the Company’s debt agreements impose restrictions with respect to the maintenance of financial ratios and the disposition of assets. The most restrictive covenants currently require the Company to maintain a minimum level of interest coverage and a minimum level of net worth, as defined in the agreements. As of December 31, 2024, the Company’s interest coverage and net worth were substantially above the minimum levels required under these covenants.
v3.25.0.1
Financial instruments and derivatives
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Financial instruments and derivatives Financial instruments and derivatives
The following table sets forth the carrying amounts and fair values of the Company’s significant financial instruments for which the carrying amount differs from the fair value.
 December 31, 2024December 31, 2023
  
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Long-term debt, net of current portion$4,985,496 $4,800,455 $2,998,002 $2,852,143 
The carrying value of cash and cash equivalents and short-term debt approximates fair value. The fair value of long-term debt is determined based on recent trade information in the financial markets of the Company’s public debt or is determined by discounting future cash flows using interest rates available to the Company for issues with similar terms and maturities, which is considered a Level 2 fair value measurement.
Cash Flow Hedges
At December 31, 2024 and 2023, the Company had derivative financial instruments outstanding to hedge anticipated transactions and certain asset and liability related cash flows. These contracts, which have maturities ranging through December 2025, qualify as cash flow hedges under GAAP. For derivative instruments that are designated and qualify as a cash flow hedge, the gain or loss on the derivative instrument is reported as a component of other comprehensive income and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings and is presented in the same income statement line item as the earnings effect of the hedged item. Cash flows from derivative
financial instruments designated as cash flow hedges are classified as cash flows from operating activities in the Condensed Consolidated Statements of Cash Flows.
Commodity Cash Flow Hedges
Certain derivative contracts entered into to manage the cost of anticipated purchases of natural gas and aluminum have been designated by the Company as cash flow hedges. At December 31, 2024, there were no natural gas swaps covering anticipated natural gas usage in 2025 and aluminum swaps covering 3,546 metric tons of aluminum represented approximately 24% of anticipated aluminum usage for 2025. The fair values of the Company’s commodity cash flow hedges netted to a gain position of $652 and a loss position of $(41) at December 31, 2024 and December 31, 2023, respectively. The amount of the gain included in accumulated other comprehensive loss at December 31, 2024, expected to be reclassified to the income statement during the next twelve months is $652. The Company also has certain natural gas hedges that are not designated as cash flow hedges. See “Non-Designated Derivatives” below for a discussion of these hedges.
Foreign Currency Cash Flow Hedges
The Company has entered into forward contracts to hedge certain anticipated foreign currency denominated sales and purchases expected to occur in 2025. The net positions of these contracts at December 31, 2024, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase26,917,468 
Mexican pesopurchase373,569 
Polish zlotypurchase121,377 
Danish kronepurchase161,128 
Swedish kronasell(6,709)
Czech korunapurchase110,834 
Canadian dollarpurchase11,045 
Europurchase3,499 
Turkish lirapurchase104,546 
British poundsell(5,388)
Euro Contracts
Europurchase40,670 
British poundpurchase30,724 
Thai bahtpurchase620,976 
Hungarian forintsell(5,560,396)
The fair value of foreign currency cash flow hedges related to forecasted sales and purchases netted to a loss position of $(1,841) at December 31, 2024, and a gain position of $1,502 at December 31, 2023. The amount of the loss expected to be reclassified from accumulated other comprehensive loss to the income statement during the next twelve months is $(1,841).
Net Investment Hedge
In 2023, the Company became a party to cross-currency swap agreements with a total notional amount of $500,000 to effectively convert a portion of the Company’s fixed-rate U.S. dollar denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt. The swap agreements, which had a maturity of December 18, 2026, provided for the Company to receive semi-annual interest payments in U.S. dollars at a fixed rate and to make semi-annual interest payments in euros at a fixed rate. The risk management objective of entering into the swap agreements was to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in euros. The agreements were designated as net investment hedges for accounting purposes. On April 15, 2024, as a result of the strengthening of the U.S. dollar against the euro, as well as a reduction in the differential between U.S. and European interest rates, the Company terminated its swap agreements and received a net cash settlement of $9,068. The foreign currency translation gain of approximately $3,143, net of tax, is included as a component of “Accumulated other comprehensive loss.”
Following the unwind of the swaps, the Company entered into new cross-currency swap agreements with a total notional amount of $500,000 in April 2024 to effectively convert a portion of the Company’s fixed-rate U.S. dollar-denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt. The new swap agreements, which have a maturity of May 1, 2027 share the same risk management objective as the terminated cross-currency swap agreements and are also designated as net investment hedges for accounting purposes.
In December 2024, the Company entered into additional cross-currency swap agreements with a total notional amount of $1,500,000, including $500,000 maturing on September 1, 2026, $500,000 maturing on September 1, 2029, and $500,000 maturing on May 1, 2030. The swaps effectively convert a portion of the Company’s fixed-rate U.S. dollar-denominated debt, including the semi-annual interest payments, to fixed-rate euro-denominated debt at the prevailing market rate at execution. The new swap agreements share the same risk management objective as the Company’s previously existing cross-currency swap agreements and are also designated as net investment hedges for accounting purposes.
The gain or loss on the net investment hedge derivative instruments is included in the “Foreign currency translation” component of “Accumulated other comprehensive loss” until the net investment is sold, diluted, or liquidated. Interest payments received for the cross-currency swaps and the related excluded components are excluded from the net investment hedge effectiveness assessment and are recorded in “Interest expense” in the Company’s Condensed Consolidated Statements of Income. The assumptions used in measuring fair value of the cross-currency swaps are considered level 2 inputs, which are based upon the Euro-to-U.S. dollar exchange rate market.
The fair value of the Company’s net investment hedges was a gain position of $11,919 and a loss position of $(5,073) at December 31, 2024 and December 31, 2023, respectively. Foreign currency translation gain of $8,880 (net of income taxes of $3,039) and loss of $3,779 (net of income taxes of $1,294) were reported as components of “Accumulated other comprehensive loss” within “Foreign currency items” at December 31, 2024 and December 31, 2023, respectively.
Non-Designated Derivatives
The Company routinely enters into other derivative contracts which are not designated for hedge accounting treatment under ASC 815, “Derivatives and Hedging.” As such, changes in fair value of these non-designated derivatives are recorded directly to income and expense in the periods that they occur.
Foreign Currency Hedges
The Company routinely enters into forward contracts or swaps to economically hedge the currency exposure of intercompany debt and foreign currency denominated receivables and payables. The net currency positions of these non-designated contracts at December 31, 2024, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase66,306,243
Indonesian rupiahpurchase20,247,238
Mexican pesopurchase339,381
Turkish lirapurchase7,875
Canadian dollarpurchase7,262
Euro Contracts
British poundpurchase74,214
Polish zlotypurchase34,451
Thai Bahtpurchase410,488
Commodity Hedges
The Company has entered into non-designated derivative contracts to manage the cost of anticipated purchases of natural gas. At December 31, 2024, these contracts consisted of natural gas swaps covering approximately 5.2 million metric million British thermal units (“MMBTUs”) representing approximately 75.5% of anticipated usage in North America for 2025.
Interest Rate Hedges
In anticipation of the offering of the Notes (see Note 11 for additional information), the Company entered into treasury lock derivative instruments with eleven banks, with a total notional principal amount of $900,000, on August 29, 2024. These instruments had the risk management objective of reducing the Company’s exposure to increases in the underlying Treasury index up to the date of pricing of the Notes. The derivatives were settled when the Notes priced on September 17, 2024, with the Company recognizing a loss on the settlement of $(11,088). The loss is included in “Interest expense” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024.
The fair value of the Company’s non-designated derivatives position was a loss of $(2,694) and $(6,790) at December 31, 2024 and December 31, 2023, respectively.
The following table sets forth the location and fair values of the Company’s derivative instruments at December 31, 2024 and December 31, 2023:
  Fair Value at December 31
DescriptionBalance Sheet Location20242023
Derivatives designated as hedging instruments:
Commodity ContractsPrepaid expenses$671 $67 
Commodity ContractsAccrued expenses and other(19)(108)
Foreign Exchange ContractsPrepaid expenses2,068 2,525 
Foreign Exchange ContractsAccrued expenses and other(3,909)(1,024)
Net investment hedgePrepaid expenses26,833 5,567 
Net investment hedgeOther Assets1,845 — 
Net investment hedgeOther liabilities(16,759)(10,640)
Derivatives not designated as hedging instruments:
Commodity ContractsPrepaid expenses$961 $12 
Commodity ContractsAccrued expenses and other(574)(6,782)
Foreign Exchange ContractsPrepaid expenses(59)130 
Foreign Exchange ContractsAccrued expenses and other(3,022)(159)
While certain of the Company’s derivative contract arrangements with its counterparties provide for the ability to settle contracts on a net basis, the Company reports its derivative positions on a gross basis. There are no collateral arrangements or requirements in these agreements.
The following tables set forth the effect of the Company’s derivative instruments on financial performance for the year ended December 31, 2024 and December 31, 2023, excluding the gains or losses on foreign currency cash flow hedges that were reclassified from accumulated other comprehensive loss to the carrying value of the capitalized expenditures:
Description
Amount of Gain or
(Loss) Recognized
in OCI on
Derivatives
Location of Gain or
(Loss) Reclassified
from Accumulated
OCI Into Income
Amount of Gain
or (Loss)
Reclassified from
Accumulated OCI
Into Income
Derivatives in Cash Flow Hedging Relationships:
Year Ended December 31, 2024
Foreign Exchange Contracts$(4,994)Net sales$(1,174)
Cost of sales$(253)
Commodity Contracts$665 Cost of sales$(28)
Year Ended December 31, 2023
Foreign Exchange Contracts$8,982 Net sales$10,860 
Cost of sales$(3,728)
Commodity Contracts$99 Cost of sales$(32)
Description
  
Gain or (Loss)
Recognized
Location of Gain or (Loss) Recognized in Income Statement
Derivatives not Designated as Hedging Instruments:
Year Ended December 31, 2024
Commodity Contracts$(2,976)
Cost of Sales
Foreign Exchange Contracts$(8,168)
Selling, general and administrative
Year Ended December 31, 2023
Commodity Contracts$(19,087)Cost of sales
Foreign Exchange Contracts$7,560 
Selling, general and administrative
Year Ended December 31, 2024Year Ended December 31, 2023
Description
Net Sales
Cost of Sales
Net Sales
Cost of Sales
Total amount of income and expense line items presented in the Consolidated Statements of Income$(1,174)$(281)$10,860 $(3,760)
Gain or (loss) on cash flow hedging relationships:
Foreign exchange contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$(1,174)$(253)$10,860 $(3,728)
Commodity contract:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$— $(28)$— $(32)
v3.25.0.1
Fair value measurements
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Fair value measurements Fair value measurements
Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
Level 1 –Observable inputs such as quoted market prices in active markets;
Level 2 –Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3 –Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
Assets that are calculated at net asset value (“NAV”) per share are not required to be categorized within the fair value hierarchy.
The following tables set forth information regarding the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:
DescriptionDecember 31, 2024Assets measured at NAV (f)Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts
$652 $— $— $652 $— 
Foreign exchange contracts
(1,841)— — (1,841)— 
 Net investment hedge11,919 — — 11,919 — 
Non-hedge derivatives, net:
Commodity contracts387 — — 387 — 
Foreign exchange contracts(3,081)— — (3,081)— 
Postretirement benefit plan assets:
 Common Collective(a)13,259 13,259 — — — 
Mutual funds(b)
43,059 — — 43,059 — 
 Fixed income securities(c)
235,952 62,458 — 173,494 — 
 Short-term investments(d)
3,493 — — 3,493 — 
 Real estate funds(e)
480 480 — — — 
      Cash and accrued income7,757 — 7,757 — — 
Total postretirement benefit plan assets$304,000 $76,197 $7,757 $220,046 $— 
DescriptionDecember 31, 2023Assets measured at NAV (f)Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts
$(41)$— $— $(41)$— 
Foreign exchange contracts
1,502 — — 1,502 — 
Net investment hedge(5,073)— — (5,073)— 
Non-hedge derivatives, net:
      Commodity contracts(6,770)— — (6,770)— 
Foreign exchange contracts(29)— — (29)— 
Postretirement benefit plan assets:
      Common Collective(a)12,958 12,958 — — — 
      Mutual funds(b)45,931 — — 45,931 — 
      Fixed income securities(c)242,702 63,849 — 178,853 — 
      Short-term investments(d)4,175 — — 4,175 — 
      Real estate funds(e)400 400 — — — 
      Cash and accrued income 2,634 — 2,634 — — 
Total postretirement benefit plan assets$308,800 $77,207 $2,634 $228,959 $— 
a.Common collective trust investments consist of domestic and international large and mid capitalization equities, including emerging markets and funds invested in both short-term and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds, private securities, and limited partnerships are valued at unit values or NAVs provided by the investment managers.
b.Mutual fund investments are comprised of equity securities of corporations with large capitalizations and also include funds invested in corporate equities in international and emerging markets and funds invested in long-term bonds, which are valued at closing prices from national exchanges.
c.Fixed income securities include funds that invest primarily in government securities and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges, fixed income pricing models, and independent financial analysts. Fixed income commingled funds are valued at unit values provided by the investment managers.
d.Short-term investments include several money market funds used for managing overall liquidity. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds are valued at unit values provided by the investment managers.
e.Includes investments in real estate funds (including office, industrial, residential and retail). Underlying real estate securities are generally valued at closing prices from national exchanges.
f.Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
The Company’s pension plan assets comprise more than 96% of its total postretirement benefit plan assets. Accordingly, the assets of the Company’s various pension plans and retiree health and life insurance plans are not shown separately, but are combined in the tables above. Postretirement benefit plan assets are netted against postretirement benefit obligations to determine the funded status of each plan. The funded status is recognized in the Company’s Consolidated Balance Sheets as shown in Note 15.
As discussed in Note 12, the Company uses derivatives to mitigate the effect of commodity fluctuations, foreign currency fluctuations and, from time to time, interest rate movements. Fair value measurements for the Company’s derivatives are classified under Level 2 because such measurements are estimated based on observable inputs such as interest rates, yield curves, spot and future commodity prices and spot and future exchange rates.
None of the Company’s financial assets or liabilities are measured at fair value using significant unobservable inputs. There were no transfers in or out of Level 1 or Level 2 fair value measurements during the years ended December 31, 2024 or 2023.
The Company has an investment in the preferred stock of a nonaffiliated private company. This investment is accounted for under the measurement alternative of cost less impairment, adjusted for any qualifying observable price changes on a non-recurring basis. Observable price changes would consist of Level 2 inputs based on privately negotiated transactions with the nonaffiliated company. The total investment in preferred stock of $21,212 is included in “Other assets” in the Company’s Consolidated Balance Sheet as of December 31, 2024.
For additional fair value information on the Company’s financial instruments, see Note 12.
v3.25.0.1
Share-based compensation plans
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Share-based compensation plans Share-based compensation plans
The Company provides share-based compensation to certain employees and non-employee directors in the form of RSUs, PCSUs, and other share-based awards. Beginning in 2024, share-based awards were issued pursuant to the Sonoco Products Company 2024 Omnibus Incentive Plan (the “2024 Plan”), which became effective upon approval by the shareholders on April 17, 2024. Awards issued from 2019 through 2023 were issued pursuant to the Sonoco Products Company 2019 Omnibus Incentive Plan (the “2019 Plan”).
A total of 2,900,000 shares of common stock are reserved for awards granted under the 2024 Plan. As of the April 17, 2024 effective date, the 2024 Plan superseded the 2019 Plan and became the only plan under which equity-based compensation may be awarded to employees and non-employee directors. However, any awards under any of the prior plans that were outstanding on the effective date of the 2024 Plan remain subject to the terms and conditions, and continue to be governed, by such prior plans. Awards issued between January 1 and April 16, 2024 were effectively issued under the 2024 Plan when such awards were transferred over to be applied against the 2024 Plan’s reserve. Share reserve reductions for restricted and performance-based stock awards and stock appreciation rights originally granted under the 2019 Plan were weighted equally on a one-for-one basis in accordance with the shareholder-approved conversion formula included within the 2024 Plan. Share awards granted under all previous plans which are forfeited, expire or are canceled without delivery of shares, or which result in forfeiture of shares back to the Company, will be added back to the total shares available under the 2024 Plan. Shares of the Company’s common stock repurchased to satisfy employee tax withholding obligations in association with the exercise of RSUs and PCSUs, but not stock appreciation rights (“SARs”), will also be added back to the total shares available under the 2024 Plan.
At December 31, 2024, a total of 2,224,042 shares remain available for future grant under the 2024 Plan. The Company issues new shares for stock unit conversions and stock appreciation right exercises.
Accounting for share-based compensation
Total compensation cost for share-based payment arrangements was $26,948, $24,738 and $28,302, for 2024, 2023 and 2022, respectively. The related tax benefit recognized in net income was $6,852, $6,162, and $7,231, for the same years, respectively. Share-based compensation expense is included in “Selling, general and administrative expenses” in the Company’s Consolidated Statements of Income. The Company accounts for forfeitures of its share-based payment arrangements as they occur.
An “excess” tax benefit is created when the tax deduction for an exercised stock appreciation right or converted stock unit exceeds the compensation cost that has been recognized in income. The additional net excess tax benefit realized was $257, $978 and $1,367 for 2024, 2023 and 2022, respectively.
Restricted Stock Units
The Company grants awards of RSUs to executive officers and certain key management employees annually on a discretionary basis. These awards vest over a three-year period with one-third vesting on each anniversary date of the grant. The expense for these RSUs is recognized following the graded-vesting method, which results in front-loaded expense being recognized during the early years of the required service period. For grants awarded prior to 2021, participants must be actively employed by the Company on the vesting date for shares to be issued, except in the event of the participant’s death, disability, or involuntary (or good reason) termination within two years of a change in control prior to full vesting, in which case shares will immediately vest. For awards granted since 2020, in the event of the participant’s death, disability or retirement prior to full vesting, shares will be issued on a pro rata basis up through the time the participant’s employment or service ceases. Once vested, these awards do not expire.
The Company from time to time grants special RSUs to certain of its executive officers and directors. These awards normally vest over a five-year period with one-third vesting on each of the third, fourth and fifth anniversaries of the grant, but in some circumstances may vest over a shorter period, or cliff vest at the end of the five-year period. Normally a participant must be actively employed by, or serving as a director of, the Company on the vesting date for shares to be issued, but the Company may make other arrangements in connection with termination of employment prior to the vesting date. Officers and directors can elect to defer receipt of RSUs, which will be issued in shares of Sonoco common stock in installments beginning no earlier than six months following separation from the Company or the Board of Directors (the “Board”), respectively. Key management employees are required to take receipt of the stock issued upon the vest date.
The weighted-average grant-date fair value of RSUs granted was $52.41, $56.87 and $53.55 per share in 2024, 2023 and 2022, respectively. The fair value of shares vesting during the year was $13,190, $10,320, and $6,243 for 2024, 2023 and 2022, respectively. Non-cash stock-based compensation associated with restricted stock grants totaled $14,748, $12,888 and $9,320 for 2024, 2023 and 2022, respectively. As of December 31, 2024, there was $11,657 of total unrecognized compensation cost related to nonvested RSUs. This cost is expected to be recognized over a weighted-average period of 24 months.
The activity related to RSUs for the year ended December 31, 2024 is as follows:
NonvestedVested
Total
Average Grant
Date Fair
Value Per Share
Outstanding, December 31, 2023
593,445 68,815 662,260 $54.71 
   Granted383,708 — 383,708 $52.41 
   Vested(234,610)234,610 — 
   Converted(231,157)(231,157)$55.27 
   Cancelled(62,103)— (62,103)$54.06 
   Dividend equivalents1,176 3,312 4,488 $55.42 
Outstanding, December 31, 2024
681,616 75,580 757,196 $53.43 
Performance Contingent Restricted Stock Units
The Company grants PCSUs annually on a discretionary basis to executive officers and certain key management employees. The ultimate number of PCSUs awarded is dependent upon the degree to which performance, relative to defined targets related to earnings and return on invested capital is achieved over a three-year performance cycle and for the 2024 and 2023 PCSU grants only, a modifier for total stock return performance.
The Company estimates the fair value of its 2024 and 2023 PCSUs based upon the Company’s stock price on the dates of grant and an estimate of the Company’s payout modifier based upon the projected total stock return performance relative to its peer group companies. The comparative market indices for the awards that vest based on total stock return to shareholders are the S&P Composite 1500 Materials Index. If the Company’s actual total stock return for the three-year measurement period is determined to be between the 25th and 75th percentile relative to its peers, no additional modifier is triggered for the particular PCSU grant upon vesting. If the Company’s total stock return for the three-year measurement period is determined to be above the 75th percentile, the modifier adds 20% to the award’s vested share payout for total stock return performance in the top quartile, and if the Company’s return falls below the 25th percentile relative to its peers, the modifier reduces the award’s share payout by 20% for performance in the bottom quartile.
PCSUs granted vest at the end of the three-year performance period if the respective performance targets are met. No units will be awarded if the performance targets are not met. Upon vesting, PCSUs are convertible into common shares on a one-for-one basis. Officers can elect to defer receipt of PCSUs, which will be issued in shares of Sonoco common stock in installments beginning no earlier than six months following separation from the Company. Key management employees are required to take receipt of the stock issued upon the vest date. Except in the event of the participant’s death, disability, or retirement, if a participant is not employed by the Company at the end of the performance period, no PCSUs will vest. However, in the event of the participant’s death, disability or retirement prior to full vesting, shares will be issued on a pro rata basis up through the time the participant’s employment or service ceases. In the event of a change in control, as defined under the 2024 Plan, all unvested PCSUs will vest at target on a pro rata basis if the change in control occurs during the three-year performance period.
The activity related to PCSUs for the year ended December 31, 2024 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value per Share
Outstanding, December 31, 2023
418,403 236,492 654,895 $53.51
   Granted253,176 — 253,176 $50.54
   Performance adjustments(21,184)— (21,184)$41.05
   Vested(330,888)330,888 — 
   Converted— (217,966)(217,966)$55.48
   Cancelled(35,832)— (35,832)$52.32
   Dividend equivalents— 667 667 $55.40
Outstanding, December 31, 2024
283,675 350,081 633,756 $52.13
2024 PCSU. As of December 31, 2024, the 2024 PCSUs to be awarded are estimated to range from 0 to 517,066 units, including the 20% total stock return modifier, and are tied to the three-year performance period ending December 31, 2026.
2023 PCSU. As of December 31, 2023, the 2023 PCSUs to be awarded are estimated to range from 0 to 410,100 units, including the 20% total stock return modifier, and are tied to the three-year performance period ending December 31, 2025.
2022 PCSU. The performance cycle for the 2022 PCSUs was completed on December 31, 2024. Outstanding stock units of 330,888 units were determined to have been earned. The fair value of these units was $16,164 as of December 31, 2024.
2021 PCSU. The performance cycle for the 2021 PCSUs was completed on December 31, 2023. Outstanding stock units of 225,530 units were determined to have been earned. The fair value of these units was $12,600 as of December 31, 2023.
2020 PCSU. The performance cycle for the 2020 PCSUs was completed on December 31, 2022. Outstanding stock units of 280,881 units were determined to have been earned. The fair value of these units was $17,052 as of December 31, 2022.
The weighted-average grant-date fair value of PCSUs granted was $50.54, $55.04, and $51.94 per share in 2024, 2023 and 2022, respectively. Non-cash stock-based compensation associated with PCSUs totaled $10,176, $9,826 and $16,686 for 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $7,873 of total unrecognized compensation cost related to nonvested PCSUs. This cost is expected to be recognized over a weighted-average period of 21 months.
Deferred compensation plans
Certain officers of the Company receive a portion of their compensation, either current or deferred, in the form of stock equivalent units. Units are granted as of the day the cash compensation would have otherwise been paid using the closing price of the Company’s common stock on that day. Deferrals into stock equivalent units are converted into phantom stock equivalents as if Sonoco shares were actually purchased. The units immediately vest and earn dividend equivalents. Units are distributed in the form of common stock upon retirement over a period elected by the employee.
Non-employee directors may elect to defer a portion of their cash retainer or other fees (except chair retainers) into phantom stock equivalent units as if Sonoco shares were actually purchased. The deferred stock equivalent units accrue dividend equivalents, and are issued in shares of Sonoco common stock beginning six months following termination of Board service. Directors must elect to receive these deferred distributions in one, three or five annual installments.
The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2023
324,602 
   Deferred34,113 
   Converted(8,541)
   Dividend equivalents11,249 
Outstanding, December 31, 2024
361,423 

Compensation deferrals for employees and directors, all of which will be settled in Company stock after retirement, totaled $2,024, $2,024, and $2,256, during 2024, 2023, and 2022, respectively.
Stock appreciation rights
Through 2019, the Company granted SARs annually on a discretionary basis to key employees. These SARs had an exercise price equal to the closing market price on the date of the grant and can be settled only in stock. All outstanding SARs are vested as of December 31, 2024. The weighted average remaining contractual life for both outstanding and exercisable SARs at December 31, 2024 was 4.2 years.
Noncash stock-based compensation expense associated with SARs totaled $0 for 2024 and 2023 and $40 for 2022. As of December 31, 2024, there is no unrecognized compensation cost remaining.
The activity related to the Company’s SARs for the year ended December 31, 2024 is as follows: 
NonvestedVestedTotal
Weighted-
average
Exercise
Price
Outstanding, December 31, 2023
— 729,515 729,515 $55.13 
   Vested— — — $— 
   Granted— — — $— 
   Exercised— (47,180)(47,180)$47.28 
   Forfeited/Expired— (18,931)(18,931)$57.41 
Outstanding, December 31, 2024
— 663,404 663,404 $55.62 
Exercisable, December 31, 2024
— 663,404 663,404 $55.62 

The aggregate intrinsic value of SARS exercised during 2024, 2023, and 2022 was $74, $158, and $582, respectively. The aggregate intrinsic value for both outstanding and exercisable SARs was $376 at December 31, 2024 using the fair market value of the Company’s stock on that date of $48.85 per share.
v3.25.0.1
Employee benefit plans
12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Employee benefit plans Employee benefit plans
Retirement plans and retiree health and life insurance plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, France, and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements. For further information regarding the Eviosys pension plan that was acquired in 2024, see the Eviosys acquisition section below.
The components of net periodic benefit cost/(income) include the following:
202420232022
Retirement Plans
Service cost$3,456 $2,878 $3,266 
Interest cost19,097 18,101 10,562 
Expected return on plan assets(11,133)(9,451)(10,302)
Amortization of prior service cost864 926 913 
Amortization of net actuarial loss4,472 4,300 6,240 
Effect of settlement loss530 1,010 479 
Effect of curtailment loss— — 43 
Net periodic benefit cost$17,286 $17,764 $11,201 
Retiree Health and Life Insurance Plans
Service cost$178 $230 $320 
Interest cost919 507 258 
Expected return on plan assets(392)(313)(439)
Amortization of prior service credit385 — — 
Amortization of net actuarial gain(899)(768)(681)
Net periodic benefit cost/(income)$191 $(344)$(542)
The following tables set forth the Plans’ obligations and assets at December 31:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Change in Benefit Obligation
Benefit obligation at January 1$413,340 $352,767 $22,571 $11,244 
Service cost3,456 2,878 178 230 
Interest cost19,097 18,101 919 507 
Plan participant contributions31 60 — — 
Plan amendments615 306 — 11,637 
Actuarial (gain)/loss(18,935)15,663 (2,389)(266)
Benefits paid(28,263)(26,703)(1,418)(788)
Impact of foreign exchange rates(8,926)8,707 (29)
Effect of settlements(2,218)(2,373)— — 
Effect of curtailments— — — — 
Acquisitions74,078 43,934 — — 
Benefit obligation at December 31$452,275 $413,340 $19,832 $22,571 
 
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Change in Plan Assets
Fair value of plan assets at January 1$295,587 $253,125 $13,213 $12,750 
Actual return on plan assets(5,203)15,968 535 553 
Company contributions18,798 13,908 835 754 
Plan participant contributions77 60 — — 
Benefits paid(28,263)(26,703)(1,360)(788)
Impact of foreign exchange rates(7,200)10,388 — — 
Effect of settlements(2,218)(2,373)— — 
Expenses paid(1,976)(1,108)(48)(56)
Acquisitions21,223 32,322 — — 
Fair value of plan assets at December 31$290,825 $295,587 $13,175 $13,213 
Funded status of the Plans$(161,450)$(117,753)$(6,657)$(9,358)

 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Total Recognized Amounts in the Consolidated Balance Sheets
Noncurrent assets $24,919 $26,599 $— $— 
Current liabilities(11,382)(9,797)(817)(1801)
Noncurrent liabilities(174,987)(134,555)(5,840)(7,557)
Net (liability)
$(161,450)$(117,753)$(6,657)$(9,358)
Items not yet recognized as a pre-tax component of net periodic benefit cost that are included in Accumulated Other Comprehensive Loss as of December 31, 2024 and 2023, are as follows:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Net actuarial loss/(gain)$109,718 $114,957 $(7,706)$(6,120)
Prior service cost5,020 5,557 11,251 11,637 
 $114,738 $120,514 $3,545 $5,517 
The pre-tax amounts recognized in Other Comprehensive Loss/(Income) include the following:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
202420232022202420232022
Adjustments arising during the period:
Net actuarial (gain)/loss$(238)$10,709 $4,839 $(2,485)$(451)$(761)
Prior service cost327 430 678 — 11,637 — 
Net settlements/curtailments(530)(1,010)(522)— — — 
Amortization recognized during the period:
Net actuarial (loss)/gain(4,472)(4,300)(6,240)899 768 681 
Prior service cost
(864)(926)(913)(385)— — 
Total recognized in other comprehensive (income)/loss$(5,777)$4,903 $(2,158)$(1,971)$11,954 $(80)
Total recognized in net periodic benefit cost and other comprehensive loss/(income)$11,509 $22,707 $9,081 $(1,780)$11,610 $(622)
The accumulated benefit obligation (“ABO”) for all defined benefit plans was $440,126 and $404,648 at December 31, 2024 and 2023, respectively.
The projected benefit obligation (“PBO”), ABO and fair value of plan assets for pension plans with ABOs in excess of plan assets were, $279,472, $270,720 and $94,384, respectively, as of December 31, 2024, and $229,397, $224,045 and $84,929, respectively, as of December 31, 2023.
Eviosys acquisition
On December 4, 2024, the Company completed the acquisition of Eviosys, which included the assumption of several defined benefit plans (the “Eviosys Plans”), including non-contributory defined benefit pension plans for certain of its employees, primarily in Germany, France, Italy, Switzerland, Spain, and Ireland. The Company determined the acquisition-date fair values of the PBO and plan assets of the Eviosys Plans to be $74,051 and $21,223, respectively, resulting in a long-term and short-term unfunded pension obligations of $51,849 and $979, respectively. The net periodic benefit costs for the Eviosys Plans were not material to Sonoco for the year ended December 31, 2024.
RTS Packaging defined benefit plan
On September 8, 2023, the Company completed the acquisition of the remaining 65% ownership interest of the RTS Packaging joint venture, which included the assumption of the RTS Packaging Pension Plan (the “RTS Plan”). At the time of the acquisition, the RTS Plan had a PBO of $43,934 and plan assets of $32,322, resulting in long-term and short term unfunded pension obligations of $11,529 and $83, respectively. Since the formation of the original joint venture, the Company had recognized its 35% share of actuarial gains and losses related to the RTS Plan in “Accumulated other comprehensive loss.” Upon the acquisition of the remaining 65% interest in RTS Packaging, a pre-tax loss of $4,756 ($3,543 after tax) was reclassified out of “Accumulated other comprehensive loss” into earnings. The pre-tax loss is reflected in “Other (expenses)/ income, net” in the Company’s Consolidated Statements of Income for the year ended December 31, 2023.
Plan termination, settlements, changes and amendments
The Company amended its U.S. Retiree Health and Life Insurance Plan in 2023 to expand the eligibility requirements for certain non-union hourly employees. The amendment resulted in an increase in both the accumulated postretirement benefit obligation and prior service cost component of accumulated other comprehensive loss of $11,637. The service cost is being amortized over the average life expectancy of the plan participants beginning in 2024.
The Company recognized settlement charges totaling $530 and $1,010 in 2024 and 2023, respectively. Settlements in both years resulted from payments made to certain participants in the Company’s non-union Canadian pension plan who elected a lump sum distribution option upon retirement. Settlements in 2023 also included payments associated with the termination of a pension plan in Taiwan.
Projected benefit payments
The following table sets forth the Company’s projected benefit payments for the next ten years:
YearRetirement Plans
Retiree Health and
Life Insurance Plans
2025$33,734 $1,642 
2026$34,132 $1,790 
2027$34,027 $1,709 
2028$35,391 $1,956 
2029$34,788 $1,829 
2030-2034$184,106 $8,773 
Assumptions
The following tables set forth the major actuarial assumptions used in determining the benefit obligation and net periodic benefit cost:
Weighted-average assumptions
used to determine benefit
obligations at December 31
U.S.
Retirement
Plans
U.S. Retiree
Health and
Life Insurance
Plans
Foreign Plans
Discount Rate
20245.52 %5.32 %6.52 %
20234.84 %4.68 %4.79 %
Rate of Compensation Increase
2024— %3.02 %3.59 %
2023— %3.03 %3.11 %
 
Weighted-average assumptions
used to determine net periodic benefit
cost for years ended December 31
U.S.
Retirement
Plans
U.S. Retiree
Health and
Life Insurance
Plans
Foreign
Plans
Discount Rate
20244.84 %4.68 %4.79 %
20235.01 %4.92 %4.97 %
20222.77 %2.48 %2.22 %
Expected Long-term Rate of Return
20243.08 %3.05 %4.36 %
20232.48 %2.45 %4.70 %
20223.27 %3.18 %3.00 %
Rate of Compensation Increase
2024— %3.03 %3.11 %
2023— %2.99 %3.29 %
2022— %3.01 %3.21 %
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected long-term rate of return assumption is based on the Company’s current and expected future portfolio mix by asset class, and expected nominal returns of these asset classes using an economic “building block” approach. Expectations for inflation and real interest rates are developed and various risk premiums are assigned to each asset class based primarily on
historical performance. The assumed rate of compensation increase reflects historical experience and management’s expectations regarding future salary and incentive increases.
Medical trends
The U.S. Retiree Health and Life Insurance Plan makes up approximately 90% of the Retiree Health liability. Therefore, the following information relates to the U.S. plan only.
Healthcare Cost Trend RatePre-age 65Post-age 65
20246.17 %7.28 %
20236.25 %7.25 %
Ultimate Trend RatePre-age 65Post-age 65
20244.50 %4.50 %
20234.50 %4.50 %
Year at which the Rate Reaches
the Ultimate Trend Rate
Pre-age 65Post-age 65
202420352035
202320332033

Based on amendments to the U.S. plan approved in 1999, which became effective in 2003, cost increases borne by the Company are limited to the Urban CPI, as defined.
Retirement plan assets
The assets of the U.S., RTS Plan, U.K., and Canadian defined benefit plans comprise approximately 82% of the total postretirement benefit plan assets. Therefore, the following disclosures relate only to the assets of these plans.
The following table sets forth the weighted-average asset allocations of the Company’s retirement plans at 2024 and 2023, by asset category.
Asset Category
  
U.S.RTSU.K.Canada
Equity securities202419.5 %22.2 %21.0 %31.4 %
202322.2 %18.6 %20.0 %29.4 %
Debt securities202478.0 %77.8 %77.1 %68.6 %
202376.6 %81.2 %79.1 %70.6 %
Cash and short-term investments20242.5 %— %1.9 %— %
20231.2 %0.2 %.9 %— %
Total2024100.0 %100.0 %100.0 %100.0 %
2023100.0 %100.0 %100.0 %100.0 %
The Company employs a total-return investment approach whereby a mix of equities and fixed income investments are used to maximize the long-term return of plan assets for a desired level of risk. Alternative assets such as real estate funds, private equity funds and hedge funds may also be used to enhance expected long-term returns while improving portfolio diversification. Risk tolerance is established through consideration of plan liabilities, plan funded status and corporate financial condition. Investment risk is measured and monitored on an ongoing basis through periodic investment portfolio reviews and periodic asset/liability studies.
U.S. defined benefit plans
The Company has adopted investment guidelines for the Active Plan based on asset/liability studies. These guidelines established a dynamic derisking framework for shifting the allocation of assets to long-duration domestic fixed income from equity and other asset categories, as the relative funding ratio of the plan increased over time. The current target allocation (midpoint) for the Active Plan investment portfolio is: Equity Securities - 20% and Debt Securities – 80%.
RTS defined benefit plan
The Company has adopted similar investment guidelines for the RTS Plan as it has for its U.S. Active Plan assets. The current target allocation (midpoint) for the RTS Plan investment portfolio is: Equity Securities – 20% and Debt Securities – 80%.
United Kingdom defined benefit plan
The equity investments consist of direct ownership and funds and are diversified among U.K. and international stocks of small and large capitalization. The current target allocation (midpoint) for the investment portfolio is: Equity Securities – 20% and Debt Securities – 80%.
Canada defined benefit plan
The equity investments consist of direct ownership and funds and are diversified among Canadian and international stocks of primarily large capitalizations and short to intermediate duration corporate and government bonds. The current target allocation (midpoint) for the investment portfolio is 30% Equity Securities and 70% Debt Securities.
Retiree health and life insurance plan assets
The following table sets forth the weighted-average asset allocations by asset category of the Company’s retiree health and life insurance plan.
Asset Category20242023
Equity securities—%—%
Debt securities100.0%100.0%
Cash—%—%
Total100.0%100.0%
Contributions
Based on current actuarial estimates, the Company anticipates that contributions to its defined benefit plans will be approximately $21,900 in 2025. No assurances can be made about funding requirements beyond 2025, however, as they will depend largely on actual investment returns and future actuarial assumptions, legislative actions, and changes to the Company’s benefit offerings.
Sonoco Retirement and Savings Plan
The Sonoco Retirement and Savings Plan is a defined contribution retirement plan provided for certain of the Company’s U.S. employees. Through December 31, 2021, the plan was comprised of both an elective and non-elective component.
The elective component of the plan, which is designed to meet the requirements of section 401(k) of the Internal Revenue Code, allows participants to set aside a portion of their wages and salaries for retirement and encourages saving by matching a portion of their contributions with contributions from the Company. The plan provides for participant contributions of 1% to 100% of gross pay. Effective December 31, 2021, the Company’s 401(k) matching contribution was increased to 100% of the first 6% of pretax and/or Roth compensation contributed by the participant. Prior to this, the Company had matched 50% on the first 4% of such participant contributions. Participants are immediately fully vested in these matching contributions. The Company’s expenses related to the plan for 2024, 2023, and 2022 were approximately $33,700, $30,684 and $29,347, respectively.
The non-elective component of the plan, the Sonoco Retirement Contribution (“SRC”), was eliminated effective December 31, 2021 and the benefit replaced by the higher 401(k) matching contribution discussed above. The final cash contribution to the SRC, totaling $21,948, was made in March 2022 for the preceding year.
Other plans
The Company also provides retirement and postretirement benefits to certain other non-U.S. employees through various Company-sponsored and local government sponsored defined contribution arrangements. For the most part, the liabilities related to these arrangements are funded in the period they arise. The Company’s expenses for these plans were not material for all years presented.
v3.25.0.1
Income taxes
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Income taxes Income taxes
The provision for taxes on income for the years ended December 31 consists of the following:
202420232022
Pretax income
Domestic$(35,733)$280,916 $257,189 
Foreign99,219 208,111 202,745 
Total pretax income$63,486 $489,027 $459,934 
Current
Federal$3,693 $54,319 $34,157 
State1,916 11,282 10,391 
Foreign57,034 63,617 61,228 
Total current$62,643 $129,218 $105,776 
Deferred
Federal$(34,828)$(3,307)$(1,884)
State(9,837)(1,646)(3,563)
Foreign(12,469)(4,535)(4,598)
Total deferred$(57,134)$(9,488)$(10,045)
Total taxes$5,509 $119,730 $95,731 
Deferred tax (liabilities)/assets are comprised of the following at December 31:
20242023
Property, plant and equipment$(266,278)$(137,880)
Intangibles(545,330)(119,225)
Leases(76,225)(48,832)
Outside basis in Metal Packaging(68,649)(68,867)
Gross deferred tax liabilities$(956,482)$(374,804)
Retiree health benefits$245 $513 
Foreign loss carryforwards79,314 62,250 
U.S. Federal loss and credit carryforwards34,082 39,131 
Capital loss carryforwards3,755 3,817 
U.S. State loss and credit carryforwards26,181 21,321 
Capitalized research and development costs103,043 87,743 
Employee benefits56,192 51,829 
Leases82,031 50,704 
Accrued liabilities and other assets71,370 58,699 
Gross deferred tax assets$456,213 $376,007 
Valuation allowance on deferred tax assets$(81,496)$(70,661)
Total deferred taxes, net1
$(581,765)$(69,458)
1 Total deferred taxes, net includes $(15,666) and $(6,228) reclassified to discontinued operations on the Consolidated Balance Sheets at December 31, 2024 and 2023, respectively. These amounts include valuation allowance on deferred tax assets of $(4,628) and $(4,395) at December 31, 2024 and 2023, respectively.
The Company has total federal net operating loss (“NOL”) carryforwards of approximately $63,615 remaining at December 31, 2024. These losses are limited based upon future taxable earnings of the Company and expire between 2033 and 2039. U.S. foreign tax credit carryforwards of approximately $20,722 exist at December 31, 2024 and expire in 2027. Foreign subsidiary loss carryforwards of approximately $339,125 remain at December 31, 2024. Their use is limited to future taxable earnings of the respective foreign subsidiaries or filing groups. Approximately $241,179 of these loss carryforwards do not have an expiration date. Of the remaining foreign subsidiary loss carryforwards, approximately $13,279 expire within the next five years and approximately $84,667 expire between 2030 and 2044. Foreign subsidiary capital loss carryforwards of approximately $15,010 exist at December 31, 2024 and do not have an expiration date. Their use is limited to future capital gains of the respective foreign subsidiaries.
Approximately $10,909 in tax value of state loss carryforwards and $22,232 of state credit carryforwards remain at December 31, 2024. These state loss and credit carryforwards are limited based upon future taxable earnings of the respective entities or filing group and expire between 2025 and 2045. State loss and credit carryforwards are reflected at their “tax” value, as opposed to the amount of expected gross deduction due to the vastly different apportionment and statutory tax rates applicable to the various entities and states in which the Company files.
A reconciliation of the U.S. federal statutory tax rate to the actual provision for/(benefit from) income taxes is as follows:
  
202420232022
Statutory tax rate$13,332 21.0 %$102,696 21.0 %$96,563 21.0 %
State income taxes, net of federal tax benefit(883)(1.4)%12,263 2.5 %10,204 2.2 %
Valuation allowance7,763 12.2 %4,486 0.9 %(10,477)(2.3)%
Tax examinations including change in reserve for uncertain tax positions(8,613)(13.6)%1,819 0.4 %296 0.1 %
Adjustments to prior year deferred taxes(9,129)(14.4)%(2,489)(0.5)%(2,110)(0.5)%
Foreign earnings taxed at other than U.S. rates12,271 19.3 %13,108 2.7 %14,613 3.2 %
Divestiture of business(2,954)(4.7)%464 0.1 %— — %
Effect of tax rate changes(1,552)(2.4)%387 0.1 %(2,151)(0.5)%
Foreign withholding taxes5,344 8.4 %4,591 0.9 %4,643 1.0 %
Tax credits(11,834)(18.6)%(18,848)(3.9)%(14,077)(3.1)%
Global intangible low-taxed income (GILTI)(5,604)(8.8)%4,853 1.0 %4,345 0.9 %
Foreign-derived intangible income(858)(1.4)%(1,106)(0.2)%(657)(0.1)%
Foreign currency gain/(loss) on distributions of previously taxed income
642 1.0 %(2,614)(0.5)%(1,280)(0.3)%
IRC Subpart F income
916 1.4 %119 — %96 — %
Executive compensation limitation
2,569 4.0 %3,767 0.8 %1,420 0.3 %
Capitalized acquisition costs7,202 11.3 %104 — %(412)(0.1)%
Other, net(3,103)(4.9)%(3,870)(0.8)%(5,285)(1.1)%
Provision for income taxes5,509 8.7 %119,730 24.5 %95,731 20.8 %
The change in “Tax examinations including change in reserve for uncertain tax positions” is shown net of associated deferred taxes and accrued interest. Included in the change are net increases in reserves for uncertain tax positions of approximately $3,405, $2,710 and $1,780 for uncertain items arising in 2024, 2023 and 2022, respectively, combined with adjustments related to prior year items, primarily decreases related to lapses of statutes of limitations in international, federal and state jurisdictions as well as overall changes in facts and judgment. These adjustments changed the reserve by a total of approximately $(13,229), $(891) and $(1,484) in 2024, 2023 and 2022, respectively.
In many of the countries in which the Company operates, earnings are taxed at rates different than in the United States. This difference is reflected in “Foreign earnings taxed at other than U.S. rates” along with other items, if any, that impacted taxes on foreign earnings in the periods presented.
The benefits included in “Adjustments to prior year deferred taxes” for each of the years presented consist primarily of adjustments to deferred tax assets and liabilities arising from changes in estimates. The adjustment to deferred tax assets and liabilities in 2024 was driven largely by post-acquisition entity restructuring.
Of the $11,834 of tax credits for 2024, $9,629 relates to research and development tax credits. The GILTI tax in 2024 of $(5,604) consists primarily of a prior year provision to return adjustment.
The expense included in “Valuation allowance” for 2024 includes $5,969 net recognized expense associated with the recording of valuation allowances on foreign NOLs which are not expected to be utilized. The benefits included in “Valuation allowance” for 2022 include a $13,182 net recognized benefit associated with the release of valuation allowance on foreign tax credits due to an increase in projected future foreign source income.
The Company maintains its assertion that its undistributed foreign earnings prior to the Eviosys acquisition are indefinitely reinvested and, accordingly, has not recorded any deferred income tax liabilities that would be due if those earnings were repatriated. However, the Company does not assert that certain current and future earnings of its Eviosys business are permanently reinvested. As of December 31, 2024, the undistributed foreign earnings total $1,071,766. While the majority of these earnings have already been taxed in the United States, a portion would be subject to foreign withholding and U.S. income taxes and credits if distributed. Computation of the deferred tax liability associated with unremitted earnings deemed to be indefinitely reinvested is not practicable at this time.
Reserve for uncertain tax positions
The following table sets forth the reconciliation of the gross amounts of unrecognized tax benefits at the beginning and ending of the periods indicated: 
202420232022
Gross Unrecognized Tax Benefits at January 1$21,677 $18,621 $18,142 
Increases in prior years’ unrecognized tax benefits627 378 223 
Decreases in prior years’ unrecognized tax benefits(1,915)(572)(144)
Increases in current year’s unrecognized tax benefits4,325 4,395 1,807 
Decreases in unrecognized tax benefits from the lapse of statutes of limitations(12,100)(1,094)(1,174)
Settlements(476)(51)(233)
Gross Unrecognized Tax Benefits at December 31$12,138 $21,677 $18,621 
Of the unrecognized tax benefit balances at December 31, 2024 and December 31, 2023, $9,857 and $19,241, respectively, would have an impact on the effective tax rate if ultimately recognized.
Interest and/or penalties related to income taxes are reported as part of income tax expense. The Company had $1,667 and $1,773 accrued for interest related to uncertain tax positions at December 31, 2024 and December 31, 2023, respectively. Tax expense for the year ended December 31, 2024, includes net interest expense of $(105), which is comprised of an interest benefit of $2,149 related to the adjustment of prior years’ items and interest expense of $2,044 on unrecognized tax benefits. The amounts listed above for accrued interest and interest expense do not reflect the benefit of a federal tax deduction which would be available if the interest were ultimately paid.
The Company and/or its subsidiaries file federal, state and local income tax returns in the United States and various foreign jurisdictions. With few exceptions, the Company is no longer subject to income tax examinations by tax authorities for years before 2018.
The Company believes that it is reasonably possible that the amount reserved for uncertain tax positions at December 31, 2024 will increase by $493 over the next twelve months. This change includes the anticipated increase in reserves related to existing positions offset by settlements of issues currently under examination and the release of existing reserves due to the expiration of the statute of limitations. Although the Company’s estimate for the potential outcome for any uncertain tax issue is highly judgmental, management believes that any reasonably foreseeable outcomes related to these matters have been adequately provided for. However, future results may include favorable or unfavorable adjustments to estimated tax liabilities in the period the assessments are made or resolved or when statutes of limitation on potential assessments expire. Additionally, the jurisdictions in which earnings or deductions are realized may differ from current estimates. As a result, the effective tax rate may fluctuate significantly on a quarterly basis. The Company has operations in many countries outside of the United States and the taxes paid on those earnings are subject to varying rates. The Company is not dependent upon the favorable benefit of any one jurisdiction to an extent that loss of those benefits would have a material effect on the Company’s overall effective tax rate.
v3.25.0.1
Revenue recognition
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Revenue recognition Revenue recognition
The following tables set forth information about revenue disaggregated by primary geographic regions for the years ended December 31, 2024, 2023 and 2022. The tables also include a reconciliation of disaggregated revenue with reportable segments. The Company’s reportable segments are aligned by product nature as disclosed in Note 20.
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,785,857 $1,431,232 $352,717 $3,569,806 
   Europe524,699 371,896 58,925 955,520 
   Canada17,486 95,863 — 113,349 
   Asia Pacific96,154 213,127 1,771 311,052 
   Other107,656 237,370 10,612 355,638 
          Total$2,531,852 $2,349,488 $424,025 $5,305,365 
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,817,268 $1,389,492 $494,112 $3,700,872 
   Europe431,189 389,261 64,936 885,386 
   Canada16,076 100,095 — 116,171 
   Asia Pacific94,136 233,446 1,812 329,394 
   Other112,379 261,819 35,405 409,603 
          Total$2,471,048 $2,374,113 $596,265 $5,441,426 
Year Ended December 31, 2022Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,936,847 $1,611,390 $503,526 $4,051,763 
   Europe421,276 434,076 68,949 924,301 
   Canada18,372 109,997 — 128,369 
   Asia Pacific91,151 275,395 1,158 367,704 
   Other96,358 253,705 37,127 387,190 
          Total$2,564,004 $2,684,563 $610,760 $5,859,327 

Contract assets represent goods produced without alternative use for which the Company is entitled to payment with margin prior to shipment. Upon shipment, the Company is entitled to bill the customer, and therefore amounts included in contract assets will be reduced with the recording of an account receivable as they represent an unconditional right to payment. Contract liabilities represent revenue deferred due to pricing mechanisms utilized by the Company in certain multi-year arrangements, volume rebates, and receipts of advanced payments. For multi-year arrangements with pricing mechanisms, the Company will generally defer revenue during the initial term of the arrangement, and will release the deferral over the back half of the contract term. Contract assets and liabilities are generally short in duration given the nature of products produced by the Company.
The following table sets forth information about contract assets and liabilities from contracts with customers. The balances of the contract assets and liabilities are located in “Other receivables” and “Accrued expenses and other”, respectively, in the Consolidated Balance Sheets.
December 31, 2024December 31, 2023
Contract Assets$67,062 $14,754 
Contract Liabilities$(60,024)$(15,252)
Significant changes in the contract assets and liabilities balances during the twelve months ended December 31, 2024 and 2023 were as follows:
December 31, 2024December 31, 2023
Contract AssetContract LiabilityContract AssetContract Liability
Beginning balance$14,754 $(15,252)$18,037 $(12,588)
Acquired as part of a business combination62,439 (47,478)— (1,436)
Revenue deferred or rebates accrued— (25,736)— (25,094)
Recognized as revenue — 2,341 — 1,936 
Rebates paid to customers— 26,101 — 21,930 
Increases due to rights to consideration for customer specific goods produced, but not billed during the period67,062 — 14,754 — 
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination(77,193)— (18,037)— 
Ending balance$67,062 $(60,024)$14,754 $(15,252)
v3.25.0.1
Commitments and contingencies
12 Months Ended
Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]  
Commitments and contingencies Commitments and contingencies
In accordance with the requirements of ASC 450, “Contingencies,” the Company records accruals for estimated losses at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. As is the case with other companies in similar industries, the Company faces exposure from actual or potential claims and legal proceedings from a variety of sources. Some of these exposures, as discussed below, have the potential to be material.
Environmental matters
The Company is subject to a variety of environmental and pollution control laws and regulations in all jurisdictions in which it operates.
Spartanburg
In connection with its acquisition of Tegrant in November 2011, the Company identified potential environmental contamination at a site in Spartanburg, South Carolina. Since the acquisition, the Company has spent a total of $2,304 on remediation of the Spartanburg site. At December 31, 2024 and 2023, the Company’s accrual for environmental contingencies related to the Spartanburg site totaled $5,096 and $5,259, respectively. The Spartanburg site and related environmental liabilities are part of the pending sale of TFP to Toppan. Accordingly, these accruals are reflected in “Current liabilities of discontinued operations” on the Company’s Consolidated Balance Sheets.
The Company cannot currently estimate its potential liability, damages or range of potential loss, if any, beyond the amounts accrued with respect to this exposure. However, the Company does not believe that the resolution of this matter has a reasonable possibility of having a material adverse effect on the Company’s financial statements.
Other environmental matters
The Company has been named as a potentially responsible party at several other environmentally contaminated sites. All of the sites are also the responsibility of other parties. The potential remediation liabilities are shared with such other parties, and, in most cases, the Company’s share, if any, cannot be reasonably estimated at the current time. However, the Company does not believe that the resolution of these matters has a reasonable possibility of having a material adverse effect on the Company’s financial statements. At December 31, 2024 and 2023, the Company’s accrual for these other sites totaled $1,933 and $1,992, respectively, and are included in “Accrued expenses and other” on the Company’s Consolidated Balance Sheets.
Commitments
As of December 31, 2024, the Company had long-term obligations to purchase electricity and steam, which it uses in its production processes, as well as long-term purchase commitments for raw materials. These purchase commitments require the Company to make total payments of approximately $82,554, as follows: $20,472 in 2025; $21,389 in 2026; $20,217 in 2027; $20,476 in 2028, and a total of $0 from 2029 through 2033.
v3.25.0.1
Shareholders’ equity and earnings per share
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Shareholders' equity and earnings per share Shareholders’ equity and earnings per share
Share repurchases
On April 20, 2021, the Board authorized the repurchase of the Company’s common stock in an aggregate amount of up to $350,000. No shares were purchased under this authorization during 2024 or 2023. A total of $137,972 remained available for share repurchases under this authorization as of December 31, 2024 and December 31, 2023.
The Company occasionally repurchases shares of its common stock to satisfy employee tax withholding obligations in association with the exercise of RSUs, PCSUs, and SARs. These repurchases, which are not part of a publicly announced plan or program, totaled 164,402 shares during 2024, 175,665 shares during 2023, and 79,347 shares during 2022, at a cost of $9,246, $10,617 and $4,547, respectively.
Earnings per share
The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except per share data):
202420232022
Numerator:
Net income from continuing operations $67,565 $379,644 $378,410 
Net loss/(income) from continuing operations attributable to noncontrolling interests
180 (768)(284)
Net income from continuing operations attributable to Sonoco67,745 378,876 378,126 
Net income attributable to Sonoco$163,949 $474,959 $466,437 
Denominator:
Weighted average common shares outstanding98,637 98,294 97,991 
Dilutive effect of share-based compensation653 596 741 
Diluted outstanding shares99,290 98,890 98,732 
Per common share:
Basic earnings per common share:
Net income from continuing operations$0.69 $3.85 $3.86 
Net income attributable to Sonoco$1.66 $4.83 $4.76 
Diluted earnings per common share:
Net income from continuing operations$0.68 $3.83 $3.83 
Net income attributable to Sonoco$1.65 $4.80 $4.72 
Cash dividends$2.07 $2.02 $1.92 
No adjustments were made to “Net income attributable to Sonoco” in the computations of net income attributable to Sonoco per common share.
Anti-dilutive securities
Potentially dilutive securities are calculated in accordance with the treasury stock method, which assumes the proceeds from the exercise of all dilutive SARs are used to repurchase the Company’s common stock. Certain SARs are not dilutive because either the exercise price is greater than the average market price of the stock during the reporting period or assumed repurchases from proceeds from the exercise of the SARs were anti-dilutive.
The average number of shares that were not dilutive and therefore not included in the computation of diluted income per share was as follows for the years ended December 31, 2024, 2023 and 2022 (in thousands):
202420232022
Anti-dilutive stock appreciation rights408 352 373 
These SARs may become dilutive in future periods if the market price of the Company’s common stock appreciates.
Noncontrolling interests
On December 4, 2024, the Company completed the acquisition of Eviosys. The acquisition included operations in the Ivory Coast and Morocco, which are owned 85.2% and 99.34%, respectively, by the Company. The Company fully consolidates these operations and reflects our partners’ ownership in noncontrolling interests on the Company’s Consolidated Balance Sheet as of December 31, 2024. The total amount of noncontrolling interests acquired was $9,533.
In November 2024, the Company completed the sale of two production facilities in China, both of which were part of the Company’s Industrial Paper Packaging segment. In addition, a production facility that was less than 100% owned by the Company was divested as a part of the sale and the disposition of the noncontrolling interest of $2,043 is reflected in the Company’s total loss on the divestiture. This loss is reported in “(Loss)/Gain on divestiture of business and other assets” in the Company’s Consolidated Statements of Income for the year ended December 31, 2024. See Note 4 for additional information.
On March 31, 2022, the Company paid $14,474 in cash to acquire the remaining 33% ownership interest in Graffo Paranaense de Embalagens S/A (“Graffo”). The transaction resulted in a $6,116 reduction in noncontrolling interest, a $7,080 charge to capital in excess of stated value, and a $1,278 reduction to accrued expenses and other on the Company’s Consolidated Balance Sheet. Graffo is part of the Company’s Thermoformed and Flexibles Packaging business and is included in the pending sale of TFP to Toppan. See Notes 1 and 2 for additional information.
v3.25.0.1
Segment reporting
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment reporting Segment reporting
The Company operates under two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other.
The products produced and sold within the Consumer Packaging segment are generally used to package a variety of consumer products and consist primarily of round and shaped rigid paper, steel and plastic containers; and metal and peelable membrane ends, closures, and components.
The primary products produced and sold within the Industrial Paper Packaging segment include paperboard tubes, cones, and cores; paper-based protective packaging; and uncoated recycled paperboard. Effective January 1, 2024, the Company began conducting its recycling operations, part of the Industrial Paper Packaging segment, as a procurement function. As a result, no recycling net sales were recorded and the margin from the Company’s recycling operations reduced “Cost of sales” for the year ended December 31, 2024.
The primary products produced within the All Other group of businesses consist of a variety of packaging materials, including plastic, paper, foam, and various other specialty materials.
The Company’s chief operating decision maker (“CODM”) is the chief executive officer. The CODM assesses segment performance and allocates resources to each segment by using each segment’s operating profit. The chief operating decision maker uses operating profit for each segment in the annual budgeting and forecasting process as well as reviewing segment operating profit quarterly when making decisions about allocating capital and operating resources to segments. Disaggregated assets by segment are not disclosed since segment assets are not regularly provided to the CODM.
Segment operating profit viewed by the Company to evaluate segment performance does not include the following: restructuring/asset impairment charges; amortization of acquisition intangibles; gains/losses from the sale of businesses or other assets; acquisition, integration and divestiture-related costs; changes in LIFO inventory reserves; derivative gains/losses; or certain other items, if any, the exclusion of which the Company’s management believes improves the comparability and analysis of the ongoing operating performance of the business. All other general corporate expenses have been allocated as operating costs to each of the Company’s reportable segments and the All Other group of businesses, except for costs related to discontinued operations.
Segment financial information
The following table sets forth financial information about each of the Company’s reportable segments:
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,531,852 $2,349,488 $4,881,340 
Intersegment sales (1)
8,022 111,682 119,704 
$2,539,874 $2,461,170 $5,001,044 
Reconciliation of sales
Other sales (2)
431,107 
Elimination of intersegment sales(126,786)
Total consolidated sales$5,305,365 
Less: (3)
Cost of sales (4)
$(2,041,078)$(1,818,324)
Other segment items (5)
(203,964)(371,192)
Segment operating profit$294,832 $271,654 $566,486 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$365 $9,223 
Depreciation, depletion and amortization (6)
$109,355 $116,149 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,471,048 $2,374,113 $4,845,161 
Intersegment sales (1)
5,171 101,822 106,993 
$2,476,219 $2,475,935 $4,952,154 
Reconciliation of sales
Other sales (2)
604,442 
Elimination of intersegment sales(115,170)
Total consolidated sales$5,441,426 
Less: (3)
Cost of sales (4)
$(1,999,514)$(1,809,803)
Other segment items (5)
(190,943)(348,215)
Segment operating profit$285,762 $317,917 $603,679 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$564 $9,783 
Depreciation, depletion and amortization (6)
$95,340 $104,723 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.

Year Ended December 31, 2022Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,564,004 $2,684,563 $5,248,567 
Intersegment sales (1)
1,779 134,214 135,993 
$2,565,783 $2,818,777 $5,384,560 
Reconciliation of sales
Other sales (2)
620,330 
Elimination of intersegment sales(145,563)
Total consolidated sales$5,859,327 
Less: (3)
Cost of sales (4)
$(1,981,621)$(2,109,080)
Other segment items (5)
(142,006)(381,838)
Segment operating profit$442,156 $327,859 $770,015 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$485 $13,722 
Depreciation, depletion and amortization (6)
$84,049 $91,944 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Reconciliation of segment operating profit to income from continuing operations before income taxes:202420232022
Segment operating profit$566,486 $603,679 $770,015 
Other operating profits(1)
53,278 85,148 58,240 
Unallocated amounts:
Restructuring/Asset impairment charges(65,370)(47,909)(52,385)
Amortization of acquisition intangibles(78,595)(67,323)(60,263)
(Loss)/Gain from divestiture of business and other assets(23,452)78,929 — 
Acquisition, integration and divestiture-related costs(91,600)(24,624)(70,210)
Changes in LIFO inventory reserves6,263 11,817 (28,445)
Derivative gains/(losses)7,225 1,912 (8,767)
Other corporate costs(2)
(46,675)(42,254)(45,210)
Other operating income/(charges), net(3)
(982)(10,326)380 
Other (expenses)/income, net(104,200)39,657 — 
Non-operating pension costs(13,842)(14,312)(7,073)
Interest expense(172,620)(135,393)(100,875)
Interest income27,570 10,026 4,527 
Income from continuing operations before income taxes$63,486 $489,027 $459,934 

(1)
Operating profit from segments below the quantitative threshold are attributable to the group of businesses within All Other.
(2)
Other corporate costs represent recurring operating expenses previously allocated to TFP that will remain with Sonoco subsequent to the divestiture.
(3)
Primarily consists of insurance gains offset by consulting fees in 2024 and losses related to highly inflationary accounting in Turkey and consulting fees, partially offset by insurance gains, in 2023.
Reconciliation of other segment disclosures to consolidated totals:202420232022
Equity in earnings of affiliates, net of tax
Consumer Packaging$365 $564 $485 
Industrial Paper Packaging9,223 9,783 13,722 
Reportable Segment Total9,588 10,347 14,207 
Adjustments— — — 
Consolidated Total$9,588 $10,347 $14,207 
Depreciation, depletion and amortization
Consumer Packaging$109,355 $95,340 $84,049 
Industrial Paper Packaging116,149 104,723 91,944 
Reportable Segment Total225,504 200,063 175,993 
Other
90,557 81,966 74,540 
Consolidated Total$316,061 $282,029 $250,533 

(1)
Other represents depreciation, depletion and amortization expense for the All Other group of businesses and total amortization of acquisition intangibles for Sonoco, excluding discontinued operations.
Geographic regions
Sales to unaffiliated customers and long-lived assets by geographic region are as follows:
202420232022
Sales to Unaffiliated Customers
United States$3,569,806 $3,700,872 $4,051,763 
Europe955,520 885,386 924,301 
Canada113,349 116,171 128,369 
Asia Pacific311,052 329,394 367,704 
Other355,638 409,603 387,190 
Total$5,305,365 $5,441,426 $5,859,327 
Long-lived Assets
United States$2,695,885 $2,779,178 $2,511,809 
Europe4,690,098 617,949 572,824 
Canada35,750 39,842 24,257 
Asia Pacific176,547 157,235 155,959 
Other300,623 149,530 75,583 
Total$7,898,903 $3,743,734 $3,340,432 
Sales are attributed to countries/regions based upon the plant location from which products are shipped. Long-lived assets are comprised of property, plant and equipment, goodwill, other intangible assets, and investments in affiliates (see Notes 1, 7 and 9).
v3.25.0.1
Accumulated other comprehensive loss
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Accumulated other comprehensive loss Accumulated other comprehensive loss
The following table summarizes the components of accumulated other comprehensive loss and the changes in accumulated other comprehensive loss, net of tax as applicable, for the years ended December 31, 2024 and 2023:
Foreign
Currency
Items
Defined
Benefit
Pension Items
Gains and Losses on Cash Flow Hedges
Accumulated
Other
Comprehensive
Loss
Balance at December 31, 2022
$(338,316)$(90,973)$(794)$(430,083)
Other comprehensive income/(loss) before reclassifications
68,705 (16,305)6,622 59,022 
Amounts reclassified from accumulated other comprehensive loss to net income2,033 7,651 (5,177)4,507 
Amounts reclassified from accumulated other comprehensive loss to fixed assets— — 292 292 
Other comprehensive income/(loss)
70,738 (8,654)1,737 63,821 
Balance at December 31, 2023
$(267,578)$(99,627)$943 $(366,262)
Other comprehensive (loss)/income before reclassifications
(146,856)4,636 (3,213)(145,433)
Amounts reclassified from accumulated other comprehensive loss to net income3,503 4,378 1,080 8,961 
Other comprehensive (loss)/income
(143,353)9,014 (2,133)(136,472)
Balance at December 31, 2024
$(410,931)$(90,613)$(1,190)$(502,734)
The following table summarizes the amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of net income for the years ended December 31, 2024 and 2023:
Amount Reclassified from Accumulated Other Comprehensive Loss
Details about Accumulated Other Comprehensive Loss ComponentsYear Ended December 31, 2024Year Ended December 31, 2023Affected Line Item in the Consolidated Statements of Net Income
Foreign currency items
Loss on Protexic and China divestitures$(3,503)$— (Loss)/Gain on divestiture of business and other assets
     Loss on RTS Packaging investment (see Note 4)
— (2,033)Other (expenses)/income, net
(3,503)(2,033)Net income
Defined benefit pension items (see Note 15)
Pension-related loss upon purchase of remaining interest in RTS Packaging joint venture— (4,756)Other (expenses)/income, net
Effect of settlement loss(530)(1,010)
Non-operating pension costs
Amortization of defined benefit pension items(4,822)(4,458)
Non-operating pension costs
(5,352)(10,224)Income from continuing operations before income taxes
974 2,573 Provision for income taxes
(4,378)(7,651)Net income
Gains and losses on cash flow hedges (see Note 12)
Foreign exchange contracts(1,174)10,860 Net Sales
Foreign exchange contracts(253)(3,728)Cost of sales
Commodity contracts(28)(32)Cost of sales
(1,455)7,100 Income from continuing operations before income taxes
375 (1,923)Provision for income taxes
(1,080)5,177 Net income
Amounts reclassified to net income from accumulated other comprehensive loss$(8,961)$(4,507)Net income

The following table summarizes the tax expense/(benefit) for the components of other comprehensive income/(loss):
For the year ended December 31, 2024
For the year ended December 31, 2023
Before Tax AmountTaxAfter Tax AmountBefore Tax AmountTaxAfter Tax Amount
Foreign currency items:
Other comprehensive (loss)/income before reclassifications
$(140,210)$(6,646)$(146,856)$67,411 $1,294 $68,705 
Amounts reclassified from accumulated other comprehensive loss to net income3,503 — 3,503 2,033 — 2,033 
Net other comprehensive (loss)/income from foreign currency items
(136,707)(6,646)(143,353)69,444 1,294 70,738 
Defined benefit pension items:
Other comprehensive income/(loss) before reclassifications
2,395 2,241 4,636 (21,815)5,510 (16,305)
Amounts reclassified from accumulated other comprehensive income/(loss) to net income
5,352 (974)4,378 10,224 (2,573)7,651 
Net other comprehensive income/(loss) from defined benefit pension items
7,747 1,267 9,014 (11,591)2,937 (8,654)
Cash flow hedges:
Other comprehensive (loss)/income before reclassifications
(4,329)1,116 (3,213)9,081 (2,459)6,622 
Amounts reclassified from accumulated other comprehensive income/(loss) to net income
1,455 (375)1,080 (7,100)1,923 (5,177)
Amounts reclassified from accumulated other comprehensive loss to fixed assets— — — 401 (109)292 
Net other comprehensive (loss)/income from cash flow hedges(2,874)741 (2,133)2,382 (645)1,737 
Other comprehensive (loss)/income
$(131,834)$(4,638)$(136,472)$60,235 $3,586 $63,821 
v3.25.0.1
Selected quarterly financial data
12 Months Ended
Dec. 31, 2024
Selected Quarterly Financial Information [Abstract]  
Selected quarterly financial data
The following table sets forth selected quarterly financial data of the Company for the years ended December 31, 2024 and December 31, 2023:
(unaudited)
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
2024
Net sales$1,308,636 $1,278,801 $1,354,652 $1,363,276 
Gross profit271,217 285,295 299,748 282,973 
Net income/(loss) from continuing operations35,512 57,410 31,392 (56,749)
Net income from discontinued operations29,761 33,541 19,817 13,256 
Net income/(loss) attributable to Sonoco65,177 90,811 50,921 (42,960)
Weighted average common shares outstanding:
Basic98,498 98,671 98,683 98,700 
Diluted99,159 99,241 99,267 98,700 
Per common share:
Basic Earnings/(Loss) Per Common Share:
     Continuing operations$0.36 $0.58 $0.32 $(0.57)
     Discontinued operations0.30 0.34 0.20 0.13 
     Basic earnings/(loss) per share attributable to Sonoco$0.66 $0.92 $0.52 $(0.44)
Diluted Earnings/(Loss) Per Common Share:
     Continuing operations$0.36 $0.58 $0.31 $(0.57)
     Discontinued operations0.30 0.34 0.20 0.13 
     Diluted earnings/(loss) per share attributable to Sonoco$0.66 $0.92 $0.51 $(0.44)
Cash dividends$0.51 $0.52 $0.52 $0.52 
2023
Net sales$1,386,972 $1,337,589 $1,381,130 $1,335,735 
Gross profit314,796 291,946 307,848 287,979 
Net income from continuing operations121,954 84,638 111,946 61,106 
Net income from discontinued operations26,310 30,111 19,112 20,724 
Net income attributable to Sonoco148,319 114,649 130,749 81,242 
Weighted average common shares outstanding:
Basic98,167 98,325 98,337 98,349 
Diluted98,615 98,872 98,912 99,164 
Per common share:
Basic Earnings Per Common Share:
     Continuing operations$1.24 $0.86 $1.14 $0.61 
     Discontinued operations0.27 0.31 0.19 0.21 
     Basic earnings per share attributable to Sonoco$1.51 $1.17 $1.33 $0.82 
Diluted Earnings Per Common Share:
     Continuing operations$1.23 $0.86 $1.13 $0.61 
     Discontinued operations0.27 0.30 0.19 0.21 
     Diluted earnings per share attributable to Sonoco$1.50 $1.16 $1.32 $0.82 
Cash dividends$0.49 $0.51 $0.51 $0.51 
v3.25.0.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2024
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]  
Schedule of valuation and qualifying accounts disclosure
Column AColumn BColumn C - Additions Column D Column E
Description
Balance at
Beginning
of Year
Charged to
Costs and
Expenses
 
Charged to
Other
 Deductions 
Balance
at End
of Year
2024
Allowance for Doubtful Accounts$18,868 $3,457   $(199)1$11,137 2$10,989 
LIFO Reserve39,528 (6,263)3— — 33,265 
Valuation Allowance on Deferred Tax Assets66,266 7,921   2,681 4— 576,868 
2023
Allowance for Doubtful Accounts$14,280 $6,479   $160 1$2,051 2$18,868 
LIFO Reserve51,342 (11,814)3— — 39,528 
Valuation Allowance on Deferred Tax Assets79,427 4,432   (17,593)4— 566,266 
2022
Allowance for Doubtful Accounts$16,445 $(297)  $(93)1$1,775 2$14,280 
LIFO Reserve22,900 28,442 3— — 51,342 
Valuation Allowance on Deferred Tax Assets90,879 (10,636)  (892)4(76)579,427 
1    Includes translation adjustments and other insignificant adjustments.
2    Includes amounts written off.
3    Includes adjustments based on pricing and inventory levels.
4    Includes translation adjustments and increases to deferred tax assets which were previously fully reserved.
5    Includes utilization of capital loss carryforwards, net operating loss carryforwards and other deferred tax assets.
All other schedules not included have been omitted because they are not required, are not applicable or the required information is given in the financial statements or notes thereto.
v3.25.0.1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pay vs Performance Disclosure                      
Net income attributable to Sonoco $ (42,960) $ 50,921 $ 90,811 $ 65,177 $ 81,242 $ 130,749 $ 114,649 $ 148,319 $ 163,949 $ 474,959 $ 466,437
v3.25.0.1
Insider Trading Arrangements
3 Months Ended
Dec. 31, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.25.0.1
Insider Trading Policies and Procedures
12 Months Ended
Dec. 31, 2024
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.0.1
Cybersecurity Risk Management and Strategy Disclosure
12 Months Ended
Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
The Company’s approach to risk management is designed to identify, assess, prioritize, and manage significant risk exposures that could affect the Company’s ability to execute its corporate strategy and fulfill its business objectives. The Company manages enterprise risk through its Risk Management Committee (“RMC”) chaired by the Company’s Vice President of Compliance, Risk and Audit with direct oversight from the Company’s General Counsel. The RMC, which is made up of senior leadership across a variety of business functions, defines the Company’s enterprise risk framework based upon analysis of industry and peer benchmarking as well as company-specific data analysis.
As a component of the Company’s enterprise risk management program, the Company’s cybersecurity risk management program outlines the Company’s cybersecurity risk management practices and capabilities, including the division of responsibilities for reviewing the Company’s cybersecurity risk exposure and risk tolerance, tracking emerging information risks, and ensuring proper escalation of certain key risks for periodic review by the Board and its committees.
Cybersecurity risk is evaluated within the population of all enterprise risks in the framework and is included in assessments overseen by the RMC that identify the risks of highest priority to the Company. For these highest priority risks, including cybersecurity risks, the RMC designates risk owners, sets common reporting processes, and monitors risk mitigation and treatment strategies to support business continuity.
The Company’s cybersecurity risk management program leverages the National Institute of Standards and Technology Cybersecurity Framework for identifying, assessing, and managing material risks from cybersecurity threats. This approach combines prevention and detection techniques, informed by internal and external sources, to identify and analyze potential threat activities. When a threat is identified, a cyber incident response plan outlines the Company’s procedures for containing, remediating, and recovering from the cybersecurity incident. Cybersecurity tenets are also incorporated into the Company’s technology policies.
The Company’s cybersecurity risk management program focuses on vulnerability management, access management, and user awareness training. Among other things, the Company implements scheduled patching and system updates, proactively scans for vulnerabilities, and engages qualified third-party experts to assess the Company’s information technology infrastructure and identify vulnerabilities and opportunities for continued focus and improvement. When vulnerabilities are identified, the Company’s information technology (“IT”) management team receives reports that assess each vulnerability and track progress in remediating that vulnerability. The IT management team also collaborates with supply chain management and the Company’s third party risk management program to onboard and monitor key third-party service providers to address the potential risk of cybersecurity threats through the use of such third parties. Annual cybersecurity training is mandatory for all users with access to the Company’s IT systems, and the Company conducts monthly tests to promote phishing awareness. In addition to these prevention methods, the Company seeks to detect potential threats through external intelligence and monitoring solutions. External commercial or governmental agencies are also engaged to assess potential threat activity relevant to the Company. The Company also monitors server and endpoint devices across the organization to detect signs of a cyberattack.
The Company has implemented and maintains an information security incident response plan (“IR Plan”), which includes processes to assess, escalate, contain, investigate, and remediate cybersecurity incidents. Upon notification of a potential cybersecurity threat, management defines the threat based on its nature as an information security event, alert, incident, or breach, and all cybersecurity incidents are categorized by level of severity based on the impact of the incident to the Company’s operations. A technical incident response team is responsible for technical response activities, including information gathering and forensic analysis, containment, and remediation efforts. The Company’s Crisis Management Team drives the Company’s enterprise-level crisis response process, leads decisions around response strategies, coordinates resources required to execute such strategies, and oversees all cybersecurity incidents categorized as Critical and High.
Although the Company did not experience a material cybersecurity incident during the year ended December 31, 2024, the scope and impact of any future incident cannot be predicted. See “Item 1A. Risk Factors – Risks Related to Information Technology and Cybersecurity” for more information on the Company’s cybersecurity-related risks.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block]
Cybersecurity risk is evaluated within the population of all enterprise risks in the framework and is included in assessments overseen by the RMC that identify the risks of highest priority to the Company. For these highest priority risks, including cybersecurity risks, the RMC designates risk owners, sets common reporting processes, and monitors risk mitigation and treatment strategies to support business continuity.
The Company’s cybersecurity risk management program leverages the National Institute of Standards and Technology Cybersecurity Framework for identifying, assessing, and managing material risks from cybersecurity threats. This approach combines prevention and detection techniques, informed by internal and external sources, to identify and analyze potential threat activities. When a threat is identified, a cyber incident response plan outlines the Company’s procedures for containing, remediating, and recovering from the cybersecurity incident. Cybersecurity tenets are also incorporated into the Company’s technology policies.
The Company’s cybersecurity risk management program focuses on vulnerability management, access management, and user awareness training. Among other things, the Company implements scheduled patching and system updates, proactively scans for vulnerabilities, and engages qualified third-party experts to assess the Company’s information technology infrastructure and identify vulnerabilities and opportunities for continued focus and improvement. When vulnerabilities are identified, the Company’s information technology (“IT”) management team receives reports that assess each vulnerability and track progress in remediating that vulnerability. The IT management team also collaborates with supply chain management and the Company’s third party risk management program to onboard and monitor key third-party service providers to address the potential risk of cybersecurity threats through the use of such third parties. Annual cybersecurity training is mandatory for all users with access to the Company’s IT systems, and the Company conducts monthly tests to promote phishing awareness. In addition to these prevention methods, the Company seeks to detect potential threats through external intelligence and monitoring solutions. External commercial or governmental agencies are also engaged to assess potential threat activity relevant to the Company. The Company also monitors server and endpoint devices across the organization to detect signs of a cyberattack.
The Company has implemented and maintains an information security incident response plan (“IR Plan”), which includes processes to assess, escalate, contain, investigate, and remediate cybersecurity incidents. Upon notification of a potential cybersecurity threat, management defines the threat based on its nature as an information security event, alert, incident, or breach, and all cybersecurity incidents are categorized by level of severity based on the impact of the incident to the Company’s operations. A technical incident response team is responsible for technical response activities, including information gathering and forensic analysis, containment, and remediation efforts. The Company’s Crisis Management Team drives the Company’s enterprise-level crisis response process, leads decisions around response strategies, coordinates resources required to execute such strategies, and oversees all cybersecurity incidents categorized as Critical and High.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Board of Directors Oversight [Text Block]
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”)
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in information technology and security, and the CISO has 32 years of information technology experience and 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations.
Cybersecurity Risk Role of Management [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in information technology and security, and the CISO has 32 years of information technology experience and 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in information technology and security, and the CISO has 32 years of information technology experience and 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in information technology and security, and the CISO has 32 years of information technology experience and 12 years of information security experience
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]
The Company’s day-to-day management of cybersecurity risks is led by the Chief Information Security Officer (“CISO”) with direct oversight from the Chief Information Officer (“CIO”). The Company’s IR Plan includes a defined escalation matrix for critical or high severity information security events involving notifications to the CISO and CIO, who further escalate critical or high severity events to the Company’s Crisis Management Team, which consists of senior management from IT, including the CIO and CISO, Human Resources, Risk and Internal Audit, Marketing and Communications, Legal, and Finance. The Crisis Management Team further elevates sufficiently critical and high severity events to the Company’s Cyber Incident Review Committee (“CIRC”), which consists of the CIO, Chief Financial Officer, Chief Accounting Officer, VP of Investor Relations, VP of Compliance, Risk and Audit, and General Counsel, or their delegates. Additional senior management from relevant business units are added to the CIRC as needed based on the nature of identified cybersecurity incidents. The CIRC preliminarily evaluates whether an incident is material and provides a proposal to the CEO and CFO, who work in consultation with the committee to make a final determination of materiality. Such determination is communicated to the Audit Committee of the Board (the “Audit Committee”).
The Company’s Crisis Management Team has relevant expertise and experience to assess and remediate cyber threats. The CIO has over 18 years of experience in information technology and security, and the CISO has 32 years of information technology experience and 12 years of information security experience.
As part of its broader oversight activities, the Board oversees risks from information security threats and other risks identified by the RMC, both directly and by way of delegation to the Audit Committee. As reflected in its charter, the Audit Committee oversees and specifically discusses the guidelines and policies by which the Company assesses and manages its cybersecurity risk exposures, as well as the steps management has taken to monitor and control such exposures. The Audit Committee also oversees the Company’s internal control over financial reporting, including with respect to financial reporting-related information systems. In addition to any communications of specifically identified cybersecurity events, the Audit Committee receives and discusses quarterly updates on cybersecurity activities, including review of annual external assessment results, training compliance and discussion of cybersecurity risks and resolutions, and is responsible for elevating significant matters to the full Board as events arise. The Board receives an annual update and provides feedback on the Company’s cybersecurity governance processes, risk management plan, and any significant activities related thereto, and also reviews risk management practices in the course of its review of the Company’s corporate strategy, business plans, Board committee reports, and other presentations. In addition to the ordinary-course Board and Audit Committee reporting and oversight described above, the Company also maintains disclosure controls and procedures designed for prompt reporting to the Board and timely public disclosure, as appropriate, of material events covered by our risk management framework, including information security risks.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.0.1
Summary of significant accounting policies (Policies)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Basis of presentation
Basis of presentation
The Consolidated Financial Statements include the accounts of Sonoco Products Company and its majority-owned subsidiaries (the “Company” or “Sonoco”) after elimination of intercompany accounts and transactions.
On December 18, 2024, the Company announced that it had entered into an agreement to sell its Thermoformed and Flexibles Packaging business and its global Trident business (collectively, “TFP”) to TOPPAN Holdings Inc. (“Toppan”) for approximately $1,800,000 on a cash-free and debt-free basis and subject to customary adjustments (the “Transaction”). The Transaction, which reflects the completion of the Company’s previously announced strategic review of its Thermoformed and Flexibles Packaging business, is subject to customary closing conditions, including regulatory approvals, and is expected to close in the first half of 2025. In accordance with applicable accounting guidance, the results of TFP, previously part of the Company’s Consumer Packaging segment, are presented as discontinued operations in the Consolidated Statements of Income and, as such, have been excluded from both continuing operations and segment results for all periods presented in this Annual Report on Form 10-K. Further, the Company reclassified the assets and liabilities of TFP as assets and liabilities of discontinued operations in the Consolidated Balance Sheets as of December 31, 2024 and 2023. The Consolidated Statements of Comprehensive Income, Changes in Total Equity, and Cash Flows are presented on a consolidated basis for both continuing operations and discontinued operations. All amounts, percentages and disclosures for all periods presented in this Annual Report on Form 10-K reflect only the continuing operations of Sonoco unless otherwise noted. See Note 2 for additional information.
Investments in affiliated companies in which the Company does not control the investee or in which the Company is not the primary beneficiary but has the ability to exercise significant influence over the investee’s financial and operating decisions, are accounted for by the equity method of accounting. Income applicable to these equity investments is reported in “Equity in earnings of affiliates, net of tax” in the Consolidated Statements of Income.
Estimates and assumptions
Estimates and assumptions
The preparation of financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Revenue recognition
Revenue recognition
The Company records revenue generally at a point in time when control transfers to the customer either upon shipment or delivery, depending on the terms of sale. Additionally, in certain cases, control transfers over time in conjunction with production where the Company is entitled to payment with margin for products produced that are customer specific and without alternative use. For products that meet these two criteria, the Company recognizes over time revenue under the input method as goods are produced. The Company commonly enters into Master Supply Arrangements with customers to provide goods and/or services over specific time periods. Customers submit purchase orders with quantities and prices to create a contract for accounting purposes. Shipping and handling expenses are considered a fulfillment cost, and are included in “Cost of Sales,” and freight charged to customers is included in “Net Sales” in the Company’s Consolidated Statements of Income.
The Company has rebate agreements with certain customers. These rebates are recorded as reductions of sales and are accrued using sales data and rebate percentages specific to each customer agreement. Accrued customer rebates are included in “Accrued expenses and other” in the Company’s Consolidated Balance Sheets.
Payment terms under the Company’s arrangements are typically short term in nature. The Company provides prompt payment discounts to certain customers if invoices are paid within a predetermined period. Prompt payment discounts are determinable within a short period after the originating sale and like sales returns, are treated as a reduction of revenue.
Accounts receivable and allowance for doubtful accounts
Accounts receivable and allowance for doubtful accounts
The Company’s trade accounts receivable are non-interest bearing and are recorded at the invoiced amounts. The allowance for doubtful accounts represents the Company’s best estimate of the amount of probable credit losses in existing accounts receivable. The Company performs an evaluation of lifetime expected credit losses inherent in its accounts receivable at each balance sheet date. Such an evaluation includes consideration of historical loss experience, trends in customer payment frequency, present economic conditions, and judgment about the future financial health of its customers and industry sector. The allowance for doubtful accounts is monitored on a regular basis and adjustments are made as needed to ensure that the account properly reflects the Company’s best estimate of uncollectible trade accounts receivable. Account balances are charged off against the allowance for doubtful accounts when the Company determines that the receivable will not be recovered.
Accounts payable and supply chain financing
Accounts payable and supply chain financing
The Company facilitates voluntary supply chain financing programs (the “SCF Programs”) to provide certain of its suppliers with the opportunity to sell receivables due from the Company to the participating financial institutions in the programs. Such sales are conducted at the sole discretion of both the suppliers and the financial institutions on a nonrecourse basis at a rate that leverages the Company’s credit rating and thus might be more beneficial to the supplier. No guarantees are provided by the Company or any of our subsidiaries under the SCF Programs. The Company’s responsibility under the agreements is limited to making payment to the financial institutions for confirmed invoices based on the terms originally negotiated with its suppliers. Both the Company and the financial institutions have the right to terminate the SCF Programs by providing 30 days prior written notice to the other party. The Company does not enter into any agreements with suppliers regarding their participation in the SCF Programs.
Research and development
Research and development
Research and development costs are charged to expense as incurred and include salaries and other directly related expenses.
Restructuring and asset impairment
Restructuring and asset impairment
Costs associated with exit or disposal activities are recognized when the liability is incurred. Identifying and calculating the cost to exit operations requires certain assumptions to be made about anticipated future liabilities, including severance costs, contractual obligations, and disposition of property, plant and equipment and leased assets. If assets become impaired as a result of a restructuring action, they are written down to fair value, less estimated costs to sell, if applicable. A number of significant estimates and assumptions are involved in the determination of fair value. The Company considers historical experience and all available information at the time the estimates are made; however, the amounts that are ultimately realized upon the sale of divested assets may differ from the estimated fair values reflected in the Company’s Consolidated Financial Statements.
Cash and cash equivalents
Cash and cash equivalents
Cash equivalents are composed of highly liquid investments with an original maturity to the Company of three months or less when purchased. Cash equivalents are recorded at cost, which approximates fair market value. The Company’s cash and cash equivalents are primarily placed with large sophisticated creditworthy financial institutions thereby limiting the Company’s credit exposure.
Inventories
Inventories
The majority of the Company’s inventories are accounted for using the first-in, first-out (FIFO) method and are stated at the lower of cost or net realizable value.
The last in, first out (“LIFO”) method is used for the valuation of certain of the Company’s domestic inventories, primarily metal, internally manufactured paper and paper purchased from third parties, and approximated 9% and 17% of total inventories at December 31, 2024 and 2023, respectively. Inventories accounted for using the LIFO method are stated at the lower of cost or market. If the FIFO method of accounting had been used for all inventories, total inventory would have been higher by $33,265 and $39,528 at December 31, 2024 and 2023, respectively.
Property, plant and equipment
Property, plant and equipment
Property, plant and equipment assets represent the original cost of land, buildings and equipment, less depreciation, computed under the straight-line method over the estimated useful lives of the assets, and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Equipment lives generally range from 3 to 11 years, and buildings range from 15 to 40 years.
Expenditures for repairs and maintenance are charged to expense as incurred. When properties are retired or otherwise disposed of, the cost and accumulated depreciation are eliminated from the asset and related allowance accounts, respectively. Gains or losses upon disposal are credited or charged to income as incurred.
The Company sold its timberland properties in March 2023. Prior to the sale, these timber resources were stated at cost and depletion expense was recognized based on the estimated number of units of timber cut during the period.
Leases
Leases
At the inception of a contract, the Company assesses whether the contract is, or contains, a lease. The assessment is based on (1) whether the contract involves the use of a distinct identified asset, (2) whether the Company obtains the right to substantially all the economic benefit from the use of the asset throughout the period, and (3) whether the Company has the right to direct the use of the asset. When the Company determines a lease exists, a leased asset and corresponding lease liability are recorded on its consolidated balance sheet. Lease contracts with a term of 12 months or less are not recorded in the consolidated balance sheet in conjunction with the Company’s practical expedient election under ASC 842, “Leases.” Leased assets represent the Company’s right to use an underlying asset during the lease term and are reviewed for impairment whenever events indicate the carrying value may not be recoverable. Lease liabilities represent the Company’s obligation arising from the lease. The Company’s leased assets and liabilities may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise those options. The Company has lease agreements with non-lease components that relate to lease components (e.g., common area maintenance such as cleaning or landscaping, etc.). The Company accounts for each lease and any non-lease components associated with that lease as a single lease component for all underlying asset classes in accordance with the scope of the lease accounting standard.
Leased assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term. When the implicit rate in the Company’s leases is not readily determinable, the Company calculates its lease liabilities using discount rates based upon the Company’s incremental secured borrowing rate, which contemplates and reflects a particular geographical region’s interest rate for the leases active within that region of the Company’s global operations. The Company further utilizes a portfolio approach by assigning a “short” rate to contracts with lease terms of 10 years or less and a “long” rate for contracts greater than 10 years. Lease payments may be fixed or variable, however, only fixed payments or in-substance fixed payments are included in determining the lease liability. Variable lease payments are recognized in operating expenses in the period in which the expense is paid during the lease term.
The Company recognizes fixed lease expense for operating leases on a straight-line basis over the lease term. For finance leases, the Company recognizes interest expense on the lease liability using the effective interest method over the lease term and the finance lease asset balance is amortized on a straight-line basis.
Goodwill
Goodwill
Goodwill is not amortized. The Company assesses its goodwill for impairment annually during the third quarter, or from time to time when warranted by the facts and circumstances surrounding individual reporting units or the Company as a whole. In performing the impairment test, the Company compares the fair value of the reporting unit with its carrying amount, and if the carrying value of the reporting unit exceeds the fair value of that reporting unit, an impairment charge is recognized for the excess.
In determining the fair value of the reporting units, management considers both the income approach and the market approach. Fair value is estimated using a discounted cash flow model (income valuation approach) based on projections of future years’ operating results and associated cash flows combined with comparable trading and transaction multiples based on guideline public companies. The calculated estimated fair value of the reporting unit reflects a number of significant management assumptions and estimates including the forecast of sales growth, gross profit margins, and discount rates. Changes in these assumptions could materially impact the estimated fair value.
The Company’s projections incorporate management's best estimates of the expected future results, which include expectations related to new and retained business and future operating margins. Projected future cash flows are then discounted to present value using a discount rate management believes is commensurate with the risks inherent in the cash flows.
Impairment of long-lived, intangible and other assets
Impairment of long-lived, intangible and other assets
Other intangible assets are amortized using the straight-line method when management has determined that the straight-line method approximates the pattern of consumption of the respective intangible assets, or in relation to the specific pattern of consumption of the assets if the straight-line method does not provide a fair approximation of the consumption of benefits. The useful lives of the Company’s intangible assets generally range from 3 to 40 years. The Company has no intangibles with indefinite lives. The Company evaluates its intangible assets for impairment whenever indicators of impairment exist.
Assumptions and estimates used in the evaluation of potential impairment can result in adjustments affecting the carrying values of long-lived, intangible and other assets and the recognition of impairment expense in the Company’s Consolidated Financial Statements. The Company evaluates its long-lived assets (property, plant and equipment), definite-lived intangible assets and other assets (including right of use lease assets, notes receivable and equity and other investments) for impairment whenever indicators of impairment exist, or when it commits to sell the asset. If the sum of the undiscounted expected future cash flows from a long-lived asset, definite-lived intangible, or other asset group is less than the carrying value of that asset group, an asset impairment charge is recognized. Key assumptions and estimates used in the projection of expected future cash flows generally include price levels, sales growth, profit margins and asset life. The amount of an impairment charge, if any, is calculated as the excess of the asset’s carrying value over its fair value, generally represented by the discounted future cash flows from that asset or, in the case of assets the Company evaluates for sale, estimated sale proceeds less costs to sell. The Company takes into consideration historical data and experience together with all other relevant information available when estimating the fair values of its assets. However, fair values that could be realized in actual transactions may differ from the estimates used to evaluate impairment. In addition, changes in the assumptions and estimates may result in a different conclusion regarding impairment.
Income taxes
Income taxes
The Company provides for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting requirements and tax laws. Assets and liabilities are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Derivatives
Derivatives
The Company uses derivatives to mitigate the effect of fluctuations in some of its raw material and energy costs, foreign currencies, and, from time to time, interest rates. The Company purchases commodities such as metal and energy, generally at market or at fixed prices that are established with the vendor as part of the purchase process for quantities expected to be consumed in the ordinary course of business. The Company may enter into commodity futures or swaps to manage the effect of price fluctuations. The Company may use foreign currency forward contracts and other risk management instruments to manage exposure to changes in foreign currency cash flows and the translation of monetary assets and liabilities on the Company’s consolidated financial statements. The Company is exposed to interest-rate fluctuations as a result of using debt as a source of financing for its operations. The Company may from time to time use traditional, unleveraged interest rate swaps to manage its exposure to interest rate movements. Additionally, the Company elected the normal purchase, normal sale scope exception for physical commodity contracts that meet the definition of a derivative. Derivative instruments, to the extent in an asset position, expose the Company to credit loss in the event of nonperformance by the counterparties to the derivative agreements. The Company manages its exposure to counterparty credit risk through minimum credit standards, diversification of counterparties and procedures to monitor concentrations of credit risk. The Company may enter into financial derivative contracts that may contain credit-risk-related contingent features, which could result in a counterparty requesting immediate payment or demanding immediate and ongoing full overnight collateralization on derivative instruments in net liability positions.
The Company records its derivatives as assets or liabilities on the balance sheet at fair value using published market prices or estimated values based on current price and/or rate quotes and discounted estimated cash flows. Changes in the fair value of derivatives designated as accounting hedges are recognized in net income, and otherwise are recognized in other comprehensive income. Amounts in accumulated other comprehensive income are reclassified into earnings in the same period or periods during which the hedged forecasted transaction affects earnings. It is the Company’s policy not to speculate in derivative instruments
Stock-Based Compensation Plans
Share-Based Compensation Plans
The Company utilizes share-based compensation in the form of restricted stock units (“RSUs”), performance contingent restricted stock units (“PCSUs”), and other share-based awards. The fair value of the Company’s RSUs is equal to the closing price of the Company’s stock on the date of grant discounted for any projected dividends that are not eligible to be received during the vesting period. The amount of share-based compensation expense associated with PCSUs is based on estimates of future performance using measures defined in the stock plan descriptions for each award granted. As of December 31, 2024, these performance measures include the following:
Adjusted earnings per share — three-year sum of forecasted future and historical annual adjusted earnings per share for the three-year measurement period associated with each award; and
Return on invested capital — three-year simple average of annual returns calculated by dividing 1) adjusted operating profit after tax (derived from historical or projected earnings) by 2) the average of total historical or projected debt plus equity for the respective annual periods.
For the awards granted in 2024 and 2023, the performance payout will be subject to adjustment by a total stock return modifier as determined by the Company’s relative performance within its targeted peer group for each grant. Changes in estimates regarding the future achievement of these performance measures may result in significant fluctuations from period to period in the amount of share-based compensation expense recognized in the Company’s Consolidated Financial Statements.
Pension and Postretirement Benefit Plans
Pension and Postretirement Benefit Plans
The Company provides non-contributory defined benefit pension plans for certain of its employees in the United States, Mexico, Belgium, Germany, Greece, France, and Turkey. The Company also sponsors contributory defined benefit pension plans covering certain of its employees in the United Kingdom, Canada and the Netherlands, and provides postretirement healthcare and life insurance benefits to a limited number of its retirees and their dependents in the United States and Canada, based on certain age and/or service eligibility requirements. The actuarial valuations used to evaluate the plans employ key assumptions that can have a significant effect on the calculated amounts.
The Company adjusts its discount rates at the end of each fiscal year based on yield curves of high-quality debt instruments over durations that match the expected benefit payouts of each plan. The expected rate of return assumption is derived by taking into consideration the targeted plan asset allocation, projected future returns by asset class and active investment management. A third-party asset return model is used to develop an expected range of returns on plan investments over a 12- to 15-year period, with the expected rate of return selected from a best estimate range within the total range of projected results. The Company periodically re-balances its plan asset portfolio in order to maintain the targeted allocation levels. The rate of compensation increase assumption is generally based on salary and incentive compensation increases.
Other assumptions and estimates impacting the projected liabilities of these plans include inflation, participant withdrawal and mortality rates, medical cost trends, and retirement ages. The Company evaluates the assumptions used in projecting the pension and postretirement liabilities and associated expenses annually. These judgments, assumptions and estimates may affect the carrying value of pension and postretirement plan net assets and liabilities and pension and postretirement plan expenses in the Company’s Consolidated Financial Statements.
Business combinations
Business combinations
The Company’s acquisitions of businesses are accounted for in accordance with ASC 805, “Business Combinations.” The Company recognizes the identifiable assets acquired, the liabilities assumed, and any noncontrolling interests in an acquired business at their fair values as of the date of acquisition. Goodwill is measured as the excess of consideration transferred, also measured at fair value, over the net of the acquisition date fair values of the identifiable assets acquired and liabilities assumed. The acquisition method of accounting requires the Company to make significant estimates and assumptions regarding the fair values of the elements of a business combination as of the date of acquisition, including the fair values of identifiable intangible assets; property, plant and equipment; deferred tax asset valuation allowances; liabilities including those related to debt, pensions and other postretirement plans; uncertain tax positions; contingent consideration and contingencies. This method also requires the Company to refine these estimates over a measurement period not to exceed one year to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the measurement of the amounts recognized as of that date. If the Company is required to adjust provisional amounts that were recorded for the fair values of assets and liabilities in connection with acquisitions, these adjustments could have a material impact on its financial condition and results of operations.
Significant estimates and assumptions in estimating the fair value of acquired patents, customer lists, trademarks, proprietary technology, and other identifiable intangible assets include future cash flows that the Company expects to generate from the acquired assets, discount rate,
customer attrition rate, and long-term revenue growth projections. Projecting discounted future cash flows requires the Company to make significant estimates regarding projected revenues, projected earnings before interest, taxes, depreciation, and amortization margins, discount rates and customer attrition rates. If the subsequent actual results and updated projections of the underlying business activity change compared with the assumptions and projections used to develop these values, the Company could record impairment charges. In addition, the Company has estimated the economic lives of certain acquired assets, and these lives are used to calculate depreciation on property, plant and equipment and amortization expense on definite-lived intangible assets. If the estimates of the economic lives change, depreciation or amortization expenses could be increased or decreased, or the acquired assets could be impaired.
For leases acquired in a business combination, the Company measures the lease liability at the present value of the remaining lease payments, as if the acquired lease were a new lease of the Company at the acquisition date. The Company measures the right-of-use asset at the same amount as the lease liability as adjusted to reflect favorable or unfavorable terms of the lease when compared with market terms.
Reportable segments
Reportable segments
The Company identifies its reportable segments by evaluating the level of detail reviewed by the chief operating decision maker and the similarities among operating segments related to gross profit margins, nature of products sold, nature of the production processes, type and class of customer, methods used to distribute products, and nature of the regulatory environment. Of these factors, the Company believes that the most significant in determining the aggregation of operating segments are the nature of the products and the type of customers served. The Company’s operating and reporting structure consists of two reportable segments, Consumer Packaging and Industrial Paper Packaging, with all remaining businesses reported as All Other.
Contingencies
Contingencies
Pursuant to GAAP for accounting for contingencies, accruals for estimated losses are recorded at the time information becomes available indicating that losses are probable and that the amounts are reasonably estimable. Amounts so accrued are not discounted. Changes in estimates and assumptions could impact the carrying value of the accruals from one period to another as additional information becomes known.
Foreign currency translation
Foreign currency translation
The Company’s foreign operations are exposed to political, geopolitical, and cultural risks, but the risks are mitigated by diversification and the relative stability of the countries in which the Company has significant operations. Because the economies in Turkey and Venezuela are considered highly inflationary under GAAP, the Company considers the U.S. dollar to be the functional currency for these operations and uses the official exchange rate when remeasuring the financial assets and liabilities of these operations. The remeasurement adjustments are recorded against earnings within the Company’s consolidated income statement.
New accounting pronouncements New accounting pronouncements
In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2024-03, “Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses,” which requires companies to disclose disaggregated amounts relating to (a) inventory purchases; (b) employee compensation; (c) depreciation; (d) intangible asset amortization; and (e) depreciation, depletion, and amortization. Further, this guidance will require companies to include certain amounts that are already required to be disclosed under current GAAP in the same disclosure as the other disaggregation requirements, disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively and disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. The standard is intended to benefit investors by providing more detailed expense disclosures that would be useful in making capital allocation decisions. This guidance is effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027 but early adoption is permitted. ASU 2024-03 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures,” which modifies the rules on income tax disclosures to require disaggregated information about a reporting entity’s effective tax rate reconciliation as well as information on income taxes paid. The standard is intended to benefit investors by providing more detailed income tax disclosures that would be useful in making capital allocation decisions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its consolidated financial statements and related disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” which is intended to improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The purpose of the amendment is to enable investors to better understand an entity’s overall performance and assess potential future cash flows. The guidance is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The guidance is to be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this standard effective with its reporting for the year ended December 31, 2024 and has provided the enhanced reportable segment financial disclosures in this Annual Report on Form 10-K.
In September 2022, the FASB issued ASU 2022-04, “Liabilities—Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations.” The amendments require that a buyer in a supplier finance program disclose qualitative and quantitative information about its supplier finance programs in each annual reporting period, including a description of key payment terms, amounts outstanding, and a rollforward of the outstanding obligation. In each interim reporting period, the amount outstanding requires disclosure. The amendments were effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years, except for the amendment on rollforward information, which was effective for fiscal years beginning after December 15, 2023. The Company adopted this standard in the first quarter of 2023, with the exception of the amendment on rollforward information, which was adopted effective with its reporting for the year ended December 31, 2024 and is included in this Annual Report on Form 10-K.
Other than the pronouncements discussed above, there have been no other newly issued nor newly applicable accounting pronouncements that have had, or are expected to have, a material impact on the Company’s financial statements.
Fair value measurement
Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. Fair value is a market-based measurement that is determined based on assumptions that market participants would use in pricing an asset or liability. A three-tier fair value hierarchy is used to prioritize the inputs in measuring fair value as follows:
Level 1 –Observable inputs such as quoted market prices in active markets;
Level 2 –Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and
Level 3 –Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions.
v3.25.0.1
Summary of significant accounting policies (Tables)
12 Months Ended
Dec. 31, 2024
Accounting Policies [Abstract]  
Affiliated companies over which the company exercised significant influence
Affiliated companies over which the Company exercised a significant influence at December 31, 2024, included:
Entity
Ownership Interest
Percentage at
December 31, 2024
Cascades Conversion, Inc.50.0 %
Cascades Sonoco, Inc.50.0 %
ISI Robotics, LLC26.4 %
Showa Products Company Ltd.22.2 %
Papertech Energía, S.L.25.0 %
Weidenhammer New Packaging, LLC40.0 %
v3.25.0.1
Discontinued operations (Tables)
12 Months Ended
Dec. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]  
Schedules of Discontinued Operations
The following table presents the assets and liabilities that are classified as discontinued operations in the Consolidated Balance Sheets as of
December 31, 2024 and 2023:
  
20242023
Cash and cash equivalents$12,050 $13,042 
Trade accounts receivable, net of allowances of $2,582 in 2024 and $2,793 in 2023
209,379 218,620 
Other receivables46,001 48,677 
Inventories
     Finished and in process80,573 86,515 
     Materials and supplies94,083 83,338 
Prepaid expenses8,788 9,426 
Current assets of discontinued operations $450,874 $459,618 
Property, plant and equipment, net of accumulated depreciation of $465,923 in 2024 and $480,416 in 2023
262,662 243,370 
Goodwill502,621 512,643 
Other intangible assets, net of accumulated amortization of $206,437 in 2024 and $189,471 in 2023
103,593 127,113 
Long-term deferred income taxes262 706 
Right of use asset-operating leases75,855 81,483 
Other assets19,317 18,794 
Non-current assets of discontinued operations$964,310 $984,109 
Payable to suppliers172,720 169,613 
Accrued expenses and other62,562 70,593 
Notes payable and current portion of long-term debt6,774 8,198 
Current liabilities of discontinued operations$242,056 $248,404 
Long-term debt29,850 37,866 
Noncurrent operating lease liabilities67,789 72,751 
Pension and other postretirement benefits— 116 
Deferred income taxes15,928 6,934 
Other liabilities344 473 
Non-current liabilities of discontinued operations$113,911 $118,140 
The following table presents key components of “Income from discontinued operations, net of taxes” for the years ended December 31, 2024, 2023, and 2022:
 Year Ended December 31,
  
202420232022
Net sales$1,291,461 $1,339,866 $1,391,225 
Cost of sales1,037,196 1,106,970 1,176,894 
Gross profit254,265 232,896 214,331 
Selling, general and administrative expenses122,488 97,131 97,762 
Restructuring/Asset impairment charges3,740 9,024 4,525 
Operating profit128,037 126,741 112,044 
Interest expense1
13,396 1,293 790 
Interest income1,668 357 94 
Income from discontinued operations before income taxes116,309 125,805 111,348 
Provision for income taxes19,934 29,548 22,778 
Net income from discontinued operations96,375 96,257 88,570 
Net income from discontinued operations attributable to noncontrolling interests(171)(174)(259)
Net income attributable to discontinued operations$96,204 $96,083 $88,311 
Weighted average common shares outstanding:
Basic98,637 98,294 97,991 
Diluted99,290 98,890 98,732 
Per common share
Net income attributable to discontinued operations:
Basic$0.97 $0.98 $0.90 
Diluted$0.97 $0.97 $0.89 
1 Includes $9,528 of interest expense in 2024 relating to certain debt contractually required to be repaid by the Company upon completion of the TFP divestiture. No such interest expense is reflected in 2023 or 2022.
The following table presents significant cash flow items from discontinued operations for the years ended December 31, 2024, 2023, and 2022:
 Year Ended December 31,
  
202420232022
Depreciation, depletion and amortization$58,798 $58,959 $58,291 
Capital expenditures
$(65,321)$(55,624)$(48,049)
v3.25.0.1
Acquisitions and divestitures (Tables)
12 Months Ended
Dec. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]  
Schedule of Preliminary Fair Value Of Assets Acquired And Measurement Period Adjustments
The Company’s preliminary fair values of the assets acquired and liabilities assumed in the acquisition of Eviosys, are as follows:
Preliminary Allocation
Trade accounts receivable$300,385 
Other receivables114,634 
Inventories445,945 
Prepaid expenses47,509 
Property, plant and equipment1,057,779 
Right of use asset - operating leases43,566 
Other intangible assets1,967,678 
Goodwill1,285,518 
Long-term deferred income taxes39,023 
Other assets3,330 
Payable to suppliers(518,766)
Accrued expenses and other(168,529)
Accrued wages and other compensation(41,749)
Notes payable and current portion of long-term debt(76,438)
Noncurrent operating lease liabilities(32,022)
Pension and other postretirement benefits(51,849)
Deferred income taxes(599,941)
Other long-term liabilities(16,714)
Noncontrolling Interests
(9,533)
Net assets acquired$3,789,826 
As a result, final fair values reflecting adjustments made during the measurement period are as follows:
Initial AllocationMeasurement Period AdjustmentsFinal Allocation
Trade accounts receivable$17,488 $— $17,488 
Inventories20,209 (947)19,262 
Prepaid expenses2,720 (589)2,131 
Property, plant and equipment73,483 753 74,236 
Right of use asset - operating leases34,604 290 34,894 
Other intangible assets199,560 (8,995)190,565 
Goodwill92,657 14,909 107,566 
Other assets2,465 (412)2,053 
Payable to suppliers(7,320)— (7,320)
Accrued expenses and other(12,436)(25)(12,461)
Accrued wages and other compensation(2,731)— (2,731)
Notes payable and current portion of long-term debt(24)— (24)
Noncurrent operating lease liabilities(29,905)— (29,905)
Pension and other postretirement benefits(10,761)(768)(11,529)
Long-term debt(1,942)— (1,942)
Deferred income taxes(3,419)(2,502)(5,921)
Other long-term liabilities(3,293)1,478 (1,815)
Net assets acquired$371,355 $3,192 $374,547 
Schedule Of Proforma Supplemental Information
The following table presents the financial results for Eviosys from December 4, 2024, the date of acquisition, through December 31, 2024:
Supplemental Information
December 4 to
Eviosys
December 31, 2024
Net sales$115,031 
Net loss
$15,086 
The following table presents the Company’s pro forma consolidated results for the years ended December 31, 2024 and December 31, 2023, assuming the acquisition of Eviosys had occurred on January 1, 2023. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2023, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Years Ended
Consolidated
December 31, 2024
December 31, 2023
Net sales$7,546,920 $8,032,135 
Net income from continuing operations
$159,926 $112,963 
Net income attributable to Sonoco1
$255,800 $208,436 
1 Includes results of discontinued operations
The following table presents the financial results for Metal Packaging from the date of acquisition through December 31, 2022:
Supplemental InformationJanuary 26 to
Metal PackagingDecember 31, 2022
Net sales$1,035,020 
Net income$62,777 
The following table presents the Company’s pro forma consolidated results for the year ended December 31, 2022, assuming the acquisition of Metal Packaging had occurred on January 1, 2021. This pro forma information is presented for informational purposes only and does not purport to represent the results of operations that would have been achieved if the acquisition had been completed at the beginning of 2021, nor is it necessarily indicative of future consolidated results.
Pro Forma Supplemental Information Year Ended
ConsolidatedDecember 31, 2022
Net sales$5,908,915 
Net income from continuing operations
$440,791 
Net income attributable to Sonoco1
$528,818 
1 Includes results of discontinued operations
Summary of the Purchase Consideration Transferred for the Acquisitions
The following table provides a summary of the purchase consideration (as defined under ASC 805) transferred for the acquisition of the remaining interest in RTS Packaging and the acquisition of the Chattanooga Mill:
Purchase Consideration
Cash consideration, net of cash acquired $313,388 
Fair value of previously held interest in RTS Packaging59,472 
Final working capital settlement
452 
Settlement of preexisting relationships1,235 
Purchase consideration transferred$374,547 
v3.25.0.1
Restructuring and asset impairment (Tables)
12 Months Ended
Dec. 31, 2024
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring and Restructuring-Related Asset Impairment Expenses by Type Incurred and by Reportable Segment
Following are the total restructuring and asset impairment charges, net of adjustments, recognized during the periods presented:
 Year Ended December 31,
  
202420232022
Restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
Other asset impairments— — 10,095 
Restructuring/Asset impairment charges$65,370 $47,909 $52,385 
The table below sets forth restructuring and restructuring-related asset impairment charges by type incurred:
 Year Ended December 31,
202420232022
Severance and Termination Benefits$37,307 $15,543 $13,808 
Asset Impairment/Disposal of Assets15,719 24,415 9,182 
Other Costs12,344 7,951 19,300 
Total restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
The table below sets forth restructuring and restructuring-related asset impairment charges by reportable segment:
 Year Ended December 31,
202420232022
Consumer Packaging$19,259 $4,111 $8,207 
Industrial Paper Packaging33,923 38,754 15,598 
All Other1,434 2,547 (44)
Corporate10,754 2,497 18,529 
Total restructuring and restructuring-related asset impairment charges$65,370 $47,909 $42,290 
Schedule of Restructuring Accrual Activity
The following table sets forth the activity in the restructuring accrual included in “Accrued expenses and other” in the Company’s Consolidated Balance Sheets:

Accrual Activity
Severance
and
Termination
Benefits
Asset
Impairment/
Disposal
of Assets
Other
Costs
Total
Liability, December 31, 2022$12,780 $— $1,286 $14,066 
2023 charges15,543 24,415 7,951 47,909 
Cash (payments)/receipts(19,437)— (8,995)(28,432)
Asset write downs/disposals— (24,415)— (24,415)
Foreign currency translation(22)— 30 
Liability, December 31, 2023
$8,864 $— $272 $9,136 
2024 charges37,307 15,719 12,344 65,370 
Cash (payments)/receipts(21,653)9,680 (11,610)(23,583)
Asset write downs/disposals— (25,399)— (25,399)
Foreign currency translation(484)— (97)(581)
Liability, December 31, 2024
$24,034 $— $909 $24,943 
v3.25.0.1
Property, plant and equipment (Tables)
12 Months Ended
Dec. 31, 2024
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment
Details of the Company’s property, plant and equipment at December 31 are as follows:
20242023
Land$314,278 $123,438 
Buildings967,237 660,001 
Machinery and equipment3,726,377 3,236,966 
Construction in progress337,796 225,660 
5,345,688 4,246,065 
Accumulated depreciation and depletion(2,626,941)(2,583,298)
Property, plant and equipment, net$2,718,747 $1,662,767 
v3.25.0.1
Leases (Tables)
12 Months Ended
Dec. 31, 2024
Leases [Abstract]  
Schedule of Balance Sheet Location and Values of Company's Lease Assets and Lease Liabilities
The following table sets forth the balance sheet location and values of the Company’s lease assets and lease liabilities at December 31, 2024 and December 31, 2023:
ClassificationBalance Sheet LocationDecember 31, 2024December 31, 2023
Lease Assets
Operating lease assetsRight of Use Asset - Operating Leases$307,688 $233,461 
Finance lease assetsOther Assets76,831 78,949 
Total lease assets$384,519 $312,410 
Lease Liabilities
Current operating lease liabilitiesAccrued expenses and other$52,648 $44,279 
Current finance lease liabilitiesNotes payable and current portion of long-term debt22,284 17,268 
Total current lease liabilities74,932 61,547 
Noncurrent operating lease liabilitiesNoncurrent Operating Lease Liabilities258,735 192,703 
Noncurrent finance lease liabilitiesLong-term Debt, net of current portion45,344 55,341 
Total noncurrent lease liabilities304,079 248,044 
Total lease liabilities$379,011 $309,591 
Schedule of Components of Company's Total Lease Costs and Other Lease Related Information
The following table sets forth the components of the Company’s total lease cost for the years ended December 31, 2024, 2023, and 2022:
Lease Cost202420232022
Operating lease cost(a)$49,327 $43,524 $40,485 
Finance lease cost:
     Amortization of lease asset(a) (b)12,871 11,789 10,524 
     Interest on lease liabilities(c)3,711 3,912 4,023 
Variable lease cost(a) (d)31,404 32,016 20,317 
Impairment charges(e)— — 61 
Total lease cost$97,313 $91,241 $75,410 
(a) Production-related and administrative amounts are included in cost of sales and selling, general and administrative expenses, respectively.
(b) Included in depreciation and amortization.
(c) Included in interest expense.
(d) Also includes short-term lease costs, which are deemed immaterial.
(e) Impairment charges are included in “Restructuring/asset impairment charges” in the Company’s Consolidated Statements of Income. See Note 5 for more information.
Schedule of Five-year Maturity Lease Liabilities
The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2024:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2025$55,277 $22,814 $78,091 
202646,883 18,488 65,371 
202740,440 6,038 46,478 
202835,633 5,000 40,633 
202933,545 3,716 37,261 
Beyond 2029183,690 20,795 204,485 
Total lease payments395,468 76,851 472,319 
     Less: Interest84,085 9,223 93,308 
Lease Liabilities$311,383 $67,628 $379,011 
Schedule of Five-year Maturity of Lease Liabilities
The following table sets forth the five-year maturity schedule of the Company’s lease liabilities as of December 31, 2024:
Maturity of Lease LiabilitiesOperating LeasesFinance LeasesTotal
2025$55,277 $22,814 $78,091 
202646,883 18,488 65,371 
202740,440 6,038 46,478 
202835,633 5,000 40,633 
202933,545 3,716 37,261 
Beyond 2029183,690 20,795 204,485 
Total lease payments395,468 76,851 472,319 
     Less: Interest84,085 9,223 93,308 
Lease Liabilities$311,383 $67,628 $379,011 
Schedule of Weighted Average Remaining Lease Terms, Discounts Rates and Other Lease Information
The following tables set forth the Company’s weighted average remaining lease term and discount rates used in the calculation of its outstanding lease liabilities at December 31, 2024, 2023, and 2022, along with other lease-related information for the years ended December 31, 2024, 2023, and 2022:
Lease Term and Discount Rate202420232022
Weighted-average remaining lease term (years):
     Operating leases10.110.010.4
     Finance leases6.77.17.7
Weighted-average discount rate:
     Operating leases4.97%5.07%4.22%
     Finance leases5.16%5.27%5.29%
Other Information202420232022
Cash paid for amounts included in the measurement of lease liabilities:
     Operating cash flows used by operating leases $48,380 $43,638 $40,595 
     Operating cash flows used by finance leases$3,711 $3,912 $4,023 
     Financing cash flows used by finance leases$15,433 $14,617 $11,090 
Leased assets obtained in exchange for new operating lease liabilities$66,585 $18,225 $32,860 
Leased assets obtained in exchange for new finance lease liabilities$11,925 $7,755 $9,349 
Modification to leased assets for increase in operating lease liabilities$37,731 $4,431 $1,215 
Modification to leased assets for increase/(decrease) in finance lease liabilities$53 $18 $(841)
Termination reclasses to decrease operating lease assets$5,765 $5,702 $(3,695)
Termination reclasses to decrease operating lease liabilities$5,768 $6,063 $(4,015)
Termination reclasses to decrease finance lease assets$270 $1,429 $(44)
Termination reclasses to decrease finance lease liabilities$271 $482 $(44)
v3.25.0.1
Goodwill and other intangible assets (Tables)
12 Months Ended
Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Changes in Goodwill
Changes in the carrying amount of goodwill by segment for the year ended December 31, 2024, are as follows:
Consumer
Packaging
Industrial Paper
Packaging
All Other
Total
Balance as of January 1, 2024
$543,598 $506,406 $248,007 $1,298,011 
Acquisitions
1,285,518 — — 1,285,518 
    Divestitures— — (16,559)(16,559)
    Foreign currency translation(21,145)(19,770)(398)(41,313)
Balance as of December 31, 2024
$1,807,971 $486,636 $231,050 $2,525,657 
Schedule of Other Intangible Assets
Details at December 31 are as follows:
20242023
Other Intangible Assets, Gross:
Patents$28,941 $23,970 
Customer lists2,679,372 995,077 
Trade names38,623 27,108 
Proprietary technology226,936 48,657 
Other2,339 6,206 
Total Other Intangible Assets, Gross$2,976,211 $1,101,018 
Accumulated Amortization:
Patents$(15,955)$(14,215)
Customer lists(332,680)(328,895)
Trade names(13,239)(8,327)
Proprietary technology(26,203)(20,813)
Other(1,436)(2,211)
Total Accumulated Amortization$(389,513)$(374,461)
Other Intangible Assets, Net$2,586,698 $726,557 
v3.25.0.1
Supply chain financing (Tables)
12 Months Ended
Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]  
Schedule of Supply Chain Finance Program
The following table sets forth the balance sheet location and rollforward of the Company’s outstanding obligations confirmed under its SCF Programs for the year ended December 31, 2024:
Balance Sheet LocationDecember 31, 2024
Confirmed obligations outstanding at the beginning of the yearPayable to suppliers$24,779 
Invoices confirmed during the year (a) (b)
96,785 
Confirmed invoices paid during the year (b)
(93,068)
Confirmed obligations outstanding at the end of the yearPayable to suppliers$28,496 

(a) Includes $7,547 of obligations under SCF programs acquired in the acquisition of Eviosys on December 4, 2024.
(b) The net payment of these obligations, exclusive of the $7,547 of obligations acquired in the acquisition of Eviosys, is included in “Net cash provided by operating activities” in the Company’s Consolidated Statements of Cash Flows.
v3.25.0.1
Debt (Tables)
12 Months Ended
Dec. 31, 2024
Debt Disclosure [Abstract]  
Debt instruments
Details of the Company’s debt at December 31 were as follows:
20242023
364-Day term loan due December 2025$1,493,568 $— 
Term loan due December 2026698,167 — 
Syndicated term loan due August 2028497,674 572,025 
1.80% notes due February 2025
399,933 399,149 
4.450% notes due September 2026
496,869 — 
2.25% notes due February 2027
298,930 298,421 
4.600% notes due September 2029
594,519 — 
3.125% notes due May 2030
596,958 596,480 
2.85% notes due February 2032
496,302 495,785 
5.000% notes due September 2034
689,802 — 
5.75% notes due November 2040
536,282 536,246 
Other foreign denominated debt, average rate of 6.0% in 2024 and 8.8% in 2023
155,048 49,418 
Finance lease obligations67,628 72,609 
Other debt18,341 16,803 
Total debt$7,040,021 $3,036,936 
Less: Notes payable and current portion of long-term debt(2,054,525)(38,934)
Long-term debt$4,985,496 $2,998,002 
The Notes consisted of the following:
Principal AmountIssuance Costs and DiscountsNet ProceedsInterest RateMaturity
2026 Notes$500,000 (3,697)$496,303 4.450 %September 1, 2026
2029 Notes600,000 (5,851)594,149 4.600 %September 1, 2029
2034 Notes700,000 (10,542)689,458 5.000 %September 1, 2034
Total$1,800,000 $(20,090)$1,779,910 
Schedule of debt maturities
The principal requirements of debt maturing in the next five years are:
  
20252026202720282029
Debt maturities by year$2,054,525 $1,218,544 $310,533 $508,115 $598,367 
v3.25.0.1
Financial instruments and derivatives (Tables)
12 Months Ended
Dec. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Carrying Amounts and Fair Values of Financial Instruments
The following table sets forth the carrying amounts and fair values of the Company’s significant financial instruments for which the carrying amount differs from the fair value.
 December 31, 2024December 31, 2023
  
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Long-term debt, net of current portion$4,985,496 $4,800,455 $2,998,002 $2,852,143 
Schedule of Net Positions of Foreign Contracts The net positions of these contracts at December 31, 2024, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase26,917,468 
Mexican pesopurchase373,569 
Polish zlotypurchase121,377 
Danish kronepurchase161,128 
Swedish kronasell(6,709)
Czech korunapurchase110,834 
Canadian dollarpurchase11,045 
Europurchase3,499 
Turkish lirapurchase104,546 
British poundsell(5,388)
Euro Contracts
Europurchase40,670 
British poundpurchase30,724 
Thai bahtpurchase620,976 
Hungarian forintsell(5,560,396)
Schedule of Net positions of Other Derivatives Contract The net currency positions of these non-designated contracts at December 31, 2024, were as follows (in thousands):
CurrencyActionQuantity
USD Contracts
Colombian pesopurchase66,306,243
Indonesian rupiahpurchase20,247,238
Mexican pesopurchase339,381
Turkish lirapurchase7,875
Canadian dollarpurchase7,262
Euro Contracts
British poundpurchase74,214
Polish zlotypurchase34,451
Thai Bahtpurchase410,488
Schedule of Location and Fair Values of Derivative Instruments
The following table sets forth the location and fair values of the Company’s derivative instruments at December 31, 2024 and December 31, 2023:
  Fair Value at December 31
DescriptionBalance Sheet Location20242023
Derivatives designated as hedging instruments:
Commodity ContractsPrepaid expenses$671 $67 
Commodity ContractsAccrued expenses and other(19)(108)
Foreign Exchange ContractsPrepaid expenses2,068 2,525 
Foreign Exchange ContractsAccrued expenses and other(3,909)(1,024)
Net investment hedgePrepaid expenses26,833 5,567 
Net investment hedgeOther Assets1,845 — 
Net investment hedgeOther liabilities(16,759)(10,640)
Derivatives not designated as hedging instruments:
Commodity ContractsPrepaid expenses$961 $12 
Commodity ContractsAccrued expenses and other(574)(6,782)
Foreign Exchange ContractsPrepaid expenses(59)130 
Foreign Exchange ContractsAccrued expenses and other(3,022)(159)
Schedule of Effect of Derivative Instruments on Financial Performance
The following tables set forth the effect of the Company’s derivative instruments on financial performance for the year ended December 31, 2024 and December 31, 2023, excluding the gains or losses on foreign currency cash flow hedges that were reclassified from accumulated other comprehensive loss to the carrying value of the capitalized expenditures:
Description
Amount of Gain or
(Loss) Recognized
in OCI on
Derivatives
Location of Gain or
(Loss) Reclassified
from Accumulated
OCI Into Income
Amount of Gain
or (Loss)
Reclassified from
Accumulated OCI
Into Income
Derivatives in Cash Flow Hedging Relationships:
Year Ended December 31, 2024
Foreign Exchange Contracts$(4,994)Net sales$(1,174)
Cost of sales$(253)
Commodity Contracts$665 Cost of sales$(28)
Year Ended December 31, 2023
Foreign Exchange Contracts$8,982 Net sales$10,860 
Cost of sales$(3,728)
Commodity Contracts$99 Cost of sales$(32)
Description
  
Gain or (Loss)
Recognized
Location of Gain or (Loss) Recognized in Income Statement
Derivatives not Designated as Hedging Instruments:
Year Ended December 31, 2024
Commodity Contracts$(2,976)
Cost of Sales
Foreign Exchange Contracts$(8,168)
Selling, general and administrative
Year Ended December 31, 2023
Commodity Contracts$(19,087)Cost of sales
Foreign Exchange Contracts$7,560 
Selling, general and administrative
Year Ended December 31, 2024Year Ended December 31, 2023
Description
Net Sales
Cost of Sales
Net Sales
Cost of Sales
Total amount of income and expense line items presented in the Consolidated Statements of Income$(1,174)$(281)$10,860 $(3,760)
Gain or (loss) on cash flow hedging relationships:
Foreign exchange contracts:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$(1,174)$(253)$10,860 $(3,728)
Commodity contract:
Amount of gain or (loss) reclassified from accumulated other comprehensive income into net income$— $(28)$— $(32)
v3.25.0.1
Fair value measurements (Tables)
12 Months Ended
Dec. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured on Recurring Basis
The following tables set forth information regarding the Company’s financial assets and financial liabilities that are measured at fair value on a recurring basis:
DescriptionDecember 31, 2024Assets measured at NAV (f)Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts
$652 $— $— $652 $— 
Foreign exchange contracts
(1,841)— — (1,841)— 
 Net investment hedge11,919 — — 11,919 — 
Non-hedge derivatives, net:
Commodity contracts387 — — 387 — 
Foreign exchange contracts(3,081)— — (3,081)— 
Postretirement benefit plan assets:
 Common Collective(a)13,259 13,259 — — — 
Mutual funds(b)
43,059 — — 43,059 — 
 Fixed income securities(c)
235,952 62,458 — 173,494 — 
 Short-term investments(d)
3,493 — — 3,493 — 
 Real estate funds(e)
480 480 — — — 
      Cash and accrued income7,757 — 7,757 — — 
Total postretirement benefit plan assets$304,000 $76,197 $7,757 $220,046 $— 
DescriptionDecember 31, 2023Assets measured at NAV (f)Level 1Level 2Level 3
Hedge derivatives, net:
Commodity contracts
$(41)$— $— $(41)$— 
Foreign exchange contracts
1,502 — — 1,502 — 
Net investment hedge(5,073)— — (5,073)— 
Non-hedge derivatives, net:
      Commodity contracts(6,770)— — (6,770)— 
Foreign exchange contracts(29)— — (29)— 
Postretirement benefit plan assets:
      Common Collective(a)12,958 12,958 — — — 
      Mutual funds(b)45,931 — — 45,931 — 
      Fixed income securities(c)242,702 63,849 — 178,853 — 
      Short-term investments(d)4,175 — — 4,175 — 
      Real estate funds(e)400 400 — — — 
      Cash and accrued income 2,634 — 2,634 — — 
Total postretirement benefit plan assets$308,800 $77,207 $2,634 $228,959 $— 
a.Common collective trust investments consist of domestic and international large and mid capitalization equities, including emerging markets and funds invested in both short-term and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds, private securities, and limited partnerships are valued at unit values or NAVs provided by the investment managers.
b.Mutual fund investments are comprised of equity securities of corporations with large capitalizations and also include funds invested in corporate equities in international and emerging markets and funds invested in long-term bonds, which are valued at closing prices from national exchanges.
c.Fixed income securities include funds that invest primarily in government securities and long-term bonds. Underlying investments are generally valued at closing prices from national exchanges, fixed income pricing models, and independent financial analysts. Fixed income commingled funds are valued at unit values provided by the investment managers.
d.Short-term investments include several money market funds used for managing overall liquidity. Underlying investments are generally valued at closing prices from national exchanges. Commingled funds are valued at unit values provided by the investment managers.
e.Includes investments in real estate funds (including office, industrial, residential and retail). Underlying real estate securities are generally valued at closing prices from national exchanges.
f.Certain assets that are measured at fair value using the NAV per share (or its equivalent) practical expedient have not been classified in the fair value hierarchy.
v3.25.0.1
Share-based compensation plans (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Summary of Activity Related to Restricted Stock Units
The activity related to RSUs for the year ended December 31, 2024 is as follows:
NonvestedVested
Total
Average Grant
Date Fair
Value Per Share
Outstanding, December 31, 2023
593,445 68,815 662,260 $54.71 
   Granted383,708 — 383,708 $52.41 
   Vested(234,610)234,610 — 
   Converted(231,157)(231,157)$55.27 
   Cancelled(62,103)— (62,103)$54.06 
   Dividend equivalents1,176 3,312 4,488 $55.42 
Outstanding, December 31, 2024
681,616 75,580 757,196 $53.43 
Summary of Activity Related to Performance Contingent Restricted Stock Units
The activity related to PCSUs for the year ended December 31, 2024 is as follows:
NonvestedVestedTotalAverage Grant Date Fair Value per Share
Outstanding, December 31, 2023
418,403 236,492 654,895 $53.51
   Granted253,176 — 253,176 $50.54
   Performance adjustments(21,184)— (21,184)$41.05
   Vested(330,888)330,888 — 
   Converted— (217,966)(217,966)$55.48
   Cancelled(35,832)— (35,832)$52.32
   Dividend equivalents— 667 667 $55.40
Outstanding, December 31, 2024
283,675 350,081 633,756 $52.13
Schedule of Other Share-Based Compensation, Activity
The activity related to deferred compensation for equity award units granted to both employees and non-employee directors combined is as follows:
Total
Outstanding, December 31, 2023
324,602 
   Deferred34,113 
   Converted(8,541)
   Dividend equivalents11,249 
Outstanding, December 31, 2024
361,423 
Company's SARs
The activity related to the Company’s SARs for the year ended December 31, 2024 is as follows: 
NonvestedVestedTotal
Weighted-
average
Exercise
Price
Outstanding, December 31, 2023
— 729,515 729,515 $55.13 
   Vested— — — $— 
   Granted— — — $— 
   Exercised— (47,180)(47,180)$47.28 
   Forfeited/Expired— (18,931)(18,931)$57.41 
Outstanding, December 31, 2024
— 663,404 663,404 $55.62 
Exercisable, December 31, 2024
— 663,404 663,404 $55.62 
v3.25.0.1
Employee benefit plans (Tables)
12 Months Ended
Dec. 31, 2024
Retirement Benefits [Abstract]  
Schedule of Components of Net Periodic Benefit Cost/(Income)
The components of net periodic benefit cost/(income) include the following:
202420232022
Retirement Plans
Service cost$3,456 $2,878 $3,266 
Interest cost19,097 18,101 10,562 
Expected return on plan assets(11,133)(9,451)(10,302)
Amortization of prior service cost864 926 913 
Amortization of net actuarial loss4,472 4,300 6,240 
Effect of settlement loss530 1,010 479 
Effect of curtailment loss— — 43 
Net periodic benefit cost$17,286 $17,764 $11,201 
Retiree Health and Life Insurance Plans
Service cost$178 $230 $320 
Interest cost919 507 258 
Expected return on plan assets(392)(313)(439)
Amortization of prior service credit385 — — 
Amortization of net actuarial gain(899)(768)(681)
Net periodic benefit cost/(income)$191 $(344)$(542)
Schedule of Plans' Obligations
The following tables set forth the Plans’ obligations and assets at December 31:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Change in Benefit Obligation
Benefit obligation at January 1$413,340 $352,767 $22,571 $11,244 
Service cost3,456 2,878 178 230 
Interest cost19,097 18,101 919 507 
Plan participant contributions31 60 — — 
Plan amendments615 306 — 11,637 
Actuarial (gain)/loss(18,935)15,663 (2,389)(266)
Benefits paid(28,263)(26,703)(1,418)(788)
Impact of foreign exchange rates(8,926)8,707 (29)
Effect of settlements(2,218)(2,373)— — 
Effect of curtailments— — — — 
Acquisitions74,078 43,934 — — 
Benefit obligation at December 31$452,275 $413,340 $19,832 $22,571 
Schedule of Fair Value of Plan Assets
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Change in Plan Assets
Fair value of plan assets at January 1$295,587 $253,125 $13,213 $12,750 
Actual return on plan assets(5,203)15,968 535 553 
Company contributions18,798 13,908 835 754 
Plan participant contributions77 60 — — 
Benefits paid(28,263)(26,703)(1,360)(788)
Impact of foreign exchange rates(7,200)10,388 — — 
Effect of settlements(2,218)(2,373)— — 
Expenses paid(1,976)(1,108)(48)(56)
Acquisitions21,223 32,322 — — 
Fair value of plan assets at December 31$290,825 $295,587 $13,175 $13,213 
Funded status of the Plans$(161,450)$(117,753)$(6,657)$(9,358)
Schedule of Recognized Amounts in Consolidated Balance Sheets
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Total Recognized Amounts in the Consolidated Balance Sheets
Noncurrent assets $24,919 $26,599 $— $— 
Current liabilities(11,382)(9,797)(817)(1801)
Noncurrent liabilities(174,987)(134,555)(5,840)(7,557)
Net (liability)
$(161,450)$(117,753)$(6,657)$(9,358)
Schedule of Amounts Recognized in Other Comprehensive Loss/(Income)
Items not yet recognized as a pre-tax component of net periodic benefit cost that are included in Accumulated Other Comprehensive Loss as of December 31, 2024 and 2023, are as follows:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
2024202320242023
Net actuarial loss/(gain)$109,718 $114,957 $(7,706)$(6,120)
Prior service cost5,020 5,557 11,251 11,637 
 $114,738 $120,514 $3,545 $5,517 
The pre-tax amounts recognized in Other Comprehensive Loss/(Income) include the following:
 Retirement Plans
Retiree Health and
Life Insurance Plans
  
202420232022202420232022
Adjustments arising during the period:
Net actuarial (gain)/loss$(238)$10,709 $4,839 $(2,485)$(451)$(761)
Prior service cost327 430 678 — 11,637 — 
Net settlements/curtailments(530)(1,010)(522)— — — 
Amortization recognized during the period:
Net actuarial (loss)/gain(4,472)(4,300)(6,240)899 768 681 
Prior service cost
(864)(926)(913)(385)— — 
Total recognized in other comprehensive (income)/loss$(5,777)$4,903 $(2,158)$(1,971)$11,954 $(80)
Total recognized in net periodic benefit cost and other comprehensive loss/(income)$11,509 $22,707 $9,081 $(1,780)$11,610 $(622)
Schedule of Company's Projected Benefit Payments
The following table sets forth the Company’s projected benefit payments for the next ten years:
YearRetirement Plans
Retiree Health and
Life Insurance Plans
2025$33,734 $1,642 
2026$34,132 $1,790 
2027$34,027 $1,709 
2028$35,391 $1,956 
2029$34,788 $1,829 
2030-2034$184,106 $8,773 
Schedule of Major Actuarial Assumptions Used in Determining PBO, ABO and Net Periodic Cost
The following tables set forth the major actuarial assumptions used in determining the benefit obligation and net periodic benefit cost:
Weighted-average assumptions
used to determine benefit
obligations at December 31
U.S.
Retirement
Plans
U.S. Retiree
Health and
Life Insurance
Plans
Foreign Plans
Discount Rate
20245.52 %5.32 %6.52 %
20234.84 %4.68 %4.79 %
Rate of Compensation Increase
2024— %3.02 %3.59 %
2023— %3.03 %3.11 %
 
Weighted-average assumptions
used to determine net periodic benefit
cost for years ended December 31
U.S.
Retirement
Plans
U.S. Retiree
Health and
Life Insurance
Plans
Foreign
Plans
Discount Rate
20244.84 %4.68 %4.79 %
20235.01 %4.92 %4.97 %
20222.77 %2.48 %2.22 %
Expected Long-term Rate of Return
20243.08 %3.05 %4.36 %
20232.48 %2.45 %4.70 %
20223.27 %3.18 %3.00 %
Rate of Compensation Increase
2024— %3.03 %3.11 %
2023— %2.99 %3.29 %
2022— %3.01 %3.21 %
Schedule of Health Care Cost Trend Rates
The U.S. Retiree Health and Life Insurance Plan makes up approximately 90% of the Retiree Health liability. Therefore, the following information relates to the U.S. plan only.
Healthcare Cost Trend RatePre-age 65Post-age 65
20246.17 %7.28 %
20236.25 %7.25 %
Ultimate Trend RatePre-age 65Post-age 65
20244.50 %4.50 %
20234.50 %4.50 %
Year at which the Rate Reaches
the Ultimate Trend Rate
Pre-age 65Post-age 65
202420352035
202320332033
Schedule of Weighted-Average Asset Allocations
The following table sets forth the weighted-average asset allocations of the Company’s retirement plans at 2024 and 2023, by asset category.
Asset Category
  
U.S.RTSU.K.Canada
Equity securities202419.5 %22.2 %21.0 %31.4 %
202322.2 %18.6 %20.0 %29.4 %
Debt securities202478.0 %77.8 %77.1 %68.6 %
202376.6 %81.2 %79.1 %70.6 %
Cash and short-term investments20242.5 %— %1.9 %— %
20231.2 %0.2 %.9 %— %
Total2024100.0 %100.0 %100.0 %100.0 %
2023100.0 %100.0 %100.0 %100.0 %
The following table sets forth the weighted-average asset allocations by asset category of the Company’s retiree health and life insurance plan.
Asset Category20242023
Equity securities—%—%
Debt securities100.0%100.0%
Cash—%—%
Total100.0%100.0%
v3.25.0.1
Income taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Provision For Taxes on Income
The provision for taxes on income for the years ended December 31 consists of the following:
202420232022
Pretax income
Domestic$(35,733)$280,916 $257,189 
Foreign99,219 208,111 202,745 
Total pretax income$63,486 $489,027 $459,934 
Current
Federal$3,693 $54,319 $34,157 
State1,916 11,282 10,391 
Foreign57,034 63,617 61,228 
Total current$62,643 $129,218 $105,776 
Deferred
Federal$(34,828)$(3,307)$(1,884)
State(9,837)(1,646)(3,563)
Foreign(12,469)(4,535)(4,598)
Total deferred$(57,134)$(9,488)$(10,045)
Total taxes$5,509 $119,730 $95,731 
Schedule of Deferred Tax Liabilities/(Assets)
Deferred tax (liabilities)/assets are comprised of the following at December 31:
20242023
Property, plant and equipment$(266,278)$(137,880)
Intangibles(545,330)(119,225)
Leases(76,225)(48,832)
Outside basis in Metal Packaging(68,649)(68,867)
Gross deferred tax liabilities$(956,482)$(374,804)
Retiree health benefits$245 $513 
Foreign loss carryforwards79,314 62,250 
U.S. Federal loss and credit carryforwards34,082 39,131 
Capital loss carryforwards3,755 3,817 
U.S. State loss and credit carryforwards26,181 21,321 
Capitalized research and development costs103,043 87,743 
Employee benefits56,192 51,829 
Leases82,031 50,704 
Accrued liabilities and other assets71,370 58,699 
Gross deferred tax assets$456,213 $376,007 
Valuation allowance on deferred tax assets$(81,496)$(70,661)
Total deferred taxes, net1
$(581,765)$(69,458)
1 Total deferred taxes, net includes $(15,666) and $(6,228) reclassified to discontinued operations on the Consolidated Balance Sheets at December 31, 2024 and 2023, respectively. These amounts include valuation allowance on deferred tax assets of $(4,628) and $(4,395) at December 31, 2024 and 2023, respectively.
Reconciliation of U.S. Federal Statutory Tax Rate to Actual Consolidated Tax Expense
A reconciliation of the U.S. federal statutory tax rate to the actual provision for/(benefit from) income taxes is as follows:
  
202420232022
Statutory tax rate$13,332 21.0 %$102,696 21.0 %$96,563 21.0 %
State income taxes, net of federal tax benefit(883)(1.4)%12,263 2.5 %10,204 2.2 %
Valuation allowance7,763 12.2 %4,486 0.9 %(10,477)(2.3)%
Tax examinations including change in reserve for uncertain tax positions(8,613)(13.6)%1,819 0.4 %296 0.1 %
Adjustments to prior year deferred taxes(9,129)(14.4)%(2,489)(0.5)%(2,110)(0.5)%
Foreign earnings taxed at other than U.S. rates12,271 19.3 %13,108 2.7 %14,613 3.2 %
Divestiture of business(2,954)(4.7)%464 0.1 %— — %
Effect of tax rate changes(1,552)(2.4)%387 0.1 %(2,151)(0.5)%
Foreign withholding taxes5,344 8.4 %4,591 0.9 %4,643 1.0 %
Tax credits(11,834)(18.6)%(18,848)(3.9)%(14,077)(3.1)%
Global intangible low-taxed income (GILTI)(5,604)(8.8)%4,853 1.0 %4,345 0.9 %
Foreign-derived intangible income(858)(1.4)%(1,106)(0.2)%(657)(0.1)%
Foreign currency gain/(loss) on distributions of previously taxed income
642 1.0 %(2,614)(0.5)%(1,280)(0.3)%
IRC Subpart F income
916 1.4 %119 — %96 — %
Executive compensation limitation
2,569 4.0 %3,767 0.8 %1,420 0.3 %
Capitalized acquisition costs7,202 11.3 %104 — %(412)(0.1)%
Other, net(3,103)(4.9)%(3,870)(0.8)%(5,285)(1.1)%
Provision for income taxes5,509 8.7 %119,730 24.5 %95,731 20.8 %
Schedule of Unrecognized Tax Benefits
The following table sets forth the reconciliation of the gross amounts of unrecognized tax benefits at the beginning and ending of the periods indicated: 
202420232022
Gross Unrecognized Tax Benefits at January 1$21,677 $18,621 $18,142 
Increases in prior years’ unrecognized tax benefits627 378 223 
Decreases in prior years’ unrecognized tax benefits(1,915)(572)(144)
Increases in current year’s unrecognized tax benefits4,325 4,395 1,807 
Decreases in unrecognized tax benefits from the lapse of statutes of limitations(12,100)(1,094)(1,174)
Settlements(476)(51)(233)
Gross Unrecognized Tax Benefits at December 31$12,138 $21,677 $18,621 
v3.25.0.1
Revenue recognition (Tables)
12 Months Ended
Dec. 31, 2024
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following tables set forth information about revenue disaggregated by primary geographic regions for the years ended December 31, 2024, 2023 and 2022. The tables also include a reconciliation of disaggregated revenue with reportable segments. The Company’s reportable segments are aligned by product nature as disclosed in Note 20.
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,785,857 $1,431,232 $352,717 $3,569,806 
   Europe524,699 371,896 58,925 955,520 
   Canada17,486 95,863 — 113,349 
   Asia Pacific96,154 213,127 1,771 311,052 
   Other107,656 237,370 10,612 355,638 
          Total$2,531,852 $2,349,488 $424,025 $5,305,365 
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,817,268 $1,389,492 $494,112 $3,700,872 
   Europe431,189 389,261 64,936 885,386 
   Canada16,076 100,095 — 116,171 
   Asia Pacific94,136 233,446 1,812 329,394 
   Other112,379 261,819 35,405 409,603 
          Total$2,471,048 $2,374,113 $596,265 $5,441,426 
Year Ended December 31, 2022Consumer PackagingIndustrial Paper PackagingAll OtherTotal
Primary geographical markets:
   United States $1,936,847 $1,611,390 $503,526 $4,051,763 
   Europe421,276 434,076 68,949 924,301 
   Canada18,372 109,997 — 128,369 
   Asia Pacific91,151 275,395 1,158 367,704 
   Other96,358 253,705 37,127 387,190 
          Total$2,564,004 $2,684,563 $610,760 $5,859,327 
Schedule of Contract Asset and Liabilities
The following table sets forth information about contract assets and liabilities from contracts with customers. The balances of the contract assets and liabilities are located in “Other receivables” and “Accrued expenses and other”, respectively, in the Consolidated Balance Sheets.
December 31, 2024December 31, 2023
Contract Assets$67,062 $14,754 
Contract Liabilities$(60,024)$(15,252)
Significant changes in the contract assets and liabilities balances during the twelve months ended December 31, 2024 and 2023 were as follows:
December 31, 2024December 31, 2023
Contract AssetContract LiabilityContract AssetContract Liability
Beginning balance$14,754 $(15,252)$18,037 $(12,588)
Acquired as part of a business combination62,439 (47,478)— (1,436)
Revenue deferred or rebates accrued— (25,736)— (25,094)
Recognized as revenue — 2,341 — 1,936 
Rebates paid to customers— 26,101 — 21,930 
Increases due to rights to consideration for customer specific goods produced, but not billed during the period67,062 — 14,754 — 
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination(77,193)— (18,037)— 
Ending balance$67,062 $(60,024)$14,754 $(15,252)
v3.25.0.1
Shareholders’ equity and earnings per share (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Summary of Earnings (Loss) Per Share
The following table sets forth the computation of basic and diluted earnings/(loss) per share (in thousands, except per share data):
202420232022
Numerator:
Net income from continuing operations $67,565 $379,644 $378,410 
Net loss/(income) from continuing operations attributable to noncontrolling interests
180 (768)(284)
Net income from continuing operations attributable to Sonoco67,745 378,876 378,126 
Net income attributable to Sonoco$163,949 $474,959 $466,437 
Denominator:
Weighted average common shares outstanding98,637 98,294 97,991 
Dilutive effect of share-based compensation653 596 741 
Diluted outstanding shares99,290 98,890 98,732 
Per common share:
Basic earnings per common share:
Net income from continuing operations$0.69 $3.85 $3.86 
Net income attributable to Sonoco$1.66 $4.83 $4.76 
Diluted earnings per common share:
Net income from continuing operations$0.68 $3.83 $3.83 
Net income attributable to Sonoco$1.65 $4.80 $4.72 
Cash dividends$2.07 $2.02 $1.92 
Schedule of Shares Not Included in Computations of Diluted Income Per Share
The average number of shares that were not dilutive and therefore not included in the computation of diluted income per share was as follows for the years ended December 31, 2024, 2023 and 2022 (in thousands):
202420232022
Anti-dilutive stock appreciation rights408 352 373 
v3.25.0.1
Segment reporting (Tables)
12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Summary of Financial Segment Information
The following table sets forth financial information about each of the Company’s reportable segments:
Year Ended December 31, 2024Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,531,852 $2,349,488 $4,881,340 
Intersegment sales (1)
8,022 111,682 119,704 
$2,539,874 $2,461,170 $5,001,044 
Reconciliation of sales
Other sales (2)
431,107 
Elimination of intersegment sales(126,786)
Total consolidated sales$5,305,365 
Less: (3)
Cost of sales (4)
$(2,041,078)$(1,818,324)
Other segment items (5)
(203,964)(371,192)
Segment operating profit$294,832 $271,654 $566,486 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$365 $9,223 
Depreciation, depletion and amortization (6)
$109,355 $116,149 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Year Ended December 31, 2023Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,471,048 $2,374,113 $4,845,161 
Intersegment sales (1)
5,171 101,822 106,993 
$2,476,219 $2,475,935 $4,952,154 
Reconciliation of sales
Other sales (2)
604,442 
Elimination of intersegment sales(115,170)
Total consolidated sales$5,441,426 
Less: (3)
Cost of sales (4)
$(1,999,514)$(1,809,803)
Other segment items (5)
(190,943)(348,215)
Segment operating profit$285,762 $317,917 $603,679 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$564 $9,783 
Depreciation, depletion and amortization (6)
$95,340 $104,723 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.

Year Ended December 31, 2022Consumer PackagingIndustrial Paper PackagingTotal Reportable Segments
Sales from external customers$2,564,004 $2,684,563 $5,248,567 
Intersegment sales (1)
1,779 134,214 135,993 
$2,565,783 $2,818,777 $5,384,560 
Reconciliation of sales
Other sales (2)
620,330 
Elimination of intersegment sales(145,563)
Total consolidated sales$5,859,327 
Less: (3)
Cost of sales (4)
$(1,981,621)$(2,109,080)
Other segment items (5)
(142,006)(381,838)
Segment operating profit$442,156 $327,859 $770,015 
Other segment disclosures:
Equity in earnings of affiliates, net of tax$485 $13,722 
Depreciation, depletion and amortization (6)
$84,049 $91,944 
(1)
Intersegment sales are recorded at a market-related transfer price.
(2)
Sales from businesses below the quantitative threshold are attributable to the group of businesses within All Other.
(3)
The significant expense categories and amounts align with the segment-level information that is regularly provided to the CODM.
(4)
Cost of sales of reportable segments excludes certain costs, primarily changes in LIFO inventory reserves, net gains or losses from derivatives, and acquisition, integration and divestiture-related costs.
(5)
Other segment items consists of:
Consumer Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
Industrial Paper Packaging: Labor and benefits, consulting and professional services, travel, communication, facilities and supplies.
(6)
Represents significant segment expenses that are regularly provided to the CODM and are included in cost of sales and other segment items within segment operating profit.
Reconciliation of segment operating profit to income from continuing operations before income taxes:202420232022
Segment operating profit$566,486 $603,679 $770,015 
Other operating profits(1)
53,278 85,148 58,240 
Unallocated amounts:
Restructuring/Asset impairment charges(65,370)(47,909)(52,385)
Amortization of acquisition intangibles(78,595)(67,323)(60,263)
(Loss)/Gain from divestiture of business and other assets(23,452)78,929 — 
Acquisition, integration and divestiture-related costs(91,600)(24,624)(70,210)
Changes in LIFO inventory reserves6,263 11,817 (28,445)
Derivative gains/(losses)7,225 1,912 (8,767)
Other corporate costs(2)
(46,675)(42,254)(45,210)
Other operating income/(charges), net(3)
(982)(10,326)380 
Other (expenses)/income, net(104,200)39,657 — 
Non-operating pension costs(13,842)(14,312)(7,073)
Interest expense(172,620)(135,393)(100,875)
Interest income27,570 10,026 4,527 
Income from continuing operations before income taxes$63,486 $489,027 $459,934 

(1)
Operating profit from segments below the quantitative threshold are attributable to the group of businesses within All Other.
(2)
Other corporate costs represent recurring operating expenses previously allocated to TFP that will remain with Sonoco subsequent to the divestiture.
(3)
Primarily consists of insurance gains offset by consulting fees in 2024 and losses related to highly inflationary accounting in Turkey and consulting fees, partially offset by insurance gains, in 2023.
Reconciliation of other segment disclosures to consolidated totals:202420232022
Equity in earnings of affiliates, net of tax
Consumer Packaging$365 $564 $485 
Industrial Paper Packaging9,223 9,783 13,722 
Reportable Segment Total9,588 10,347 14,207 
Adjustments— — — 
Consolidated Total$9,588 $10,347 $14,207 
Depreciation, depletion and amortization
Consumer Packaging$109,355 $95,340 $84,049 
Industrial Paper Packaging116,149 104,723 91,944 
Reportable Segment Total225,504 200,063 175,993 
Other
90,557 81,966 74,540 
Consolidated Total$316,061 $282,029 $250,533 

(1)
Other represents depreciation, depletion and amortization expense for the All Other group of businesses and total amortization of acquisition intangibles for Sonoco, excluding discontinued operations.
Sales to Unaffiliated Customers and Long-Lived Assets by Geographic Region
Sales to unaffiliated customers and long-lived assets by geographic region are as follows:
202420232022
Sales to Unaffiliated Customers
United States$3,569,806 $3,700,872 $4,051,763 
Europe955,520 885,386 924,301 
Canada113,349 116,171 128,369 
Asia Pacific311,052 329,394 367,704 
Other355,638 409,603 387,190 
Total$5,305,365 $5,441,426 $5,859,327 
Long-lived Assets
United States$2,695,885 $2,779,178 $2,511,809 
Europe4,690,098 617,949 572,824 
Canada35,750 39,842 24,257 
Asia Pacific176,547 157,235 155,959 
Other300,623 149,530 75,583 
Total$7,898,903 $3,743,734 $3,340,432 
v3.25.0.1
Accumulated other comprehensive loss (Tables)
12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Summary of Components of Accumulated Other Comprehensive Loss
The following table summarizes the components of accumulated other comprehensive loss and the changes in accumulated other comprehensive loss, net of tax as applicable, for the years ended December 31, 2024 and 2023:
Foreign
Currency
Items
Defined
Benefit
Pension Items
Gains and Losses on Cash Flow Hedges
Accumulated
Other
Comprehensive
Loss
Balance at December 31, 2022
$(338,316)$(90,973)$(794)$(430,083)
Other comprehensive income/(loss) before reclassifications
68,705 (16,305)6,622 59,022 
Amounts reclassified from accumulated other comprehensive loss to net income2,033 7,651 (5,177)4,507 
Amounts reclassified from accumulated other comprehensive loss to fixed assets— — 292 292 
Other comprehensive income/(loss)
70,738 (8,654)1,737 63,821 
Balance at December 31, 2023
$(267,578)$(99,627)$943 $(366,262)
Other comprehensive (loss)/income before reclassifications
(146,856)4,636 (3,213)(145,433)
Amounts reclassified from accumulated other comprehensive loss to net income3,503 4,378 1,080 8,961 
Other comprehensive (loss)/income
(143,353)9,014 (2,133)(136,472)
Balance at December 31, 2024
$(410,931)$(90,613)$(1,190)$(502,734)
Summary of Effects on Net Income of Significant Amounts Reclassified from Accumulated Other Comprehensive Loss
The following table summarizes the amounts reclassified from accumulated other comprehensive loss and the affected line items in the consolidated statements of net income for the years ended December 31, 2024 and 2023:
Amount Reclassified from Accumulated Other Comprehensive Loss
Details about Accumulated Other Comprehensive Loss ComponentsYear Ended December 31, 2024Year Ended December 31, 2023Affected Line Item in the Consolidated Statements of Net Income
Foreign currency items
Loss on Protexic and China divestitures$(3,503)$— (Loss)/Gain on divestiture of business and other assets
     Loss on RTS Packaging investment (see Note 4)
— (2,033)Other (expenses)/income, net
(3,503)(2,033)Net income
Defined benefit pension items (see Note 15)
Pension-related loss upon purchase of remaining interest in RTS Packaging joint venture— (4,756)Other (expenses)/income, net
Effect of settlement loss(530)(1,010)
Non-operating pension costs
Amortization of defined benefit pension items(4,822)(4,458)
Non-operating pension costs
(5,352)(10,224)Income from continuing operations before income taxes
974 2,573 Provision for income taxes
(4,378)(7,651)Net income
Gains and losses on cash flow hedges (see Note 12)
Foreign exchange contracts(1,174)10,860 Net Sales
Foreign exchange contracts(253)(3,728)Cost of sales
Commodity contracts(28)(32)Cost of sales
(1,455)7,100 Income from continuing operations before income taxes
375 (1,923)Provision for income taxes
(1,080)5,177 Net income
Amounts reclassified to net income from accumulated other comprehensive loss$(8,961)$(4,507)Net income
Summary of Before and After Tax Amounts for Comprehensive Income (Loss) Components
The following table summarizes the tax expense/(benefit) for the components of other comprehensive income/(loss):
For the year ended December 31, 2024
For the year ended December 31, 2023
Before Tax AmountTaxAfter Tax AmountBefore Tax AmountTaxAfter Tax Amount
Foreign currency items:
Other comprehensive (loss)/income before reclassifications
$(140,210)$(6,646)$(146,856)$67,411 $1,294 $68,705 
Amounts reclassified from accumulated other comprehensive loss to net income3,503 — 3,503 2,033 — 2,033 
Net other comprehensive (loss)/income from foreign currency items
(136,707)(6,646)(143,353)69,444 1,294 70,738 
Defined benefit pension items:
Other comprehensive income/(loss) before reclassifications
2,395 2,241 4,636 (21,815)5,510 (16,305)
Amounts reclassified from accumulated other comprehensive income/(loss) to net income
5,352 (974)4,378 10,224 (2,573)7,651 
Net other comprehensive income/(loss) from defined benefit pension items
7,747 1,267 9,014 (11,591)2,937 (8,654)
Cash flow hedges:
Other comprehensive (loss)/income before reclassifications
(4,329)1,116 (3,213)9,081 (2,459)6,622 
Amounts reclassified from accumulated other comprehensive income/(loss) to net income
1,455 (375)1,080 (7,100)1,923 (5,177)
Amounts reclassified from accumulated other comprehensive loss to fixed assets— — — 401 (109)292 
Net other comprehensive (loss)/income from cash flow hedges(2,874)741 (2,133)2,382 (645)1,737 
Other comprehensive (loss)/income
$(131,834)$(4,638)$(136,472)$60,235 $3,586 $63,821 
v3.25.0.1
Selected quarterly financial data (Tables)
12 Months Ended
Dec. 31, 2024
Selected Quarterly Financial Information [Abstract]  
Schedule of Selected Quarterly Financial Data
The following table sets forth selected quarterly financial data of the Company for the years ended December 31, 2024 and December 31, 2023:
(unaudited)
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
2024
Net sales$1,308,636 $1,278,801 $1,354,652 $1,363,276 
Gross profit271,217 285,295 299,748 282,973 
Net income/(loss) from continuing operations35,512 57,410 31,392 (56,749)
Net income from discontinued operations29,761 33,541 19,817 13,256 
Net income/(loss) attributable to Sonoco65,177 90,811 50,921 (42,960)
Weighted average common shares outstanding:
Basic98,498 98,671 98,683 98,700 
Diluted99,159 99,241 99,267 98,700 
Per common share:
Basic Earnings/(Loss) Per Common Share:
     Continuing operations$0.36 $0.58 $0.32 $(0.57)
     Discontinued operations0.30 0.34 0.20 0.13 
     Basic earnings/(loss) per share attributable to Sonoco$0.66 $0.92 $0.52 $(0.44)
Diluted Earnings/(Loss) Per Common Share:
     Continuing operations$0.36 $0.58 $0.31 $(0.57)
     Discontinued operations0.30 0.34 0.20 0.13 
     Diluted earnings/(loss) per share attributable to Sonoco$0.66 $0.92 $0.51 $(0.44)
Cash dividends$0.51 $0.52 $0.52 $0.52 
2023
Net sales$1,386,972 $1,337,589 $1,381,130 $1,335,735 
Gross profit314,796 291,946 307,848 287,979 
Net income from continuing operations121,954 84,638 111,946 61,106 
Net income from discontinued operations26,310 30,111 19,112 20,724 
Net income attributable to Sonoco148,319 114,649 130,749 81,242 
Weighted average common shares outstanding:
Basic98,167 98,325 98,337 98,349 
Diluted98,615 98,872 98,912 99,164 
Per common share:
Basic Earnings Per Common Share:
     Continuing operations$1.24 $0.86 $1.14 $0.61 
     Discontinued operations0.27 0.31 0.19 0.21 
     Basic earnings per share attributable to Sonoco$1.51 $1.17 $1.33 $0.82 
Diluted Earnings Per Common Share:
     Continuing operations$1.23 $0.86 $1.13 $0.61 
     Discontinued operations0.27 0.30 0.19 0.21 
     Diluted earnings per share attributable to Sonoco$1.50 $1.16 $1.32 $0.82 
Cash dividends$0.49 $0.51 $0.51 $0.51 
v3.25.0.1
Summary of significant accounting policies - Company Held Significant Investment (Details)
Dec. 31, 2024
Cascades Conversion, Inc.  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 50.00%
Cascades Sonoco, Inc.  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 50.00%
ISI Robotics, LLC  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 26.40%
Showa Products Company Ltd.  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 22.20%
Papertech Energía, S.L.  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 25.00%
Weidenhammer New Packaging, LLC  
Noncontrolling Interest [Line Items]  
Ownership percentage by joint venture 40.00%
v3.25.0.1
Summary of significant accounting policies - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 04, 2024
USD ($)
Dec. 31, 2024
USD ($)
segment
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Nov. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
Summary Of Significant Accounting Policies [Line Items]              
Carrying value of equity investments   $ 67,801 $ 56,399        
Research and development costs   $ 23,000 $ 23,900 $ 23,100      
Percentage of LIFO inventory (percent)   9.00% 17.00%        
LIFO inventory amount   $ 33,265 $ 39,528        
Portfolio approach, lease, short rate term (or less)   10 years          
Portfolio approach, lease, long rate term (greater than)   10 years          
Number of reportable segments | segment   2          
Eviosys              
Summary Of Significant Accounting Policies [Line Items]              
Trade receivables sold and derecognized $ 73,487            
Dispositions              
Summary Of Significant Accounting Policies [Line Items]              
Consideration for disposal of business held for sale         $ 302    
Minimum              
Summary Of Significant Accounting Policies [Line Items]              
Intangible assets, useful life   3 years          
Expected years of return on plan of investment   12 years          
Minimum | Equipment              
Summary Of Significant Accounting Policies [Line Items]              
Property plant and equipment, useful life   3 years          
Minimum | Buildings              
Summary Of Significant Accounting Policies [Line Items]              
Property plant and equipment, useful life   15 years          
Maximum              
Summary Of Significant Accounting Policies [Line Items]              
Intangible assets, useful life   40 years          
Expected years of return on plan of investment   15 years          
Maximum | Equipment              
Summary Of Significant Accounting Policies [Line Items]              
Property plant and equipment, useful life   11 years          
Maximum | Buildings              
Summary Of Significant Accounting Policies [Line Items]              
Property plant and equipment, useful life   40 years          
Net sales | Customer concentration | Customers that sponsor/promote multi-vendor supply chain finance arrangements | Multi-Vendor Supply Chain Finance Arrangement              
Summary Of Significant Accounting Policies [Line Items]              
Customer concentrations (percent)   12.00% 15.00%        
Chilean tube              
Summary Of Significant Accounting Policies [Line Items]              
Percentage ownership in equity method investment (percent)   19.50%          
Sustainable Protective Packaging Solutions              
Summary Of Significant Accounting Policies [Line Items]              
Percentage ownership in equity method investment (percent)           39.90% 20.50%
Sustainable Protective Packaging Solutions | Preferred Stock              
Summary Of Significant Accounting Policies [Line Items]              
Increase in investment           $ 18,512  
v3.25.0.1
Discontinued operations - Balance Sheet (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Disposal Group, Including Discontinued Operations [Line Items]    
Current assets of discontinued operations $ 450,874 $ 459,618
Current liabilities of discontinued operations 242,056 248,404
Deferred income taxes 15,666 6,228
Non-current liabilities of discontinued operations 113,911 118,140
Discontinued Operations, Held-for-Sale    
Disposal Group, Including Discontinued Operations [Line Items]    
Cash and cash equivalents 12,050 13,042
Trade accounts receivable, net of allowances of $$2,582 in 2024 and $$2,793 in 2023 209,379 218,620
Trade accounts receivable, net of allowances 2,582 2,793
Other receivables 46,001 48,677
Finished and in process 80,573 86,515
Materials and supplies 94,083 83,338
Prepaid expenses 8,788 9,426
Current assets of discontinued operations 450,874 459,618
Property, plant and equipment, net of accumulated depreciation of $465,923 in 2024 and $480,416 in 2023 262,662 243,370
Property plant and equipment, accumulated depreciation 465,923 480,416
Goodwill 502,621 512,643
Other intangible assets, net of accumulated amortization of $206,437 in 2024 and $189,471 in 2023 103,593 127,113
Intangible assets, accumulated amortization 206,437 189,471
Long-term deferred income taxes 262 706
Right of use asset-operating leases 75,855 81,483
Other assets 19,317 18,794
Non-current assets of discontinued operations 964,310 984,109
Payable to suppliers 172,720 169,613
Accrued expenses and other 62,562 70,593
Notes payable and current portion of long-term debt 6,774 8,198
Current liabilities of discontinued operations 242,056 248,404
Long-term debt 29,850 37,866
Noncurrent operating lease liabilities 67,789 72,751
Pension and other postretirement benefits 0 116
Deferred income taxes 15,928 6,934
Other liabilities 344 473
Non-current liabilities of discontinued operations $ 113,911 $ 118,140
v3.25.0.1
Discontinued operations - Income Statement (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disposal Group, Including Discontinued Operations [Line Items]                      
Net income from discontinued operations $ 13,256 $ 19,817 $ 33,541 $ 29,761 $ 20,724 $ 19,112 $ 30,111 $ 26,310 $ 96,375 $ 96,257 $ 88,570
Net income from discontinued operations attributable to noncontrolling interests                 $ (171) $ (174) $ (259)
Weighted average common shares outstanding:                      
Basic (in shares) 98,700 98,683 98,671 98,498 98,349 98,337 98,325 98,167 98,637 98,294 97,991
Diluted (in shares) 98,700 99,267 99,241 99,159 99,164 98,912 98,872 98,615 99,290 98,890 98,732
Net income attributable to discontinued operations:                      
Basic (usd per share) $ 0.13 $ 0.20 $ 0.34 $ 0.30 $ 0.21 $ 0.19 $ 0.31 $ 0.27 $ 0.97 $ 0.98 $ 0.90
Diluted (usd per share) $ 0.13 $ 0.20 $ 0.34 $ 0.30 $ 0.21 $ 0.19 $ 0.30 $ 0.27 $ 0.97 $ 0.97 $ 0.89
Discontinued Operations, Held-for-Sale                      
Disposal Group, Including Discontinued Operations [Line Items]                      
Net sales                 $ 1,291,461 $ 1,339,866 $ 1,391,225
Cost of sales                 1,037,196 1,106,970 1,176,894
Gross profit                 254,265 232,896 214,331
Selling, general and administrative expenses                 122,488 97,131 97,762
Restructuring/Asset impairment charges                 3,740 9,024 4,525
Operating profit                 128,037 126,741 112,044
Interest expense                 13,396 1,293 790
Interest income                 1,668 357 94
Income from discontinued operations before income taxes                 116,309 125,805 111,348
Provision for income taxes                 19,934 29,548 22,778
Net income from discontinued operations                 96,375 96,257 88,570
Net income from discontinued operations attributable to noncontrolling interests                 (171) (174) (259)
Net income attributable to discontinued operations                 $ 96,204 $ 96,083 $ 88,311
Weighted average common shares outstanding:                      
Basic (in shares)                 98,637 98,294 97,991
Diluted (in shares)                 99,290 98,890 98,732
Net income attributable to discontinued operations:                      
Basic (usd per share)                 $ 0.97 $ 0.98 $ 0.90
Diluted (usd per share)                 $ 0.97 $ 0.97 $ 0.89
Discontinued Operations, Held-for-Sale | Thermoformed and Flexible Packaging business and its Global Trident business                      
Disposal Group, Including Discontinued Operations [Line Items]                      
Interest expense                 $ 9,528    
v3.25.0.1
Discontinued operations - Cash Flows Statement (Details) - Discontinued Operations, Held-for-Sale - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disposal Group, Including Discontinued Operations [Line Items]      
Depreciation, depletion and amortization $ 58,798 $ 58,959 $ 58,291
Capital expenditures $ (65,321) $ (55,624) $ (48,049)
v3.25.0.1
Acquisitions and divestitures - Acquisitions - Additional Information (Details)
$ in Thousands
3 Months Ended 12 Months Ended 16 Months Ended
Dec. 04, 2024
USD ($)
employee
country
manufacturing_facility
termLoanFacility
Jun. 01, 2024
USD ($)
Dec. 01, 2023
USD ($)
Sep. 08, 2023
USD ($)
Nov. 15, 2022
USD ($)
Aug. 31, 2022
USD ($)
Aug. 31, 2022
USD ($)
acquisition
Aug. 31, 2022
USD ($)
manufacturing_plant
Jan. 26, 2022
USD ($)
manufacturing_plant
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
acquisition
Dec. 31, 2022
USD ($)
acquisition
Dec. 31, 2024
USD ($)
Business Acquisition [Line Items]                            
Acquisition, integration, and divestiture-related costs                     $ 125,169 $ 24,624 $ 70,210  
Cash consideration, net of cash acquired                     3,793,569 372,616 1,427,020  
Goodwill                     2,525,657 1,298,011   $ 2,525,657
Cost of sales                            
Business Acquisition [Line Items]                            
Acquisition, integration, and divestiture-related costs                       $ 5,227 $ 33,155  
Platinum Equity                            
Business Acquisition [Line Items]                            
Joint venture, ownership (percent)                 51.00%          
Ball Corporation                            
Business Acquisition [Line Items]                            
Joint venture, ownership (percent)                 49.00%          
Industira Paranaense de Tubos Conicais LTDA                            
Business Acquisition [Line Items]                            
Asset purchase   $ 2,660                        
Eviosys                            
Business Acquisition [Line Items]                            
Total consideration $ 3,789,826                          
Approximate number of employees (employee) | employee 6,500                          
Number of manufacturing facilities | manufacturing_facility 44                          
Number of countries in which entity operates | country 17                          
Number of term loan facilities used in acquisition | termLoanFacility 2                          
Remeasurement loss $ 113,697                          
Payments for settlement of foreign currency forward contracts 34,414                          
Expected value of goodwill to be tax deductible                     0     0
Acquisition related costs                     272,303      
Property, plant and equipment                     1,057,779     1,057,779
Other intangible assets $ 1,967,678                   1,967,678     1,967,678
Goodwill                     1,285,518     1,285,518
Eviosys | Cost of sales                            
Business Acquisition [Line Items]                            
Acquisition, integration, and divestiture-related costs                     5,806      
2023 Acquisitions                            
Business Acquisition [Line Items]                            
Number of acquisitions | acquisition                       2    
Cash consideration, net of cash acquired                       $ 372,616    
Inapel                            
Business Acquisition [Line Items]                            
Total consideration     $ 64,390                      
Cash consideration, net of cash acquired     $ 59,228                      
Contingent purchase liability                   $ 2,340 2,333     2,333
Final working capital settlement                   $ 489        
RTS Packaging                            
Business Acquisition [Line Items]                            
Voting interest acquired       65.00%                    
Interest held in acquiree before subsequent acquisition (percent)       35.00%                    
Business combination, carrying value       $ 8,654                    
Business combination, net gain       44,029                    
Accumulated other comprehensive loss including foreign currency translation losses       2,033                    
Accumulated other comprehensive loss including define pension plan, before tax       4,756                    
RTS Packaging and Chattanooga Mill                            
Business Acquisition [Line Items]                            
Total consideration       374,547                    
Expected value of goodwill to be tax deductible                     83,000     83,000
Cash consideration, net of cash acquired       313,388                    
Final working capital settlement       452                    
Fair value of previously held interest in RTS Packaging       59,472                    
Property, plant and equipment       73,483             74,236     74,236
Other intangible assets       199,560             190,565     190,565
Goodwill       92,657             $ 107,566     107,566
Inventories                           $ (947)
Chattanooga Mill                            
Business Acquisition [Line Items]                            
Settlement of unfavorable contract       $ 7,086                    
2022 Acquisitions                            
Business Acquisition [Line Items]                            
Number of acquisitions | acquisition                         3  
Cash consideration, net of cash acquired                         $ 1,444,618  
Skjern                            
Business Acquisition [Line Items]                            
Total consideration         $ 89,610                  
Property, plant and equipment         40,489                  
Other intangible assets         39,330                  
Goodwill         32,194                  
Liabilities         $ (22,403)                  
Nordeste                            
Business Acquisition [Line Items]                            
Total consideration           $ 6,419                
Number of acquisitions             2 2            
Contingent purchase liability           2,486 $ 2,486 $ 2,486            
Property, plant and equipment           1,374 1,374 1,374            
Other intangible assets           3,031 3,031 3,031            
Goodwill           2,014 $ 2,014 $ 2,014            
Payments to acquire businesses, gross           $ 3,933                
Metalpack Packaging                            
Business Acquisition [Line Items]                            
Acquisition related costs                         28,171  
Cash consideration, net of cash acquired                 $ 1,348,589          
Number of facilities acquired | manufacturing_plant                 8          
Inventories                         $ 33,155  
v3.25.0.1
Acquisitions and divestitures - Schedule of Preliminary Fair Value Of Assets Acquired And Measurement Period Adjustments (Details) - USD ($)
$ in Thousands
16 Months Ended
Dec. 31, 2024
Dec. 04, 2024
Dec. 31, 2023
Sep. 08, 2023
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]        
Goodwill $ 2,525,657   $ 1,298,011  
Eviosys        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]        
Trade accounts receivable 300,385      
Other receivables 114,634      
Inventories 445,945      
Prepaid expenses 47,509      
Property, plant and equipment 1,057,779      
Right of use asset - operating leases 43,566      
Other intangible assets 1,967,678 $ 1,967,678    
Goodwill 1,285,518      
Long-term deferred income taxes 39,023      
Other assets 3,330      
Payable to suppliers (518,766)      
Accrued expenses and other (168,529)      
Accrued wages and other compensation 41,749      
Notes payable and current portion of long-term debt (76,438)      
Noncurrent operating lease liabilities (32,022)      
Pension and other postretirement benefits 51,849      
Deferred income taxes (599,941)      
Other long-term liabilities (16,714)      
Noncontrolling Interests (9,533)      
Net assets acquired 3,789,826      
RTS Packaging and Chattanooga Mill        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]        
Trade accounts receivable 17,488     $ 17,488
Inventories 19,262     20,209
Prepaid expenses 2,131     2,720
Property, plant and equipment 74,236     73,483
Right of use asset - operating leases 34,894     34,604
Other intangible assets 190,565     199,560
Goodwill 107,566     92,657
Other assets 2,053     2,465
Payable to suppliers (7,320)     (7,320)
Accrued expenses and other (12,461)     (12,436)
Accrued wages and other compensation 2,731     2,731
Notes payable and current portion of long-term debt (24)     (24)
Noncurrent operating lease liabilities (29,905)     (29,905)
Pension and other postretirement benefits 11,529     10,761
Long-term debt (1,942)     (1,942)
Deferred income taxes (5,921)     (3,419)
Other long-term liabilities (1,815)     (3,293)
Net assets acquired 374,547     $ 371,355
Measurement Period Adjustments        
Inventories (947)      
Prepaid expenses (589)      
Property, plant and equipment 753      
Right of use asset - operating leases 290      
Other intangible assets (8,995)      
Goodwill 14,909      
Other assets (412)      
Accrued expenses and other (25)      
Pension and other postretirement benefits (768)      
Deferred income taxes (2,502)      
Other long-term liabilities 1,478      
Net assets acquired $ 3,192      
v3.25.0.1
Acquisitions and divestitures - Pro Forma and Supplemental Information (Details) - USD ($)
$ in Thousands
1 Months Ended 11 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Eviosys          
Supplemental Information          
Net sales $ 115,031        
Net loss $ 15,086        
Pro Forma Supplemental Information          
Net sales     $ 7,546,920 $ 8,032,135  
Net income from continuing operations     159,926 112,963  
Net income attributable to Sonoco1     $ 255,800 $ 208,436  
Metalpack Packaging          
Supplemental Information          
Net sales   $ 1,035,020      
Net loss   $ 62,777      
Pro Forma Supplemental Information          
Net sales         $ 5,908,915
Net income from continuing operations         440,791
Net income attributable to Sonoco1         $ 528,818
v3.25.0.1
Acquisitions and divestitures - Summary of the Purchase Consideration Transferred for the Acquisitions (Details) - USD ($)
$ in Thousands
12 Months Ended
Sep. 08, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]        
Cash consideration, net of cash acquired   $ 3,793,569 $ 372,616 $ 1,427,020
RTS Packaging and Chattanooga Mill        
Business Acquisition [Line Items]        
Cash consideration, net of cash acquired $ 313,388      
Fair value of previously held interest in RTS Packaging 59,472      
Final working capital settlement 452      
Settlement of preexisting relationships 1,235      
Purchase consideration transferred $ 374,547      
v3.25.0.1
Acquisitions and divestitures - Divestitures - Additional Information (Details)
a in Thousands
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 23, 2024
USD ($)
Jul. 01, 2023
USD ($)
Mar. 29, 2023
USD ($)
a
Jan. 26, 2023
USD ($)
Nov. 30, 2024
USD ($)
productionFacility
Sep. 29, 2024
USD ($)
Jun. 30, 2024
USD ($)
Oct. 01, 2023
USD ($)
Jul. 02, 2023
USD ($)
Apr. 02, 2023
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 18, 2024
USD ($)
Apr. 01, 2024
USD ($)
Business Acquisition [Line Items]                                
Goodwill, impairment loss                       $ 0        
Pre-tax gain                       $ (23,452,000) $ 78,929,000 $ 0    
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]                       Pre-tax gain        
Dispositions                                
Business Acquisition [Line Items]                                
Number of production facilities | productionFacility         2                      
Consideration for disposal of business held for sale         $ 302,000                      
Reclassified cumulative translation losses         590,000                      
Asset write off         $ 25,607,000                      
Dispositions | Thermoformed and Flexible Packaging business and its Global Trident business                                
Business Acquisition [Line Items]                                
Consideration for disposal of business held for sale                             $ 1,800,000,000  
Dispositions | Black Diamond Capital Management LLC                                
Business Acquisition [Line Items]                                
Consideration for disposal of business held for sale                               $ 80,267,000
Write off of assets as part of the sale totaling             $ 905,000                  
Working capital adjustment           $ 1,805,000                    
Dispositions | Protective Solutions "Protexic"                                
Business Acquisition [Line Items]                                
Net assets disposed             74,644,000                  
Goodwill, impairment loss             16,559,000                  
Cumulative translation adjustment losses             2,913,000                  
Dispositions | US BulkSak Business                                
Business Acquisition [Line Items]                                
Consideration for disposal of business held for sale   $ 1,096,000                 $ 20,271,000   $ 20,271,000      
Net assets disposed   13,437,000                            
Goodwill, impairment loss   3,333,000                            
Write off of assets as part of the sale totaling   6,834,000           $ (537,000) $ 7,371,000              
Proceeds from the sale of business, net                     $ 18,271,000          
Restricted cash                       $ 2,000,000        
Pre-tax gain   $ 85,000                            
Dispositions | US BulkSak Business | Maximum                                
Business Acquisition [Line Items]                                
Funds held in escrow, term                       18 months        
Dispositions | Sonoco Sustainability Solutions                                
Business Acquisition [Line Items]                                
Goodwill, impairment loss                   $ 3,042,000            
Write off of assets as part of the sale totaling                   4,274,000            
Proceeds from the sale of business, net       $ 13,839,000                        
Restricted cash       1,500,000                        
Pre-tax gain                   $ 11,065,000            
Consideration from disposal, equity interest, value received             $ 1,250,000                  
Dispositions | Northstar                                
Business Acquisition [Line Items]                                
Proceeds from the sale of business, net $ 8,630,000                              
Pre-tax gain $ 3,630,000                              
Consideration from disposal, equity interest, value received       $ 5,000,000                        
Consideration from disposal, equity interest percentage received       2.70%                        
Dispositions | Timberland Properties                                
Business Acquisition [Line Items]                                
Proceeds from the sale of business, net     $ 70,802,000                          
Area of land | a     55                          
Disposed assets net book value                       $ 9,857,000        
Gain on the sale of business                       $ 60,945,000        
v3.25.0.1
Acquisitions and Divestitures - Additional Ownership Investment (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Mar. 31, 2024
Schedule of Equity Method Investments [Line Items]          
Interest income   $ 27,570 $ 10,026 $ 4,527  
Sustainable Protective Packaging Solutions          
Schedule of Equity Method Investments [Line Items]          
Percentage ownership in equity method investment (percent) 39.90%       20.50%
Payments to increase investment $ 10,000        
Interest income 145        
Investment in preferred stock   $ 21,212      
Fair value remeasurement, gain in investment 5,867        
Sustainable Protective Packaging Solutions | Preferred Stock          
Schedule of Equity Method Investments [Line Items]          
Increase in investment 18,512        
Increase in investment, fair value remeasurement 5,400        
Reclassification of convertible notes to preferred stock in investment 2,500        
Reclassification of convertible notes to preferred stock, fair value adjustment $ 467        
v3.25.0.1
Acquisitions and divestitures - Acquisition, Integration, and Divestiture-Related Costs (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Business Acquisition [Line Items]      
Acquisition, integration, and divestiture-related costs $ 125,169 $ 24,624 $ 70,210
Interest Expense      
Business Acquisition [Line Items]      
Acquisition, integration, and divestiture-related costs $ 33,569    
Cost of sales      
Business Acquisition [Line Items]      
Acquisition, integration, and divestiture-related costs   $ 5,227 $ 33,155
v3.25.0.1
Restructuring and asset impairment - Schedule of Restructuring and Restructuring-Related Asset Impairment Expenses by Type Incurred and by Reportable Segment (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges $ 65,370 $ 47,909 $ 42,290
Other asset impairments 0 0 10,095
Restructuring/Asset impairment charges 65,370 47,909 52,385
Operating segments | Consumer Packaging      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 19,259 4,111 8,207
Operating segments | Industrial Paper Packaging      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 33,923 38,754 15,598
Total Reportable Segments      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 1,434 2,547 (44)
Corporate      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 10,754 2,497 18,529
Severance and Termination Benefits      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 37,307 15,543 13,808
Restructuring/Asset impairment charges 37,307 15,543  
Asset Impairment/Disposal of Assets      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 15,719 24,415 9,182
Restructuring/Asset impairment charges 15,719 24,415  
Other Costs      
Restructuring Cost and Reserve [Line Items]      
Restructuring and restructuring-related asset impairment charges 12,344 7,951 $ 19,300
Restructuring/Asset impairment charges $ 12,344 $ 7,951  
v3.25.0.1
Restructuring and asset impairment - Schedule of Restructuring Accrual Activity (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restructuring Reserve [Roll Forward]      
Liability, beginning balance $ 9,136 $ 14,066  
2023/2024 Charges 65,370 47,909 $ 52,385
Cash (payments)/receipts (23,583) (28,432)  
Asset write downs/disposals (25,399) (24,415)  
Foreign currency translation (581) 8  
Liability, ending balance 24,943 9,136 14,066
Severance and Termination Benefits      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 8,864 12,780  
2023/2024 Charges 37,307 15,543  
Cash (payments)/receipts (21,653) (19,437)  
Asset write downs/disposals 0 0  
Foreign currency translation (484) (22)  
Liability, ending balance 24,034 8,864 12,780
Asset Impairment/Disposal of Assets      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 0 0  
2023/2024 Charges 15,719 24,415  
Cash (payments)/receipts 9,680 0  
Asset write downs/disposals (25,399) (24,415)  
Foreign currency translation 0 0  
Liability, ending balance 0 0 0
Other Costs      
Restructuring Reserve [Roll Forward]      
Liability, beginning balance 272 1,286  
2023/2024 Charges 12,344 7,951  
Cash (payments)/receipts (11,610) (8,995)  
Asset write downs/disposals 0 0  
Foreign currency translation (97) 30  
Liability, ending balance $ 909 $ 272 $ 1,286
v3.25.0.1
Restructuring and asset impairment - Additional Information (Details)
$ in Thousands
12 Months Ended
Jul. 01, 2022
USD ($)
Dec. 31, 2024
USD ($)
facility
employee
Dec. 31, 2023
USD ($)
position
Dec. 31, 2022
USD ($)
manufacturing_plant
Disposal Group, Including Discontinued Operations [Line Items]        
Future additional charges expected to be recognized   $ 3,000    
Other asset impairments   $ 0 $ 0 $ 10,095
Impact of new accounting pronouncements        
Disposal Group, Including Discontinued Operations [Line Items]        
Other asset impairments $ 3,747      
Industrial Paper Packaging        
Disposal Group, Including Discontinued Operations [Line Items]        
Number of small tube and core plants | manufacturing_plant       2
Organizational Effectiveness Efforts        
Disposal Group, Including Discontinued Operations [Line Items]        
Elimination of positions due to realignment of cost structure (position)   300 200  
Number of facilities closed | facility   2    
v3.25.0.1
Book cash overdrafts and cash pooling (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 431,010 $ 138,895
Outstanding A/P check    
Cash and Cash Equivalents [Line Items]    
Outstanding A/P checks 15,799 24,638
Outstanding Payroll Checks    
Cash and Cash Equivalents [Line Items]    
Outstanding A/P checks 162 0
Notional Pooling Arrangement    
Cash and Cash Equivalents [Line Items]    
Cash and cash equivalents $ 12,915 $ 1,308
v3.25.0.1
Property, plant and equipment - Summary of Property, Plant and Equipment (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Abstract]    
Land $ 314,278 $ 123,438
Buildings 967,237 660,001
Machinery and equipment 3,726,377 3,236,966
Construction in progress 337,796 225,660
Property, plant and equipment, gross 5,345,688 4,246,065
Accumulated depreciation and depletion (2,626,941) (2,583,298)
Property, plant and equipment, net $ 2,718,747 $ 1,662,767
v3.25.0.1
Property, plant and equipment - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Property, Plant and Equipment [Abstract]      
Depreciation and depletion expense $ 224,595 $ 202,917 $ 179,746
v3.25.0.1
Leases - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
option
Dec. 04, 2024
USD ($)
Dec. 31, 2023
Sep. 08, 2023
USD ($)
Dec. 31, 2022
Lessee, Lease, Description [Line Items]          
Number of renewal options | option 1        
Lease liability $ 311,383        
Weighted average remaining lease term 10 years 1 month 6 days   10 years   10 years 4 months 24 days
Weighted average discount rate 4.97%   5.07%   4.22%
Eviosys          
Lessee, Lease, Description [Line Items]          
Lease liability   $ 42,468      
Weighted average remaining lease term   8 years 1 month 6 days      
Weighted average discount rate   4.50%      
RTS Packaging and Chattanooga Mill          
Lessee, Lease, Description [Line Items]          
Lease liability       $ 34,604  
Weighted average remaining lease term       11 years 6 months  
Weighted average discount rate       6.40%  
Minimum          
Lessee, Lease, Description [Line Items]          
Lease renewal term 1 year        
Maximum          
Lessee, Lease, Description [Line Items]          
Lease renewal term 5 years        
v3.25.0.1
Leases - Schedule of Balance Sheet Location and Values of Company's Lease Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Leases [Abstract]    
Operating lease assets $ 307,688 $ 233,461
Finance lease assets 76,831 78,949
Total lease assets 384,519 312,410
Current operating lease liabilities 52,648 44,279
Current finance lease liabilities 22,284 17,268
Total current lease liabilities 74,932 61,547
Noncurrent operating lease liabilities 258,735 192,703
Noncurrent finance lease liabilities 45,344 55,341
Total noncurrent lease liabilities 304,079 248,044
Total lease liabilities $ 379,011 $ 309,591
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other Assets Other Assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued expenses and other Accrued expenses and other
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List] Notes payable and current portion of long-term debt Notes payable and current portion of long-term debt
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Long-term Debt Long-term Debt
v3.25.0.1
Leases - Schedule of Components of Company's Total Lease Costs and Other Lease Related Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Leases [Abstract]      
Operating lease cost $ 49,327 $ 43,524 $ 40,485
Amortization of lease asset 12,871 11,789 10,524
Interest on lease liabilities 3,711 3,912 4,023
Variable lease cost 31,404 32,016 20,317
Impairment charges 0 0 61
Total lease cost $ 97,313 $ 91,241 $ 75,410
v3.25.0.1
Leases - Schedule of Five-year Maturity of Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Operating Leases    
2025 $ 55,277  
2026 46,883  
2027 40,440  
2028 35,633  
2029 33,545  
Beyond 2029 183,690  
Total lease payments 395,468  
Less: Interest 84,085  
Operating lease liability 311,383  
Finance Leases    
2025 22,814  
2026 18,488  
2027 6,038  
2028 5,000  
2029 3,716  
Beyond 2029 20,795  
Total lease payments 76,851  
Less: Interest 9,223  
Finance lease obligations 67,628 $ 72,609
Total    
2025 78,091  
2026 65,371  
2027 46,478  
2028 40,633  
2029 37,261  
Beyond 2029 204,485  
Total lease payments 472,319  
Less: Interest 93,308  
Lease Liabilities $ 379,011  
v3.25.0.1
Leases - Schedule of Weighted Average Remaining Lease Terms, Discounts Rates and Other Lease Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Weighted-average remaining lease term (years):      
Operating leases 10 years 1 month 6 days 10 years 10 years 4 months 24 days
Finance leases 6 years 8 months 12 days 7 years 1 month 6 days 7 years 8 months 12 days
Weighted-average discount rate:      
Operating leases 4.97% 5.07% 4.22%
Finance leases 5.16% 5.27% 5.29%
Cash paid for amounts included in the measurement of lease liabilities:      
Operating cash flows used by operating leases $ 48,380 $ 43,638 $ 40,595
Operating cash flows used by finance leases 3,711 3,912 4,023
Financing cash flows used by finance leases 15,433 14,617 11,090
Leased assets obtained in exchange for new operating lease liabilities 66,585 18,225 32,860
Leased assets obtained in exchange for new finance lease liabilities 11,925 7,755 9,349
Modification to leased assets for increase in operating lease liabilities 37,731 4,431 1,215
Modification to leased assets for increase/(decrease) in finance lease liabilities 53 18 (841)
Termination reclasses to decrease operating lease assets 5,765 5,702 (3,695)
Termination reclasses to decrease operating lease liabilities 5,768 6,063 (4,015)
Termination reclasses to decrease finance lease assets 270 1,429 (44)
Termination reclasses to decrease finance lease liabilities $ 271 $ 482 $ (44)
v3.25.0.1
Goodwill and other intangible assets - Changes in Goodwill by Segment (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
Goodwill [Roll Forward]  
Balance as of January 1, 2024 $ 1,298,011
Acquisitions 1,285,518
Divestitures (16,559)
Foreign currency translation (41,313)
Balance as of December 31, 2024 2,525,657
Total Reportable Segments  
Goodwill [Roll Forward]  
Balance as of January 1, 2024 248,007
Acquisitions 0
Divestitures (16,559)
Foreign currency translation (398)
Balance as of December 31, 2024 231,050
Consumer Packaging | Operating segments  
Goodwill [Roll Forward]  
Balance as of January 1, 2024 543,598
Acquisitions 1,285,518
Divestitures 0
Foreign currency translation (21,145)
Balance as of December 31, 2024 1,807,971
Industrial Paper Packaging | Operating segments  
Goodwill [Roll Forward]  
Balance as of January 1, 2024 506,406
Acquisitions 0
Divestitures 0
Foreign currency translation (19,770)
Balance as of December 31, 2024 $ 486,636
v3.25.0.1
Goodwill and other intangible assets - Additional Information (Details) - USD ($)
12 Months Ended
Dec. 04, 2024
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Sep. 29, 2024
Goodwill [Line Items]          
Goodwill, impairment loss   $ 0      
Goodwill   2,525,657,000 $ 1,298,011,000    
Indefinite-lived intangible assets   0      
Aggregate amortization expenses   78,595,000 $ 67,323,000 $ 60,263,000  
Amortization expense on other intangible assets in 2025   173,400,000      
Amortization expense on other intangible assets in 2026   171,600,000      
Amortization expense on other intangible assets in 2027   170,300,000      
Amortization expense on other intangible assets in 2028   169,700,000      
Amortization expense on other intangible assets in 2029   $ 167,200,000      
Minimum          
Goodwill [Line Items]          
Useful lives of intangible asset   3 years      
Minimum | Other          
Goodwill [Line Items]          
Useful lives of intangible asset   3 years      
Maximum          
Goodwill [Line Items]          
Useful lives of intangible asset   40 years      
Maximum | Other          
Goodwill [Line Items]          
Useful lives of intangible asset   40 years      
Protective Solutions "Protexic"          
Goodwill [Line Items]          
Decrease in accumulated amortization   $ 54,860,000      
Decrease in other intangible assets   54,860,000      
Eviosys          
Goodwill [Line Items]          
Goodwill   1,285,518,000      
Other intangible assets $ 1,967,678,000 1,967,678,000      
Weighted average useful life 18 years 10 months 24 days        
Plastics - Medical reporting unit          
Goodwill [Line Items]          
Goodwill   63,575,000      
Excess of fair value of reporting unit over carrying value (percent)         18.70%
Plastics - Medical reporting unit | Discount Rate          
Goodwill [Line Items]          
Discount rate (percent)         11.50%
Change necessary in order for estimated fair value to fall below carrying value (percent)         13.80%
Plastics - Food Reporting Unit          
Goodwill [Line Items]          
Goodwill   198,807,000      
Excess of fair value of reporting unit over carrying value (percent)         18.90%
Plastics - Food Reporting Unit | Discount Rate          
Goodwill [Line Items]          
Discount rate (percent)         10.50%
Change necessary in order for estimated fair value to fall below carrying value (percent)         12.40%
Metal Packaging Reporting Unit          
Goodwill [Line Items]          
Goodwill   $ 384,315,000      
Excess of fair value of reporting unit over carrying value (percent)         12.60%
Metal Packaging Reporting Unit | Discount Rate          
Goodwill [Line Items]          
Discount rate (percent)         11.00%
Change necessary in order for estimated fair value to fall below carrying value (percent)         12.10%
v3.25.0.1
Goodwill and other intangible assets - Summary of Other Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross $ 2,976,211 $ 1,101,018
Total Accumulated Amortization (389,513) (374,461)
Other Intangible Assets, Net 2,586,698 726,557
Patents    
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross 28,941 23,970
Total Accumulated Amortization (15,955) (14,215)
Customer lists    
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross 2,679,372 995,077
Total Accumulated Amortization (332,680) (328,895)
Trade names    
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross 38,623 27,108
Total Accumulated Amortization (13,239) (8,327)
Proprietary technology    
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross 226,936 48,657
Total Accumulated Amortization (26,203) (20,813)
Other    
Other Intangible Assets, Gross:    
Total Other Intangible Assets, Gross 2,339 6,206
Total Accumulated Amortization $ (1,436) $ (2,211)
v3.25.0.1
Supply chain financing (Details) - USD ($)
$ in Thousands
1 Months Ended 12 Months Ended
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Supplier Finance Program, Obligation [Roll Forward]      
Confirmed obligations outstanding at the beginning of the year   $ 24,779  
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Payable to suppliers Payable to suppliers Payable to suppliers
Invoices confirmed during the year   $ 96,785  
Confirmed invoices paid during the year   (93,068)  
Confirmed obligations outstanding at the end of the year $ 28,496 $ 28,496  
Supplier Finance Program, Obligation, Statement of Financial Position [Extensible Enumeration] Payable to suppliers Payable to suppliers Payable to suppliers
Eviosys      
Supplier Finance Program, Obligation [Roll Forward]      
Invoices confirmed during the year $ 7,547    
v3.25.0.1
Debt - Schedule of Debt (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Debt Instrument [Line Items]    
Finance lease obligations $ 67,628 $ 72,609
Total debt 7,040,021 3,036,936
Less: Notes payable and current portion of long-term debt (2,054,525) (38,934)
Long-term Debt 4,985,496 2,998,002
364-Day term loan due December 2025    
Debt Instrument [Line Items]    
Debt 1,493,568 0
Term loan due December 2026    
Debt Instrument [Line Items]    
Debt 698,167 0
Syndicated term loan due August 2028    
Debt Instrument [Line Items]    
Debt $ 497,674 572,025
1.80% notes due February 2025    
Debt Instrument [Line Items]    
Stated interest rate (percent) 1.80%  
Debt $ 399,933 399,149
4.450% notes due September 2026    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.45%  
Debt $ 496,869 0
2.25% notes due February 2027    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.25%  
Debt $ 298,930 298,421
4.600% notes due September 2029    
Debt Instrument [Line Items]    
Stated interest rate (percent) 4.60%  
Debt $ 594,519 0
3.125% notes due May 2030    
Debt Instrument [Line Items]    
Stated interest rate (percent) 3.125%  
Debt $ 596,958 596,480
2.85% notes due February 2032    
Debt Instrument [Line Items]    
Stated interest rate (percent) 2.85%  
Debt $ 496,302 495,785
5.000% notes due September 2034    
Debt Instrument [Line Items]    
Stated interest rate (percent) 5.00%  
Debt $ 689,802 0
5.75% notes due November 2040    
Debt Instrument [Line Items]    
Stated interest rate (percent) 5.75%  
Debt $ 536,282 $ 536,246
Other foreign denominated debt, average rate of 6.0% in 2024 and 8.8% in 2023    
Debt Instrument [Line Items]    
Weighted average interest rate (percent) 6.00% 8.80%
Debt $ 155,048 $ 49,418
Other debt    
Debt Instrument [Line Items]    
Debt $ 18,341 $ 16,803
v3.25.0.1
Debt - Additional Information (Details) - USD ($)
1 Months Ended 12 Months Ended
Dec. 04, 2024
Sep. 16, 2024
Jul. 12, 2024
Jun. 22, 2024
May 03, 2024
Sep. 08, 2023
Aug. 07, 2023
Jun. 30, 2021
Dec. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Sep. 19, 2024
May 02, 2024
Line of Credit Facility [Line Items]                          
Committed availability under credit facilities                 $ 179,660,000 $ 179,660,000      
Less: Notes payable and current portion of long-term debt                 (2,054,525,000) (2,054,525,000) $ (38,934,000)    
Cash and cash equivalents on hand, including discontinued operations                 443,060,000 443,060,000      
Revolving Credit Facility                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity         $ 1,250,000,000               $ 350,000,000
Debt term         5 years                
Committed availability under credit facilities                 1,250,000,000 1,250,000,000      
Revolving Credit Facility | LIBOR                          
Line of Credit Facility [Line Items]                          
Basis points (percent)               1.375%          
Unsecured Debt                          
Line of Credit Facility [Line Items]                          
Face amount                       $ 1,800,000,000  
Debt                       $ 1,779,910,000  
Syndicated term loan due August 2028                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity             $ 900,000,000            
Proceeds from lines of credit           $ 270,000,000 $ 600,000,000            
Repayments of credit facility                   75,000,000 295,000,000    
Debt                 497,674,000 497,674,000 572,025,000    
Syndicated term loan due August 2028 | SOFR                          
Line of Credit Facility [Line Items]                          
Basis points, adjustment (percent)             0.10%            
Basis points (percent)             1.90%            
Commercial paper, average rate of 0.00% in 2024                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity         $ 1,250,000,000               $ 750,000,000
Line of credit facility, Increase in commitment         $ 500,000,000                
Debt                 0 0      
Other foreign denominated debt, average rate of 6.0% in 2024 and 8.8% in 2023                          
Line of Credit Facility [Line Items]                          
Debt                 155,048,000 155,048,000 49,418,000    
1.80% notes due February 2025                          
Line of Credit Facility [Line Items]                          
Debt                 $ 399,933,000 $ 399,933,000 $ 399,149,000    
Stated interest rate (percent)                 1.80% 1.80%      
Eviosys                          
Line of Credit Facility [Line Items]                          
Trade receivables sold and derecognized $ 73,487,000                        
Eviosys | Bridge Loan | Senior Unsecured Bridge Term Loan Facility                          
Line of Credit Facility [Line Items]                          
Debt issuance costs                 $ 19,000,000 $ 19,000,000      
Eviosys | Term Loan Agreement | Line of Credit                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity     $ 700,000,000                    
Basis points, adjustment (percent)     0.10%                    
Eviosys | 364-Day Term Credit Agreement                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity   $ 1,500,000,000                      
Debt term   364 days   364 days                  
Eviosys | 364-Day Term Credit Agreement | Bridge Loan | Senior Unsecured Bridge Term Loan Facility                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity       $ 4,000,000,000                  
Eviosys | Other foreign denominated debt, average rate of 6.0% in 2024 and 8.8% in 2023                          
Line of Credit Facility [Line Items]                          
Trade receivables sold and derecognized                 $ 73,487,000        
v3.25.0.1
Debt - Debt Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Sep. 19, 2024
Dec. 31, 2023
Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount   $ 1,800,000  
Issuance Costs and Discounts   (20,090)  
Net Proceeds   1,779,910  
2026 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 496,869   $ 0
Interest Rate 4.45%    
2026 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount   500,000  
Issuance Costs and Discounts   (3,697)  
Net Proceeds   $ 496,303  
Interest Rate   4.45%  
2029 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 594,519   0
Interest Rate 4.60%    
2029 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount   $ 600,000  
Issuance Costs and Discounts   (5,851)  
Net Proceeds   $ 594,149  
Interest Rate   4.60%  
2034 Notes      
Line of Credit Facility [Line Items]      
Net Proceeds $ 689,802   $ 0
Interest Rate 5.00%    
2034 Notes | Unsecured Debt      
Line of Credit Facility [Line Items]      
Principal Amount   $ 700,000  
Issuance Costs and Discounts   (10,542)  
Net Proceeds   $ 689,458  
Interest Rate   5.00%  
v3.25.0.1
Debt - Maturities (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Debt Disclosure [Abstract]  
2025 $ 2,054,525
2026 1,218,544
2027 310,533
2028 508,115
2029 $ 598,367
v3.25.0.1
Financial instruments and derivatives - Carrying Amounts and Fair Values of Financial Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Carrying Amount    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Long-term debt, net of current portion $ 4,985,496 $ 2,998,002
Fair Value    
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Long-term debt, net of current portion $ 4,800,455 $ 2,852,143
v3.25.0.1
Financial instruments and derivatives - Additional Information (Details)
$ in Thousands, MMBTU in Millions
12 Months Ended
Sep. 17, 2024
USD ($)
Apr. 15, 2024
USD ($)
Dec. 31, 2024
USD ($)
MMBTU
t
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Aug. 29, 2024
USD ($)
bank
Apr. 30, 2024
USD ($)
Derivative [Line Items]              
Other comprehensive loss     $ (136,849) $ 63,391 $ (70,198)    
Loss on settlement of derivative $ (11,088)            
Total fair value of other derivatives not designated as hedging instruments     (2,694) (6,790)      
Cash Flow Hedges | Derivatives designated as hedging instruments:              
Derivative [Line Items]              
Price risk cash flow hedge derivative, at fair value, net     652 (41)      
Commodity loss expected to be reclassified to the income statement during the next 12 months     652        
Fair value of foreign currency cash flow hedges, gain     (1,841) 1,502      
Foreign currency gain (loss) expected to be reclassified to the income statement during the next 12 months     $ (1,841)        
Net investment hedge | Derivatives designated as hedging instruments: | Currency Swap              
Derivative [Line Items]              
Received a cash settlement   $ 9,068          
Foreign currency translation gain   $ 3,143          
Natural gas swaps | Derivatives not designated as hedging instruments:              
Derivative [Line Items]              
Anticipated usage percentage covered by a swap contract for the next fiscal year (percent)     0.755        
Approximate amount of commodity covered by swap contracts outstanding (btu) | MMBTU     5.2        
Natural gas swaps | Cash Flow Hedges | Derivatives designated as hedging instruments:              
Derivative [Line Items]              
Approximate amount of commodity covered by swap contracts outstanding (tonne) | t     3,546        
Aluminum Swaps | Cash Flow Hedges | Derivatives designated as hedging instruments:              
Derivative [Line Items]              
Anticipated usage percentage covered by a swap contract for the next fiscal year (percent)     0.24        
Currency Swap | Net investment hedge              
Derivative [Line Items]              
Notional amount     $ 1,500,000 500,000     $ 500,000
Loss on derivative used in net investment hedge, after tax     11,919 (5,073)      
Other comprehensive loss     8,880 (3,779)      
Net investment hedges, tax     3,039 $ (1,294)      
Currency Swap Maturing September 1, 2026 | Net investment hedge              
Derivative [Line Items]              
Notional amount     500,000        
Currency Swap Maturing September 1, 2029 | Net investment hedge              
Derivative [Line Items]              
Notional amount     500,000        
Currency Swap Maturing May 1, 2030 | Net investment hedge              
Derivative [Line Items]              
Notional amount     $ 500,000        
Treasury Lock              
Derivative [Line Items]              
Notional amount           $ 900,000  
Number of banks | bank           11  
v3.25.0.1
Financial instruments and derivatives - Net Positions of Foreign Contracts (Details) - Dec. 31, 2024 - Cash Flow Hedges - Derivatives designated as hedging instruments:
₺ in Thousands, € in Thousands, ฿ in Thousands, £ in Thousands, zł in Thousands, kr in Thousands, kr in Thousands, Kč in Thousands, Ft in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
COP ($)
MXN ($)
PLN (zł)
DKK (kr)
SEK (kr)
CZK (Kč)
CAD ($)
EUR (€)
TRY (₺)
GBP (£)
THB (฿)
HUF (Ft)
USD Contracts                        
Derivative [Line Items]                        
Net purchase/(sell) position of derivatives $ 26,917,468 $ 373,569 zł 121,377 kr 161,128   Kč 110,834 $ 11,045 € 3,499 ₺ 104,546      
Net sell position of derivatives         kr (6,709)         £ (5,388)    
Euro Contracts                        
Derivative [Line Items]                        
Net purchase/(sell) position of derivatives               € 40,670   £ 30,724 ฿ 620,976  
Net sell position of derivatives                       Ft (5,560,396)
v3.25.0.1
Financial instruments and derivatives - Net Positions of Foreign Contracts Non-Designated Derivatives (Details) - Dec. 31, 2024 - purchase - Derivatives not designated as hedging instruments:
₺ in Thousands, ฿ in Thousands, £ in Thousands, zł in Thousands, Rp in Thousands, $ in Thousands, $ in Thousands, $ in Thousands
COP ($)
MXN ($)
PLN (zł)
CAD ($)
TRY (₺)
GBP (£)
THB (฿)
IDR (Rp)
USD Contracts                
Derivative [Line Items]                
Notional amount $ 66,306,243 $ 339,381   $ 7,262 ₺ 7,875     Rp 20,247,238
Euro Contracts                
Derivative [Line Items]                
Notional amount     zł 34,451     £ 74,214 ฿ 410,488  
v3.25.0.1
Financial instruments and derivatives - Location and Fair Values of Derivative Instruments (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Derivatives designated as hedging instruments: | Commodity Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets $ 671 $ 67
Derivatives designated as hedging instruments: | Commodity Contracts | Accrued expenses and other    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (19) (108)
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 2,068 2,525
Derivatives designated as hedging instruments: | Foreign Exchange Contracts | Accrued expenses and other    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (3,909) (1,024)
Derivatives designated as hedging instruments: | Net investment hedge | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 26,833 5,567
Derivatives designated as hedging instruments: | Net investment hedge | Other assets    
Derivatives, Fair Value [Line Items]    
Derivatives assets 1,845 0
Derivatives designated as hedging instruments: | Net investment hedge | Other liabilities    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (16,759) (10,640)
Derivatives not designated as hedging instruments: | Commodity Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets 961 12
Derivatives not designated as hedging instruments: | Commodity Contracts | Accrued expenses and other    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities (574) (6,782)
Derivatives not designated as hedging instruments: | Foreign Exchange Contracts | Prepaid expenses    
Derivatives, Fair Value [Line Items]    
Derivatives assets (59) 130
Derivatives not designated as hedging instruments: | Foreign Exchange Contracts | Accrued expenses and other    
Derivatives, Fair Value [Line Items]    
Derivatives liabilities $ (3,022) $ (159)
v3.25.0.1
Financial instruments and derivatives - Effect of Derivative Instruments on Financial Performance (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized $ 7,225 $ 1,912 $ (8,767)
Foreign Exchange Contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivatives (4,994) 8,982  
Foreign Exchange Contracts | Derivatives not designated as hedging instruments:      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized (8,168) 7,560  
Foreign Exchange Contracts | Net sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI Into Income (1,174) 10,860  
Foreign Exchange Contracts | Cost of sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI Into Income (253) (3,728)  
Commodity Contracts      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Recognized in OCI on Derivatives 665 99  
Commodity Contracts | Derivatives not designated as hedging instruments:      
Derivative Instruments, Gain (Loss) [Line Items]      
Gain or (Loss) Recognized (2,976) (19,087)  
Commodity Contracts | Cost of sales      
Derivative Instruments, Gain (Loss) [Line Items]      
Amount of Gain or (Loss) Reclassified from Accumulated OCI Into Income $ (28) $ (32)  
v3.25.0.1
Financial instruments and derivatives - Reclassification of Gains and Losses (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Sales from external customers $ 5,001,044 $ 4,952,154 $ 5,384,560
Cost of sales (4,166,132) (4,238,857) $ (4,634,009)
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Sales from external customers (1,174) 10,860  
Cost of sales (281) (3,760)  
Foreign Exchange Contracts | Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Sales from external customers (1,174) 10,860  
Cost of sales (253) (3,728)  
Commodity Contracts | Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]      
Sales from external customers 0 0  
Cost of sales $ (28) $ (32)  
v3.25.0.1
Fair value measurements - Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets $ 304,000 $ 308,800
Common Collective    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 13,259 12,958
Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 43,059 45,931
Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 235,952 242,702
Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 3,493 4,175
Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 480 400
Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 7,757 2,634
Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 76,197 77,207
Assets measured at NAV | Common Collective    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 13,259 12,958
Assets measured at NAV | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Assets measured at NAV | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 62,458 63,849
Assets measured at NAV | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Assets measured at NAV | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 480 400
Assets measured at NAV | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 7,757 2,634
Level 1 | Common Collective    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 1 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 7,757 2,634
Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 220,046 228,959
Level 2 | Common Collective    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 2 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 43,059 45,931
Level 2 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 173,494 178,853
Level 2 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 3,493 4,175
Level 2 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 2 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Common Collective    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Mutual funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Fixed income securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Short-term investments    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Real estate funds    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Level 3 | Cash and accrued income    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total postretirement benefit plan assets 0 0
Net investment hedge | Fair Value, Recurring | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 11,919 (5,073)
Net investment hedge | Fair Value, Recurring | Hedge derivatives, net: | Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Net investment hedge | Fair Value, Recurring | Hedge derivatives, net: | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Net investment hedge | Fair Value, Recurring | Hedge derivatives, net: | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 11,919 (5,073)
Net investment hedge | Fair Value, Recurring | Hedge derivatives, net: | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 652 (41)
Commodity Contracts | Fair Value, Recurring | Hedge derivatives, net: | Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 652 (41)
Commodity Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 387 (6,770)
Commodity Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Commodity Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 387 (6,770)
Commodity Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (1,841) 1,502
Foreign Exchange Contracts | Fair Value, Recurring | Hedge derivatives, net: | Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (1,841) 1,502
Foreign Exchange Contracts | Fair Value, Recurring | Hedge derivatives, net: | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Non-hedge derivatives, net:    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (3,081) (29)
Foreign Exchange Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Assets measured at NAV    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative 0 0
Foreign Exchange Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative (3,081) (29)
Foreign Exchange Contracts | Fair Value, Recurring | Non-hedge derivatives, net: | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net position of derivative $ 0 $ 0
v3.25.0.1
Fair value measurements - Additional Information (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Percentage of postretirement benefit plan assets comprised of pension plan assets (more than) 96.00%
Level 2 | Fair Value, Recurring  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Investment in preferred stock $ 21,212
v3.25.0.1
Share-based compensation plans - Additional Information (Details)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2024
USD ($)
installment
$ / shares
shares
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for grant (in shares) | shares 2,224,042    
Compensation cost for share-based payment arrangements $ 26,948 $ 24,738 $ 28,302
Related tax benefit recognized in net income 6,852 6,162 7,231
Additional net excess tax benefit realized $ 257 $ 978 $ 1,367
2024 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Capital shares reserved for future issuance (in shares) | shares 2,900,000    
Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 52.41    
Vested units in period (in shares) | shares 0    
Performance Contingent Restricted Stock Units (PCSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 3 years    
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 50.54 $ 55.04 $ 51.94
Noncash stock-based compensation associated performance contingent restricted stock units $ 10,176 $ 9,826 $ 16,686
Total unrecognized compensation cost related to nonvested awards $ 7,873    
Weighted-average period 21 months    
Performance period 3 years    
Stock return payout percentage 0.20    
Vested units in period (in shares) | shares 0    
Performance Contingent Restricted Stock Units (PCSUs) | 2024 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Performance period 3 years    
Stock return payout percentage 0.20    
Total performance contingent restricted stock units vested , minimum (in shares) | shares 0    
Total performance contingent restricted stock units, maximum (in shares) | shares 517,066    
Performance Contingent Restricted Stock Units (PCSUs) | 2023 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Performance period   3 years  
Stock return payout percentage   0.20  
Total performance contingent restricted stock units vested , minimum (in shares) | shares   0  
Total performance contingent restricted stock units, maximum (in shares) | shares   410,100  
Performance Contingent Restricted Stock Units (PCSUs) | 2022 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units $ 16,164    
Total performance contingent restricted stock units, maximum (in shares) | shares 330,888    
Performance Contingent Restricted Stock Units (PCSUs) | 2021 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units   $ 12,600  
Vested units in period (in shares) | shares   225,530  
Performance Contingent Restricted Stock Units (PCSUs) | 2020 PCSU      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Fair value of vested units     $ 17,052
Vested units in period (in shares) | shares     280,881
Performance Contingent Restricted Stock Units (PCSUs) | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 25.00%    
Performance Contingent Restricted Stock Units (PCSUs) | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 75.00%    
Deferred Compensation Plans      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation deferrals in current year $ 2,024 $ 2,024 $ 2,256
Stock Appreciation Rights (SARs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Compensation cost for share-based payment arrangements   0 40
Total unrecognized compensation cost related to nonvested awards $ 0    
Vesting percentage 33.33%    
Weighted average remaining contractual life for SAR's, outstanding 4 years 2 months 12 days    
Aggregate intrinsic value of options and SARs exercised $ 74 $ 158 $ 582
Aggregate intrinsic value for SAR's, outstanding $ 376    
Fair market value of the Company’s stock used to calculate intrinsic value (usd per share) | $ / shares $ 48.85    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 3 years    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executive Officers and Key Management Employees | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs)      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Minimum vesting period 5 years    
Granted, weighted-average grant date fair value (usd per share) | $ / shares $ 52.41 $ 56.87 $ 53.55
Fair value of vested units $ 13,190 $ 10,320 $ 6,243
Noncash stock-based compensation associated performance contingent restricted stock units 14,748 $ 12,888 $ 9,320
Total unrecognized compensation cost related to nonvested awards $ 11,657    
Weighted-average period 24 months    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Four      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Executives and Directors | Restricted Stock Units (RSUs) | Share-based Compensation Award, Tranche Five      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting percentage 33.33%    
Non-employee directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche One      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 1    
Non-employee directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche Two      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 3    
Non-employee directors | Deferred Compensation Plans | Share-based Compensation Award, Tranche Three      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of annual distribution installments | installment 5    
v3.25.0.1
Share-based compensation plans - Activity Related to PCSUs, Restricted Stock Units and Deferred Compensation Plans (Details) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Restricted Stock Units (RSUs)      
Number of Shares      
Beginning Balance (in shares) 662,260    
Granted (in shares) 383,708    
Vested (in shares) 0    
Converted (in shares) (231,157)    
Cancelled (in shares) (62,103)    
Dividend equivalents (in shares) 4,488    
Ending Balance (in shares) 757,196 662,260  
Average Grant Date Fair Value per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 54.71    
Granted, weighted-average grant date fair value (usd per share) 52.41    
Converted, weighted-average grant date fair value (usd per share) 55.27    
Cancelled, weighted-average grant date fair value (usd per share) 54.06    
Dividend equivalents, weighted-average grant date fair value (usd per share) 55.42    
Ending Balance, weighted-average grant date fair value (usd per share) $ 53.43 $ 54.71  
Restricted Stock Units (RSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 593,445    
Granted (in shares) 383,708    
Vested (in shares) 234,610    
Converted (in shares)    
Cancelled (in shares) (62,103)    
Dividend equivalents (in shares) 1,176    
Ending Balance (in shares) 681,616 593,445  
Restricted Stock Units (RSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 68,815    
Granted (in shares) 0    
Vested (in shares) 234,610    
Converted (in shares) (231,157)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 3,312    
Ending Balance (in shares) 75,580 68,815  
Performance Contingent Restricted Stock Units (PCSUs)      
Number of Shares      
Beginning Balance (in shares) 654,895    
Granted (in shares) 253,176    
Performance adjustments (in shares) (21,184)    
Vested (in shares) 0    
Converted (in shares) (217,966)    
Cancelled (in shares) (35,832)    
Dividend equivalents (in shares) 667    
Ending Balance (in shares) 633,756 654,895  
Average Grant Date Fair Value per Share      
Beginning Balance, weighted-average grant date fair value (usd per share) $ 53.51    
Granted, weighted-average grant date fair value (usd per share) 50.54 $ 55.04 $ 51.94
Performance adjustments, weighted-average grant date fair value (usd per share) 41.05    
Converted, weighted-average grant date fair value (usd per share) 55.48    
Cancelled, weighted-average grant date fair value (usd per share) 52.32    
Dividend equivalents, weighted-average grant date fair value (usd per share) 55.40    
Ending Balance, weighted-average grant date fair value (usd per share) $ 52.13 $ 53.51  
Performance Contingent Restricted Stock Units (PCSUs) | Nonvested      
Number of Shares      
Beginning Balance (in shares) 418,403    
Granted (in shares) 253,176    
Performance adjustments (in shares) (21,184)    
Vested (in shares) 330,888    
Converted (in shares) 0    
Cancelled (in shares) (35,832)    
Dividend equivalents (in shares) 0    
Ending Balance (in shares) 283,675 418,403  
Performance Contingent Restricted Stock Units (PCSUs) | Vested      
Number of Shares      
Beginning Balance (in shares) 236,492    
Granted (in shares) 0    
Performance adjustments (in shares) 0    
Vested (in shares) 330,888    
Converted (in shares) (217,966)    
Cancelled (in shares) 0    
Dividend equivalents (in shares) 667    
Ending Balance (in shares) 350,081 236,492  
Deferred Compensation Plans      
Number of Shares      
Beginning Balance (in shares) 324,602    
Deferred (in shares) 34,113    
Converted (in shares) (8,541)    
Dividend equivalents (in shares) 11,249    
Ending Balance (in shares) 361,423 324,602  
v3.25.0.1
Share-based compensation plans - Company's SARs (Details) - Stock Appreciation Rights (SARs) - $ / shares
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Number of Shares      
Beginning Balance (in shares) 729,515    
Vested (in shares) 0    
Granted (in shares) 0    
Exercised (in shares) (47,180)    
Forfeited/Expired (in shares) (18,931)    
Ending Balance (in shares) 663,404 729,515  
Exercisable (in shares) 663,404    
Average Grant Date Fair Value Per Share      
Beginning Balance, weighted-average exercise price (usd per share) $ 55.13    
Vested, weighted-average exercise price (usd per share) 0    
Granted, weighted-average exercise price (usd per share) 0    
Exercised, weighted-average exercise price (usd per share) 47.28    
Forfeited/Expired, weighted average exercise price (usd per share) 57.41    
Ending Balance, weighted average exercise price (usd per share) 55.62 $ 55.13  
Exercisable, weighted-average exercise price (usd per share) $ 55.62    
Nonvested      
Number of Shares      
Beginning Balance (in shares) 0    
Vested (in shares) 0    
Granted (in shares) 0 0 0
Exercised (in shares) 0    
Forfeited/Expired (in shares) 0    
Ending Balance (in shares) 0 0  
Exercisable (in shares) 0    
Vested      
Number of Shares      
Beginning Balance (in shares) 729,515    
Vested (in shares) 0    
Granted (in shares) 0    
Exercised (in shares) (47,180)    
Forfeited/Expired (in shares) (18,931)    
Ending Balance (in shares) 663,404 729,515  
Exercisable (in shares) 663,404    
v3.25.0.1
Employee benefit plans - Components of Net Periodic Benefit Cost (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Retirement Plans      
Defined Benefit Plan Disclosure [Line Items]      
Service cost $ 3,456 $ 2,878 $ 3,266
Interest cost 19,097 18,101 10,562
Expected return on plan assets (11,133) (9,451) (10,302)
Amortization of prior service cost / (credit) 864 926 913
Amortization of net actuarial gain (loss) 4,472 4,300 6,240
Effect of settlement loss 530 1,010 479
Effect of curtailment loss 0 0 43
Net periodic benefit cost/(income) 17,286 17,764 11,201
Retiree Health and Life Insurance Plans      
Defined Benefit Plan Disclosure [Line Items]      
Service cost 178 230 320
Interest cost 919 507 258
Expected return on plan assets (392) (313) (439)
Amortization of prior service cost / (credit) 385 0 0
Amortization of net actuarial gain (loss) (899) (768) (681)
Net periodic benefit cost/(income) $ 191 $ (344) $ (542)
v3.25.0.1
Employee benefit plans - Plans' Obligation and Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Change in Plan Assets      
Fair value of plan assets at January 1 $ 308,800    
Fair value of plan assets at December 31 304,000 $ 308,800  
Retirement Plans      
Change in Benefit Obligation      
Benefit obligation at January 1 413,340 352,767  
Service cost 3,456 2,878 $ 3,266
Interest cost 19,097 18,101 10,562
Plan participant contributions 31 60  
Plan amendments 615 306  
Actuarial (gain)/loss (18,935) 15,663  
Benefits paid (28,263) (26,703)  
Impact of foreign exchange rates (8,926) 8,707  
Effect of settlements (2,218) (2,373)  
Effect of curtailments 0 0  
Acquisitions 74,078 43,934  
Benefit obligation at December 31 452,275 413,340 352,767
Change in Plan Assets      
Fair value of plan assets at January 1 295,587 253,125  
Actual return on plan assets (5,203) 15,968  
Company contributions 18,798 13,908  
Plan participant contributions 77 60  
Benefits paid (28,263) (26,703)  
Impact of foreign exchange rates (7,200) 10,388  
Effect of settlements (2,218) (2,373)  
Expenses paid (1,976) (1,108)  
Acquisitions 21,223 32,322  
Fair value of plan assets at December 31 290,825 295,587 253,125
Funded status of the Plans (161,450) (117,753)  
Retiree Health and Life Insurance Plans      
Change in Benefit Obligation      
Benefit obligation at January 1 22,571 11,244  
Service cost 178 230 320
Interest cost 919 507 258
Plan participant contributions 0 0  
Plan amendments 0 11,637  
Actuarial (gain)/loss (2,389) (266)  
Benefits paid (1,418) (788)  
Impact of foreign exchange rates (29) 7  
Effect of settlements 0 0  
Effect of curtailments 0 0  
Acquisitions 0 0  
Benefit obligation at December 31 19,832 22,571 11,244
Change in Plan Assets      
Fair value of plan assets at January 1 13,213 12,750  
Actual return on plan assets 535 553  
Company contributions 835 754  
Plan participant contributions 0 0  
Benefits paid (1,360) (788)  
Impact of foreign exchange rates 0 0  
Effect of settlements 0 0  
Expenses paid (48) (56)  
Acquisitions 0 0  
Fair value of plan assets at December 31 13,175 13,213 $ 12,750
Funded status of the Plans $ (6,657) $ (9,358)  
v3.25.0.1
Employee benefit plans - Recognized Amounts in Consolidated Balance Sheets (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent liabilities $ (180,827) $ (142,784)
Retirement Plans    
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent assets 24,919 26,599
Current liabilities (11,382) (9,797)
Noncurrent liabilities (174,987) (134,555)
Net (liability) (161,450) (117,753)
Retiree Health and Life Insurance Plans    
Total Recognized Amounts in the Consolidated Balance Sheets    
Noncurrent assets 0 0
Current liabilities (817) (1,801)
Noncurrent liabilities (5,840) (7,557)
Net (liability) $ (6,657) $ (9,358)
v3.25.0.1
Employee benefit plans - Component of Net Periodic Pension Cost that are Included in Accumulated Other Comprehensive Loss (Income) (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Defined Benefit Plan Disclosure [Line Items]    
Prior service cost $ 11,637  
Retirement Plans    
Defined Benefit Plan Disclosure [Line Items]    
Net actuarial loss/(gain) 109,718 $ 114,957
Prior service cost 5,020 5,557
Amount in accumulated other comprehensive loss (income) 114,738 120,514
Retiree Health and Life Insurance Plans    
Defined Benefit Plan Disclosure [Line Items]    
Net actuarial loss/(gain) (7,706) (6,120)
Prior service cost 11,251 11,637
Amount in accumulated other comprehensive loss (income) $ 3,545 $ 5,517
v3.25.0.1
Employee benefit plans - Amounts Recognized in Other Comprehensive Loss/(Income) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Retirement Plans      
Adjustments arising during the period:      
Net actuarial (gain)/loss $ (238) $ 10,709 $ 4,839
Prior service cost 327 430 678
Net settlements/curtailments (530) (1,010) (522)
Amortization recognized during the period:      
Net actuarial (loss)/gain (4,472) (4,300) (6,240)
Prior service cost (864) (926) (913)
Total recognized in other comprehensive (income)/loss (5,777) 4,903 (2,158)
Total recognized in net periodic benefit cost and other comprehensive loss/(income) 11,509 22,707 9,081
Retiree Health and Life Insurance Plans      
Adjustments arising during the period:      
Net actuarial (gain)/loss (2,485) (451) (761)
Prior service cost 0 11,637 0
Net settlements/curtailments 0 0 0
Amortization recognized during the period:      
Net actuarial (loss)/gain 899 768 681
Prior service cost (385) 0 0
Total recognized in other comprehensive (income)/loss (1,971) 11,954 (80)
Total recognized in net periodic benefit cost and other comprehensive loss/(income) $ (1,780) $ 11,610 $ (622)
v3.25.0.1
Employee benefit plans - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended 144 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2021
Dec. 04, 2024
Sep. 08, 2023
Defined Benefit Plan Disclosure [Line Items]              
Defined benefit plans, accumulated benefit obligation $ 440,126 $ 404,648          
Projected benefit obligation (PBO) with accumulated benefit obligations in excess of plan assets 279,472 229,397          
Accumulated benefit obligation (ABO) with accumulated benefit obligations in excess of plan assets 270,720 224,045          
Fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets 94,384 84,929          
Total postretirement benefit plan assets 304,000 308,800          
Prior service cost $ 11,637            
Percentage of retiree health liability 90.00%            
Projected contributions to retirement plan $ 21,900            
Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Total postretirement benefit plan assets 290,825 295,587 $ 253,125        
Defined benefit plan, benefit obligation 452,275 413,340 352,767        
Accumulated other comprehensive loss including define pension plan, before tax (109,718) (114,957)          
Prior service cost $ 5,020 $ 5,557          
United States | Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Total 100.00% 100.00%          
United States | Retirement Plans | Equity securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 19.50% 22.20%          
United States | Retirement Plans | Debt securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 78.00% 76.60%          
Canada | Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Non-cash settlement charges $ 530 $ 1,010          
Total 100.00% 100.00%          
Canada | Retirement Plans | Equity securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 31.40% 29.40%          
Current target allocation for investment portfolio 30.00%            
Canada | Retirement Plans | Debt securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 68.60% 70.60%          
Current target allocation for investment portfolio 70.00%            
U.K. | Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Total 100.00% 100.00%          
U.K. | Retirement Plans | Equity securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 21.00% 20.00%          
Current target allocation for investment portfolio 20.00%            
U.K. | Retirement Plans | Debt securities              
Defined Benefit Plan Disclosure [Line Items]              
Total 77.10% 79.10%          
Current target allocation for investment portfolio 80.00%            
Eviosys Plans | United States | Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Total postretirement benefit plan assets           $ 21,223  
Defined benefit plan, long-term unfunded pension obligations           51,849  
Defined benefit plan, short-term unfunded pension obligations           979  
Defined benefit plan, benefit obligation           $ 74,051  
RTS Packaging Pension Plan              
Defined Benefit Plan Disclosure [Line Items]              
Total 82.00%            
RTS Packaging Pension Plan | Retirement Plans | Equity securities              
Defined Benefit Plan Disclosure [Line Items]              
Current target allocation for investment portfolio 20.00%            
RTS Packaging Pension Plan | Retirement Plans | Debt securities              
Defined Benefit Plan Disclosure [Line Items]              
Current target allocation for investment portfolio 80.00%            
RTS Packaging Pension Plan | United States | Retirement Plans              
Defined Benefit Plan Disclosure [Line Items]              
Total postretirement benefit plan assets             $ 32,322
Defined benefit plan, long-term unfunded pension obligations             11,529
Defined benefit plan, short-term unfunded pension obligations             83
Defined benefit plan, benefit obligation             $ 43,934
Active Plan Investment Portfolio | United States | Retirement Plans | Equity securities              
Defined Benefit Plan Disclosure [Line Items]              
Current target allocation for investment portfolio 20.00%            
Active Plan Investment Portfolio | United States | Retirement Plans | Debt securities              
Defined Benefit Plan Disclosure [Line Items]              
Current target allocation for investment portfolio 80.00%            
Sonoco Savings Plan              
Defined Benefit Plan Disclosure [Line Items]              
Defined contribution plan contribution percentage, minimum 1.00%            
Defined contribution plan contribution percentage, maximum 100.00%            
Defined contribution plan, employer matching contribution (percent)       100.00%      
Employer matching contribution, percent of employees' gross pay (percent)       6.00%      
Percentage of participants modified matching contribution to be matched towards safe Harbor under companies savings plan         50.00%    
Modify matching employee contribution to profit sharing under companies savings plan         4.00%    
Companies expense related to the plan $ 33,700 $ 30,684 29,347        
Sonoco Investment and Retirement Plan              
Defined Benefit Plan Disclosure [Line Items]              
Cash contributions to the SIRP     $ 21,948        
RTS Packaging              
Defined Benefit Plan Disclosure [Line Items]              
Voting interest acquired             65.00%
Interest held in acquiree before subsequent acquisition (percent)             35.00%
Accumulated other comprehensive loss including define pension plan, before tax             $ 4,756
Accumulated other comprehensive loss including define pension plan, after tax             $ 3,543
v3.25.0.1
Employee benefit plans - Company's Projected Benefit Payments (Details)
$ in Thousands
Dec. 31, 2024
USD ($)
Retirement Plans  
Defined Benefit Plan Disclosure [Line Items]  
2025 $ 33,734
2026 34,132
2027 34,027
2028 35,391
2029 34,788
2030-2034 184,106
Retiree Health and Life Insurance Plans  
Defined Benefit Plan Disclosure [Line Items]  
2025 1,642
2026 1,790
2027 1,709
2028 1,956
2029 1,829
2030-2034 $ 8,773
v3.25.0.1
Employee benefit plans - Major Actuarial Assumptions Used in Determining PBO, ABO and Net Periodic Cost (Details)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
United States | Retirement Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 5.52% 4.84%  
Rate of Compensation Increase 0.00% 0.00%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 4.84% 5.01% 2.77%
Expected Long-term Rate of Return 3.08% 2.48% 3.27%
Rate of Compensation Increase 0.00% 0.00% 0.00%
United States | Retiree Health and Life Insurance Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 5.32% 4.68%  
Rate of Compensation Increase 3.02% 3.03%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 4.68% 4.92% 2.48%
Expected Long-term Rate of Return 3.05% 2.45% 3.18%
Rate of Compensation Increase 3.03% 2.99% 3.01%
Foreign Plans      
Weighted-average assumptions used to determine benefit obligations      
Discount Rate 6.52% 4.79%  
Rate of Compensation Increase 3.59% 3.11%  
Weighted-average assumptions used to determine net periodic benefit cost      
Discount Rate 4.79% 4.97% 2.22%
Expected Long-term Rate of Return 4.36% 4.70% 3.00%
Rate of Compensation Increase 3.11% 3.29% 3.21%
v3.25.0.1
Employee benefit plans - Health Care Cost Trend Rates Related to U.S. Plan (Details) - United States
Dec. 31, 2024
Dec. 31, 2023
Pre-age 65    
Defined Benefit Plan Disclosure [Line Items]    
Healthcare Cost Trend Rate 6.17% 6.25%
Ultimate Trend Rate 4.50% 4.50%
Post-age 65    
Defined Benefit Plan Disclosure [Line Items]    
Healthcare Cost Trend Rate 7.28% 7.25%
Ultimate Trend Rate 4.50% 4.50%
v3.25.0.1
Employee benefit plans - Weighted-Average Asset Allocations (Details)
Dec. 31, 2024
Dec. 31, 2023
Retirement Plans | U.S.    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | U.S. | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 19.50% 22.20%
Retirement Plans | U.S. | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 78.00% 76.60%
Retirement Plans | U.S. | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 2.50% 1.20%
Retirement Plans | RTS    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | RTS | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 22.20% 18.60%
Retirement Plans | RTS | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 77.80% 81.20%
Retirement Plans | RTS | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.20%
Retirement Plans | U.K.    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | U.K. | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 21.00% 20.00%
Retirement Plans | U.K. | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 77.10% 79.10%
Retirement Plans | U.K. | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 1.90% 0.90%
Retirement Plans | Canada    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retirement Plans | Canada | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 31.40% 29.40%
Retirement Plans | Canada | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 68.60% 70.60%
Retirement Plans | Canada | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
Retiree Health and Life Insurance Plans    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retiree Health and Life Insurance Plans | Equity securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
Retiree Health and Life Insurance Plans | Debt securities    
Defined Benefit Plan Disclosure [Line Items]    
Total 100.00% 100.00%
Retiree Health and Life Insurance Plans | Cash and short-term investments    
Defined Benefit Plan Disclosure [Line Items]    
Total 0.00% 0.00%
v3.25.0.1
Income taxes - Provision for Taxes on Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Pretax income      
Domestic $ (35,733) $ 280,916 $ 257,189
Foreign 99,219 208,111 202,745
Income from continuing operations before income taxes 63,486 489,027 459,934
Current      
Federal 3,693 54,319 34,157
State 1,916 11,282 10,391
Foreign 57,034 63,617 61,228
Total current 62,643 129,218 105,776
Deferred      
Federal (34,828) (3,307) (1,884)
State (9,837) (1,646) (3,563)
Foreign (12,469) (4,535) (4,598)
Total deferred (57,134) (9,488) (10,045)
Total taxes $ 5,509 $ 119,730 $ 95,731
v3.25.0.1
Income taxes - Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]    
Property, plant and equipment $ (266,278) $ (137,880)
Intangibles (545,330) (119,225)
Leases (76,225) (48,832)
Outside basis in Metal Packaging (68,649) (68,867)
Gross deferred tax liabilities (956,482) (374,804)
Retiree health benefits 245 513
Foreign loss carryforwards 79,314 62,250
U.S. Federal loss and credit carryforwards 34,082 39,131
Capital loss carryforwards 3,755 3,817
U.S. State loss and credit carryforwards 26,181 21,321
Capitalized research and development costs 103,043 87,743
Employee benefits 56,192 51,829
Leases 82,031 50,704
Accrued liabilities and other assets 71,370 58,699
Gross deferred tax assets 456,213 376,007
Valuation allowance on deferred tax assets (81,496) (70,661)
Total deferred taxes, net (581,765) (69,458)
Deferred taxes, net, discontinued operations (15,666) (6,228)
Deferred tax assets, valuation allowance, discontinued operations $ (4,628) $ (4,395)
v3.25.0.1
Income taxes - Additional Information (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Taxes [Line Items]      
Tax credit carryforwards, foreign $ 20,722    
Capital loss carryforwards 3,755 $ 3,817  
Increase (decrease) in reserve for uncertain tax positions (8,613) 1,819 $ 296
Tax credits 11,834 18,848 14,077
Tax cuts and jobs act, global intangible low-tax income, net tax expense (benefit) amount 9,629    
Global intangible low-taxed income (GILTI) (5,604)    
Expense (benefits) included in valuation allowance 5,969   (13,182)
Undistributed earnings 1,071,766    
Unrecognized tax benefits 9,857 19,241  
Accrued for interest 1,667 1,773  
Income taxes, net interest expense 105    
Interest benefit   2,149  
Interest expense 2,044    
Expected decrease in reserve for uncertain tax benefits 493    
U.S. Federal      
Income Taxes [Line Items]      
Loss carryforwards 63,615    
Foreign      
Income Taxes [Line Items]      
Loss carryforwards 339,125    
Loss carryforwards not subject to expiration 241,179    
Capital loss carryforwards 15,010    
Foreign | Next five years      
Income Taxes [Line Items]      
Operating loss carryforwards subject to expiration 13,279    
Foreign | Tax years, 2030 - 2044      
Income Taxes [Line Items]      
Operating loss carryforwards subject to expiration 84,667    
State      
Income Taxes [Line Items]      
Loss carryforwards 10,909    
State credit carry forwards 22,232    
Uncertain Items Arising During Year      
Income Taxes [Line Items]      
Increase (decrease) in reserve for uncertain tax positions 3,405 2,710 1,780
Uncertain Items Arising During Prior Years      
Income Taxes [Line Items]      
Increase (decrease) in reserve for uncertain tax positions $ (13,229) $ (891) $ (1,484)
v3.25.0.1
Income taxes - Reconciliation of U.S. Federal Statutory Tax Rate to Actual Consolidated Tax Expense (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Effective Income Tax Rate Reconciliation, Amount [Abstract]      
Statutory tax rate $ 13,332 $ 102,696 $ 96,563
State income taxes, net of federal tax benefit (883) 12,263 10,204
Valuation allowance 7,763 4,486 (10,477)
Tax examinations including change in reserve for uncertain tax positions (8,613) 1,819 296
Adjustments to prior year deferred taxes (9,129) (2,489) (2,110)
Foreign earnings taxed at other than U.S. rates 12,271 13,108 14,613
Divestiture of business (2,954) 464 0
Effect of tax rate changes (1,552) 387 (2,151)
Foreign withholding taxes 5,344 4,591 4,643
Tax credits (11,834) (18,848) (14,077)
Global intangible low-taxed income (GILTI) (5,604) 4,853 4,345
Foreign-derived intangible income (858) (1,106) (657)
Foreign currency gain/(loss) on distributions of previously taxed income 642 (2,614) (1,280)
IRC Subpart F income 916 119 96
Executive compensation limitation $ 2,569 $ 3,767 $ 1,420
Capitalized acquisition costs 11.30% 0.00% (0.10%)
Other, net $ (3,103) $ (3,870) $ (5,285)
Total taxes $ 5,509 $ 119,730 $ 95,731
Effective Income Tax Rate Reconciliation, Percent [Abstract]      
Statutory tax rate (percent) 21.00% 21.00% 21.00%
State income taxes, net of federal tax benefit (percent) (1.40%) 2.50% 2.20%
Valuation allowance (percent) 12.20% 0.90% (2.30%)
Tax examinations including change in reserve for uncertain tax positions (percent) (13.60%) 0.40% 0.10%
Adjustments to prior year deferred taxes (percent) (14.40%) (0.50%) (0.50%)
Foreign earnings taxed at other than U.S. rates (percent) 19.30% 2.70% 3.20%
Disposition of business (percent) (4.70%) 0.10% 0.00%
Effect of tax rate changes (percent) (2.40%) 0.10% (0.50%)
Deduction related to qualified production activities (percent) 8.40% 0.90% 1.00%
Tax credit (percent) (18.60%) (3.90%) (3.10%)
Global intangible low-tax income (GILTI) (percent) (8.80%) 1.00% 0.90%
Foreign-derivative intangible income (percent) (1.40%) (0.20%) (0.10%)
Foreign currency gain/(loss) on distributions of previously taxed income (percent) 1.00% (0.50%) (0.30%)
IRC Subpart F Income (percent) 1.40% 0.00% 0.00%
Executive compensation limitation 4.00% 0.80% 0.30%
Capitalized acquisition costs (percent) $ 7,202 $ 104 $ (412)
Other, net (percent) (4.90%) (0.80%) (1.10%)
Total taxes (percent) 8.70% 24.50% 20.80%
v3.25.0.1
Income taxes - Reconciliation of Gross Amounts of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Unrecognized Tax Benefits [Roll Forward]      
Gross Unrecognized Tax Benefits at January 1 $ 21,677 $ 18,621 $ 18,142
Increases in prior years’ unrecognized tax benefits 627 378 223
Decreases in prior years’ unrecognized tax benefits (1,915) (572) (144)
Increases in current year’s unrecognized tax benefits 4,325 4,395 1,807
Decreases in unrecognized tax benefits from the lapse of statutes of limitations (12,100) (1,094) (1,174)
Settlements (476) (51) (233)
Gross Unrecognized Tax Benefits at December 31 $ 12,138 $ 21,677 $ 18,621
v3.25.0.1
Revenue recognition - Disaggregated Revenues (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Disaggregation of Revenue [Line Items]                      
Net sales $ 1,363,276 $ 1,354,652 $ 1,278,801 $ 1,308,636 $ 1,335,735 $ 1,381,130 $ 1,337,589 $ 1,386,972 $ 5,305,365 $ 5,441,426 $ 5,859,327
United States                      
Disaggregation of Revenue [Line Items]                      
Net sales                 3,569,806 3,700,872 4,051,763
Europe                      
Disaggregation of Revenue [Line Items]                      
Net sales                 955,520 885,386 924,301
Canada                      
Disaggregation of Revenue [Line Items]                      
Net sales                 113,349 116,171 128,369
Asia Pacific                      
Disaggregation of Revenue [Line Items]                      
Net sales                 311,052 329,394 367,704
Other                      
Disaggregation of Revenue [Line Items]                      
Net sales                 355,638 409,603 387,190
Operating segments | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 2,531,852 2,471,048 2,564,004
Operating segments | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 2,349,488 2,374,113 2,684,563
Operating segments | United States | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 1,785,857 1,817,268 1,936,847
Operating segments | United States | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 1,431,232 1,389,492 1,611,390
Operating segments | Europe | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 524,699 431,189 421,276
Operating segments | Europe | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 371,896 389,261 434,076
Operating segments | Canada | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 17,486 16,076 18,372
Operating segments | Canada | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 95,863 100,095 109,997
Operating segments | Asia Pacific | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 96,154 94,136 91,151
Operating segments | Asia Pacific | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 213,127 233,446 275,395
Operating segments | Other | Consumer Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 107,656 112,379 96,358
Operating segments | Other | Industrial Paper Packaging                      
Disaggregation of Revenue [Line Items]                      
Net sales                 237,370 261,819 253,705
Total Reportable Segments                      
Disaggregation of Revenue [Line Items]                      
Net sales                 424,025 596,265 610,760
Total Reportable Segments | United States                      
Disaggregation of Revenue [Line Items]                      
Net sales                 352,717 494,112 503,526
Total Reportable Segments | Europe                      
Disaggregation of Revenue [Line Items]                      
Net sales                 58,925 64,936 68,949
Total Reportable Segments | Canada                      
Disaggregation of Revenue [Line Items]                      
Net sales                 0 0 0
Total Reportable Segments | Asia Pacific                      
Disaggregation of Revenue [Line Items]                      
Net sales                 1,771 1,812 1,158
Total Reportable Segments | Other                      
Disaggregation of Revenue [Line Items]                      
Net sales                 $ 10,612 $ 35,405 $ 37,127
v3.25.0.1
Revenue recognition - Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]      
Contract Assets $ 67,062 $ 14,754 $ 18,037
Contract Liabilities $ (60,024) $ (15,252) $ (12,588)
v3.25.0.1
Revenue recognition - Significant Changes in Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Contract Asset    
Beginning balance $ 14,754 $ 18,037
Acquired as part of a business combination 62,439  
Increases due to rights to consideration for customer specific goods produced, but not billed during the period 67,062 14,754
Transferred to receivables from contract assets recognized at the beginning of the period and acquired as part of business combination (77,193) (18,037)
Ending balance 67,062 14,754
Contract Liability    
Beginning balance (15,252) (12,588)
Acquired as part of a business combination (47,478) (1,436)
Revenue deferred or rebates accrued (25,736) (25,094)
Recognized as revenue 2,341 1,936
Rebates paid to customers 26,101 21,930
Ending balance $ (60,024) $ (15,252)
v3.25.0.1
Commitments and contingencies (Details) - USD ($)
$ in Thousands
158 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Site Contingency [Line Items]    
Total future payments $ 82,554  
Payments in 2025 20,472  
Payments in 2026 21,389  
Payments in 2027 20,217  
Payments in 2028 20,476  
Payments in 2029 - 2033 0  
Multiple sites    
Site Contingency [Line Items]    
Environmental accrual 1,933 $ 1,992
Tegrant Holding Corporation    
Site Contingency [Line Items]    
Payment towards remediation of sites 2,304  
Tegrant Holding Corporation | Spartanburg, South Carolina Site    
Site Contingency [Line Items]    
Environmental accrual $ 5,096 $ 5,259
v3.25.0.1
Shareholders’ equity and earnings per share - Additional Information (Details)
$ in Thousands
1 Months Ended 12 Months Ended
Mar. 31, 2022
USD ($)
Nov. 30, 2024
productionFacility
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
Dec. 04, 2024
Apr. 20, 2021
USD ($)
Apr. 30, 2015
Equity [Line Items]                
Number of shares authorized for repurchase             $ 350,000  
Number of shares repurchased (in shares) | shares     0 0        
Number of shares available for repurchase (in shares)     $ 137,972 $ 137,972        
Non-controlling interest from acquisition     9,533          
Divestiture of non-controlling interest     2,043          
Purchase of noncontrolling interest $ 14,474   0 0 $ 14,474      
Writeoff of book value         $ 13,196      
Capital in excess of stated value     183,250 $ 159,047        
Dispositions                
Equity [Line Items]                
Number of production facilities | productionFacility   2            
Ivory Coast | Eviosys                
Equity [Line Items]                
Ownership percentage by parent           85.20%    
Morocco | Eviosys                
Equity [Line Items]                
Ownership percentage by parent           99.34%    
Graffo Paranaense de Embalagens S/A                
Equity [Line Items]                
Percentage of noncontrolling owner               33.00%
Writeoff of book value     6,116          
Capital in excess of stated value     7,080          
Decrease in accrued liabilities     $ (1,278)          
Tax Withholding Obligations                
Equity [Line Items]                
Number of shares repurchased (in shares) | shares     164,402 175,665 79,347      
Cost of shares repurchased     $ 9,246 $ 10,617 $ 4,547      
Non- controlling Interests                
Equity [Line Items]                
Non-controlling interest from acquisition     9,533          
Divestiture of non-controlling interest     $ 2,043          
Writeoff of book value         $ 6,116      
v3.25.0.1
Shareholders’ equity and earnings per share - Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Numerator:                      
Net income from continuing operations $ (56,749) $ 31,392 $ 57,410 $ 35,512 $ 61,106 $ 111,946 $ 84,638 $ 121,954 $ 67,565 $ 379,644 $ 378,410
Net loss/(income) from continuing operations attributable to noncontrolling interests                 180 (768) (284)
Net income from continuing operations attributable to Sonoco                 67,745 378,876 378,126
Net income attributable to Sonoco $ (42,960) $ 50,921 $ 90,811 $ 65,177 $ 81,242 $ 130,749 $ 114,649 $ 148,319 $ 163,949 $ 474,959 $ 466,437
Denominator:                      
Weighted average common shares outstanding (in shares) 98,700 98,683 98,671 98,498 98,349 98,337 98,325 98,167 98,637 98,294 97,991
Dilutive effect of stock-based compensation (in shares)                 653 596 741
Diluted outstanding shares (in shares) 98,700 99,267 99,241 99,159 99,164 98,912 98,872 98,615 99,290 98,890 98,732
Basic earnings per common share:                      
Net income from continuing operations (usd per share) $ (0.57) $ 0.32 $ 0.58 $ 0.36 $ 0.61 $ 1.14 $ 0.86 $ 1.24 $ 0.69 $ 3.85 $ 3.86
Net income attributable to Sonoco (usd per share) (0.44) 0.52 0.92 0.66 0.82 1.33 1.17 1.51 1.66 4.83 4.76
Diluted earnings per common share:                      
Net income from continuing operations (usd per share) (0.57) 0.31 0.58 0.36 0.61 1.13 0.86 1.23 0.68 3.83 3.83
Net income attributable to Sonoco (usd per share) (0.44) 0.51 0.92 0.66 0.82 1.32 1.16 1.50 1.65 4.80 4.72
Cash dividends (usd per share) $ 0.52 $ 0.52 $ 0.52 $ 0.51 $ 0.51 $ 0.51 $ 0.51 $ 0.49 $ 2.07 $ 2.02 $ 1.92
v3.25.0.1
Shareholders’ equity and earnings per share - Shares Not Included in Computations of Diluted Income Per Share (Details) - shares
shares in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Equity [Abstract]      
Anti-dilutive stock appreciation rights (in shares) 408 352 373
v3.25.0.1
Segment reporting - Additional Information (Details)
12 Months Ended
Dec. 31, 2024
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.0.1
Segment reporting - Financial Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]                      
Sales from external customers                 $ 5,001,044 $ 4,952,154 $ 5,384,560
Other sales                 431,107 604,442 620,330
Total sales $ 1,363,276 $ 1,354,652 $ 1,278,801 $ 1,308,636 $ 1,335,735 $ 1,381,130 $ 1,337,589 $ 1,386,972 5,305,365 5,441,426 5,859,327
Cost of sales                 (4,166,132) (4,238,857) (4,634,009)
Segment operating profit                 326,578 589,049 563,355
Other segment disclosures:                      
Equity in earnings of affiliates, net of tax                 9,588 10,347 14,207
Depreciation, depletion and amortization                 374,859 340,988 308,824
Consumer Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 2,539,874 2,476,219 2,565,783
Industrial Paper Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 2,461,170 2,475,935 2,818,777
Operating segments                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 4,881,340 4,845,161 5,248,567
Segment operating profit                 566,486 603,679 770,015
Other segment disclosures:                      
Equity in earnings of affiliates, net of tax                 9,588 10,347 14,207
Depreciation, depletion and amortization                 225,504 200,063 175,993
Operating segments | Consumer Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 2,531,852 2,471,048 2,564,004
Total sales                 2,531,852 2,471,048 2,564,004
Cost of sales                 (2,041,078) (1,999,514) (1,981,621)
Other segment items                 (203,964) (190,943) (142,006)
Segment operating profit                 294,832 285,762 442,156
Other segment disclosures:                      
Equity in earnings of affiliates, net of tax                 365 564 485
Depreciation, depletion and amortization                 109,355 95,340 84,049
Operating segments | Industrial Paper Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 2,349,488 2,374,113 2,684,563
Total sales                 2,349,488 2,374,113 2,684,563
Cost of sales                 (1,818,324) (1,809,803) (2,109,080)
Other segment items                 (371,192) (348,215) (381,838)
Segment operating profit                 271,654 317,917 327,859
Other segment disclosures:                      
Equity in earnings of affiliates, net of tax                 9,223 9,783 13,722
Depreciation, depletion and amortization                 116,149 104,723 91,944
Intersegment sales                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 119,704 106,993 135,993
Total sales                 (126,786) (115,170) (145,563)
Intersegment sales | Consumer Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 8,022 5,171 1,779
Intersegment sales | Industrial Paper Packaging                      
Segment Reporting Information [Line Items]                      
Sales from external customers                 $ 111,682 $ 101,822 $ 134,214
v3.25.0.1
Segment reporting - Reconciliation of Segment Operating Profit to Income Before Income Taxes (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Segment operating profit $ 326,578 $ 589,049 $ 563,355
Restructuring/Asset impairment charges (65,370) (47,909) (52,385)
Amortization of acquisition intangibles (78,595) (67,323) (60,263)
(Loss)/Gain from divestiture of business and other assets (23,452) 78,929 0
Acquisition, integration and divestiture-related costs (91,600) (24,624) (70,210)
Changes in LIFO inventory reserves 6,263 11,817 (28,445)
Derivative gains/(losses) $ 7,225 $ 1,912 $ (8,767)
Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag Derivative gains/(losses) Derivative gains/(losses) Derivative gains/(losses)
Other corporate costs $ (46,675) $ (42,254) $ (45,210)
Other operating income/(charges), net (982) (10,326) 380
Other (expenses)/income, net (104,200) 39,657 0
Non-operating pension costs (13,842) (14,312) (7,073)
Interest expense (172,620) (135,393) (100,875)
Interest income 27,570 10,026 4,527
Income from continuing operations before income taxes 63,486 489,027 459,934
Operating segments      
Segment Reporting Information [Line Items]      
Segment operating profit 566,486 603,679 770,015
Total Reportable Segments      
Segment Reporting Information [Line Items]      
Segment operating profit $ 53,278 $ 85,148 $ 58,240
v3.25.0.1
Segment reporting - Reconciliation of Other Segment to Consolidated Totals (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax $ 9,588 $ 10,347 $ 14,207
Depreciation, depletion and amortization 374,859 340,988 308,824
Continuing Operations      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,588 10,347 14,207
Depreciation, depletion and amortization 316,061 282,029 250,533
Operating segments      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,588 10,347 14,207
Depreciation, depletion and amortization 225,504 200,063 175,993
Operating segments | Consumer Packaging      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 365 564 485
Depreciation, depletion and amortization 109,355 95,340 84,049
Operating segments | Industrial Paper Packaging      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 9,223 9,783 13,722
Depreciation, depletion and amortization 116,149 104,723 91,944
Other      
Segment Reporting Information [Line Items]      
Equity in earnings of affiliates, net of tax 0 0 0
Depreciation, depletion and amortization $ 90,557 $ 81,966 $ 74,540
v3.25.0.1
Segment reporting - Sales to Unaffiliated Customers and Long-Lived Assets by Geographic Region (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Sales to Unaffiliated Customers                      
Total sales $ 1,363,276 $ 1,354,652 $ 1,278,801 $ 1,308,636 $ 1,335,735 $ 1,381,130 $ 1,337,589 $ 1,386,972 $ 5,305,365 $ 5,441,426 $ 5,859,327
Long-lived Assets                      
Long-lived Assets 7,898,903       3,743,734       7,898,903 3,743,734 3,340,432
United States                      
Sales to Unaffiliated Customers                      
Total sales                 3,569,806 3,700,872 4,051,763
Long-lived Assets                      
Long-lived Assets 2,695,885       2,779,178       2,695,885 2,779,178 2,511,809
Europe                      
Sales to Unaffiliated Customers                      
Total sales                 955,520 885,386 924,301
Long-lived Assets                      
Long-lived Assets 4,690,098       617,949       4,690,098 617,949 572,824
Canada                      
Sales to Unaffiliated Customers                      
Total sales                 113,349 116,171 128,369
Long-lived Assets                      
Long-lived Assets 35,750       39,842       35,750 39,842 24,257
Asia Pacific                      
Sales to Unaffiliated Customers                      
Total sales                 311,052 329,394 367,704
Long-lived Assets                      
Long-lived Assets 176,547       157,235       176,547 157,235 155,959
Other                      
Sales to Unaffiliated Customers                      
Total sales                 355,638 409,603 387,190
Long-lived Assets                      
Long-lived Assets $ 300,623       $ 149,530       $ 300,623 $ 149,530 $ 75,583
v3.25.0.1
Accumulated other comprehensive loss - Accumulated Other Comprehensive Income Loss and Changes in Accumulated Other Comprehensive Loss, Net of Tax (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Beginning balance $ 2,431,835 $ 2,072,797 $ 1,849,541
Other comprehensive loss (136,849) 63,391 (70,198)
Ending balance 2,286,213 2,431,835 2,072,797
Foreign Currency Items      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Beginning balance (267,578) (338,316)  
Other comprehensive income/(loss) before reclassifications (146,856) 68,705  
Amounts reclassified from accumulated other comprehensive loss to net income 3,503 2,033  
Amounts reclassified from accumulated other comprehensive loss to fixed assets   0  
Other comprehensive loss (143,353) 70,738  
Ending balance (410,931) (267,578) (338,316)
Defined Benefit Pension Items      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Beginning balance (99,627) (90,973)  
Other comprehensive income/(loss) before reclassifications 4,636 (16,305)  
Amounts reclassified from accumulated other comprehensive loss to net income 4,378 7,651  
Amounts reclassified from accumulated other comprehensive loss to fixed assets   0  
Other comprehensive loss 9,014 (8,654)  
Ending balance (90,613) (99,627) (90,973)
Gains and Losses on Cash Flow Hedges      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Beginning balance 943 (794)  
Other comprehensive income/(loss) before reclassifications (3,213) 6,622  
Amounts reclassified from accumulated other comprehensive loss to net income 1,080 (5,177)  
Amounts reclassified from accumulated other comprehensive loss to fixed assets   292  
Other comprehensive loss (2,133) 1,737  
Ending balance (1,190) 943 (794)
Accumulated Other Comprehensive Loss      
Increase (Decrease) in Stockholders' Equity [Roll Forward]      
Beginning balance (366,262) (430,083)  
Other comprehensive income/(loss) before reclassifications (145,433) 59,022  
Amounts reclassified from accumulated other comprehensive loss to net income 8,961 4,507  
Amounts reclassified from accumulated other comprehensive loss to fixed assets   292  
Other comprehensive loss (136,472) 63,821  
Ending balance $ (502,734) $ (366,262) $ (430,083)
v3.25.0.1
Accumulated other comprehensive loss - Effects on Net Income of Significant Amounts Reclassified from Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
(Loss)/Gain on divestiture of business and other assets $ (23,452) $ 57,104 $ 0
Other (expenses)/income, net (104,200) 39,657 0
Net income 163,940 475,901 466,980
Income from continuing operations before income taxes 63,486 489,027 459,934
Provision for income taxes (5,509) (119,730) (95,731)
Sales from external customers 5,001,044 4,952,154 5,384,560
Cost of sales (4,166,132) (4,238,857) $ (4,634,009)
Reclassification out of Accumulated Other Comprehensive Income      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (8,961) (4,507)  
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
(Loss)/Gain on divestiture of business and other assets (3,503) 0  
Other (expenses)/income, net 0 (2,033)  
Net income (3,503) (2,033)  
Reclassification out of Accumulated Other Comprehensive Income | Pension-related loss upon purchase of remaining interest in RTS Packaging joint venture      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Other (expenses)/income, net 0 (4,756)  
Reclassification out of Accumulated Other Comprehensive Income | Defined Benefit Pension Items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (4,378) (7,651)  
Income from continuing operations before income taxes (5,352) (10,224)  
Provision for income taxes 974 2,573  
Reclassification out of Accumulated Other Comprehensive Income | Effect of settlement loss      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Non-operating pension costs (530) (1,010)  
Reclassification out of Accumulated Other Comprehensive Income | Amortization of defined benefit pension items      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Non-operating pension costs (4,822) (4,458)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Net income (1,080) 5,177  
Income from continuing operations before income taxes (1,455) 7,100  
Provision for income taxes 375 (1,923)  
Sales from external customers (1,174) 10,860  
Cost of sales (281) (3,760)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Foreign Exchange Contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Sales from external customers (1,174) 10,860  
Cost of sales (253) (3,728)  
Reclassification out of Accumulated Other Comprehensive Income | Gains and Losses on Cash Flow Hedges | Commodity Contracts      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Sales from external customers 0 0  
Cost of sales $ (28) $ (32)  
v3.25.0.1
Accumulated other comprehensive loss - Components of Other Comprehensive Income (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Foreign Currency Items    
Gains and losses on cash flow hedges:    
Other comprehensive (loss)/income before reclassifications, Before Tax Amount $ (140,210) $ 67,411
Other comprehensive (loss)/income before reclassifications, Tax (Expense) Benefit (6,646) 1,294
Other comprehensive (loss)/income before reclassifications (146,856) 68,705
Amounts reclassified from accumulated other comprehensive income loss before tax 3,503 2,033
Amounts reclassified from accumulated other comprehensive income loss, tax 0 0
Amounts reclassified from accumulated other comprehensive income loss net of tax 3,503 2,033
Other comprehensive income/(loss), Before Tax Amount (136,707) 69,444
Other comprehensive income/(loss), Tax (Expense) Benefit (6,646) 1,294
Other comprehensive (loss)/income (143,353) 70,738
Defined Benefit Pension Items    
Gains and losses on cash flow hedges:    
Other comprehensive (loss)/income before reclassifications, Before Tax Amount 2,395 (21,815)
Other comprehensive (loss)/income before reclassifications, Tax (Expense) Benefit 2,241 5,510
Other comprehensive (loss)/income before reclassifications 4,636 (16,305)
Amounts reclassified from accumulated other comprehensive income loss before tax 5,352 10,224
Amounts reclassified from accumulated other comprehensive income loss, tax (974) (2,573)
Amounts reclassified from accumulated other comprehensive income loss net of tax 4,378 7,651
Other comprehensive income/(loss), Before Tax Amount 7,747 (11,591)
Other comprehensive income/(loss), Tax (Expense) Benefit 1,267 2,937
Other comprehensive (loss)/income 9,014 (8,654)
Cash flow hedges:    
Gains and losses on cash flow hedges:    
Other comprehensive (loss)/income before reclassifications, Before Tax Amount (4,329) 9,081
Other comprehensive (loss)/income before reclassifications, Tax (Expense) Benefit 1,116 (2,459)
Other comprehensive (loss)/income before reclassifications (3,213) 6,622
Amounts reclassified from accumulated other comprehensive income loss before tax 1,455 (7,100)
Amounts reclassified from accumulated other comprehensive income loss, tax (375) 1,923
Amounts reclassified from accumulated other comprehensive income loss net of tax 1,080 (5,177)
Amounts reclassified from accumulated other comprehensive loss to fixed assets, before tax 0 401
Amounts reclassified from accumulated other comprehensive loss to fixed assets, tax 0 (109)
Amounts reclassified from accumulated other comprehensive loss to fixed assets, after tax 0 292
Other comprehensive income/(loss), Before Tax Amount (2,874) 2,382
Other comprehensive income/(loss), Tax (Expense) Benefit 741 (645)
Other comprehensive (loss)/income (2,133) 1,737
Other comprehensive (loss)/income    
Gains and losses on cash flow hedges:    
Other comprehensive income/(loss), Before Tax Amount (131,834) 60,235
Other comprehensive income/(loss), Tax (Expense) Benefit (4,638) 3,586
Other comprehensive (loss)/income $ (136,472) $ 63,821
v3.25.0.1
Selected quarterly financial data (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Oct. 01, 2023
Jul. 02, 2023
Apr. 02, 2023
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Selected Quarterly Financial Information [Abstract]                      
Net sales $ 1,363,276 $ 1,354,652 $ 1,278,801 $ 1,308,636 $ 1,335,735 $ 1,381,130 $ 1,337,589 $ 1,386,972 $ 5,305,365 $ 5,441,426 $ 5,859,327
Gross profit 282,973 299,748 285,295 271,217 287,979 307,848 291,946 314,796 1,139,233 1,202,569 1,225,318
Net income from continuing operations (56,749) 31,392 57,410 35,512 61,106 111,946 84,638 121,954 67,565 379,644 378,410
Net income from discontinued operations 13,256 19,817 33,541 29,761 20,724 19,112 30,111 26,310 96,375 96,257 88,570
Net income/(loss) attributable to Sonoco $ (42,960) $ 50,921 $ 90,811 $ 65,177 $ 81,242 $ 130,749 $ 114,649 $ 148,319 $ 163,949 $ 474,959 $ 466,437
Weighted average common shares outstanding:                      
Basic (in shares) 98,700 98,683 98,671 98,498 98,349 98,337 98,325 98,167 98,637 98,294 97,991
Diluted (in shares) 98,700 99,267 99,241 99,159 99,164 98,912 98,872 98,615 99,290 98,890 98,732
Basic earnings per common share:                      
Continuing operations (usd per share) $ (0.57) $ 0.32 $ 0.58 $ 0.36 $ 0.61 $ 1.14 $ 0.86 $ 1.24 $ 0.69 $ 3.85 $ 3.86
Discontinued operations (usd per share) 0.13 0.20 0.34 0.30 0.21 0.19 0.31 0.27 0.97 0.98 0.90
Basic (usd per share) (0.44) 0.52 0.92 0.66 0.82 1.33 1.17 1.51 1.66 4.83 4.76
Diluted earnings per common share:                      
Continuing operations (usd per share) (0.57) 0.31 0.58 0.36 0.61 1.13 0.86 1.23 0.68 3.83 3.83
Diluted - attributable to Sonoco discontinued operations (usd per share) 0.13 0.20 0.34 0.30 0.21 0.19 0.30 0.27 0.97 0.97 0.89
Diluted (usd per share) (0.44) 0.51 0.92 0.66 0.82 1.32 1.16 1.50 1.65 4.80 4.72
Cash dividends                      
Cash dividends (usd per share) $ 0.52 $ 0.52 $ 0.52 $ 0.51 $ 0.51 $ 0.51 $ 0.51 $ 0.49 $ 2.07 $ 2.02 $ 1.92
v3.25.0.1
Schedule II - Valuation and Qualifying Accounts (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Allowance for Doubtful Accounts      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year $ 18,868 $ 14,280 $ 16,445
Charged to Costs and Expenses 3,457 6,479 (297)
Charged to Other (199) 160 (93)
Deductions 11,137 2,051 1,775
Balance at End of Year 10,989 18,868 14,280
LIFO Reserve      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 39,528 51,342 22,900
Charged to Costs and Expenses (6,263) (11,814) 28,442
Charged to Other 0 0 0
Deductions 0 0 0
Balance at End of Year 33,265 39,528 51,342
Valuation Allowance on Deferred Tax Assets      
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]      
Balance at Beginning of Year 66,266 79,427 90,879
Charged to Costs and Expenses 7,921 4,432 (10,636)
Charged to Other 2,681 (17,593) (892)
Deductions 0 0 (76)
Balance at End of Year $ 76,868 $ 66,266 $ 79,427